levonorgestrel has been researched along with Pregnancy in 885 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 102 (11.53) | 18.7374 |
| 1990's | 170 (19.21) | 18.2507 |
| 2000's | 183 (20.68) | 29.6817 |
| 2010's | 295 (33.33) | 24.3611 |
| 2020's | 135 (15.25) | 2.80 |
| Authors | Studies |
|---|---|
| He, C; He, X; Huirne, JAF; Mol, BW; Yan, L; Zhang, J; Zhu, C | 1 |
| He, C; He, X; Huirne, JAF; Liang, Y; Mol, BW; Sun, T; Xie, L; Yan, L; Zhang, J; Zhao, X; Zhu, C | 1 |
| Bahamondes, L; Castro, S; Furlani, RM; Garcia, E; Machado, HC; Monteiro, I | 1 |
| Aqua, K; Bauerfeind, A; Böhnke, T; Donders, G; Frenz, AK; Hauck, B; Kallner, HK; Llata, ES; Römer, T; Salomon, J; Stovall, DW; Sørdal, T; Zvolanek, M | 1 |
| Brant, AR; Emery, J; Kollikonda, S; Mei, L; Yao, M | 1 |
| Campo, G; Candiani, M; Giardina, P; Pagliardini, L; Papaleo, E; Patruno, C; Rebecchi, A; Vanni, VS | 1 |
| Bauerfeind, A; Becker, K; DiBello, J; Franke, C; Heinemann, K; Koro, C; Reed, S | 1 |
| Brand, RM; Cottrell, ML; Gatto, GJ; Johnson, LM; Krovi, SA; Li, L; Norton, C; van der Straten, A | 1 |
| Chen, YY; Cheng, LY; Chu, LC; Lan, KC; Ou, YC; Tsai, CC | 1 |
| Abern, L; Cook, J; De Guzman, G; Diego, D; Kiely, K; Krempasky, C; Maguire, K | 1 |
| Huguelet, PS; Laurin, JL; Moyer, G; Thornhill, D | 1 |
| Kaye, DK; Mbalinda, SN; Ssebatta, G | 1 |
| Bahamondes, L; Charles, CM; Juliato, CT; Laporte, M; Metelus, S; Paez, GO; Peloggia, A | 1 |
| Bahamondes, L; de Carvalho, LS; Laporte, M; Marcelino, AC; Peloggia, A | 1 |
| Batista Castello Girão, MJ; de Moraes Andrade, TR; Farah, D; Fonseca, MCM; Sansone, D | 1 |
| Cuenot, F; Desplas, D; Dray-Spira, R; Drouin, J; Duranteau, L; Roland, N; Weill, A; Zureik, M | 1 |
| George, M; Kalantaridou, S; Papadimitriou, S; Paschopoulos, M; Tsonis, O; Zisi, M; Zygouris, D | 1 |
| Marquez, CM; Sadowski, EA; Schrager, S; Yogendran, L | 1 |
| Du, ZQ; Liang, YQ; Yao, Z; Zhang, X; Zhao, SF; Zhao, XL | 1 |
| Endler, M; Gemzell Danielsson, K; Li, R | 1 |
| Arencibia Sánchez, O; Bataller, Á; Cabrera, S; Corbalán, S; Coronado, P; Domingo, J; Domingo, S; Espinosa, E; Fiol, G; Gil-Ibañez, B; Gil-Moreno, A; Iacoponi, S; Lago, V; Laseca Modrego, M; Marina, T; Martín Salamanca, B; Minig, L; Munmanny, M; Padilla-Iserte, P; Rodriguez, JR; Sala Ferichola, M; Utrilla-Layna, J | 1 |
| Chen, H; Hu, S; Jiang, H; Li, M; Song, H; Xiong, X; Xu, J | 1 |
| Brynhildsen, J; Kopp Kallner, H; Lichtenstein Liljeblad, K | 1 |
| Dove, MS; Gariepy, AM; Hathaway, M; Lewis, CA; McDonald-Mosley, R; Murphy, E; Nunez-Eddy, C; Schwarz, EB; Sonalkar, S; Tancredi, DJ; Zuckerman, D | 1 |
| Nugent, R; Watkins, L; Wojcik, N | 1 |
| Buca, D; D'Antonio, F; De Rocco, S; Dessole, M; Fanfani, F; Leombroni, M; Liberati, M; Lucidi, A; Nappi, L; Oronzii, L; Petrillo, M; Scambia, G | 1 |
| Feng, W; Shen, Y; Yang, J; Yi, J | 1 |
| Chen, BA; Creinin, MD; Cwiak, C; Olariu, AI; Schreiber, CA; Turok, DK | 1 |
| Cesta, CE; Graner, S; Kieler, H; Kopp-Kallner, H; Linder, M; Segovia Chacón, S | 1 |
| Bertoia, ML; Dhanda, S; Evans, A; Kaplan, S; Lass, A; Roy, D; Seeger, JD; Wang, FT | 1 |
| Shao, L; Teng, Y; Yang, Z | 1 |
| Frances Fei, Y; O'Brien, K; Rosen, MW; Russell, C | 1 |
| Elgemark, K; Envall, N; Graner, S; Kopp Kallner, H; McTaggart, J; Ramirez Löfström, J; Sörensen, D | 1 |
| Chaurasia, H; Joshi, B; Moray, KV; Sachin, O | 1 |
| Ashcraft, AM; Farjo, S; Murray, PJ; Ponte, CD | 1 |
| Callegari, LS; Fudin, H; Gawron, LM; He, T; Lewis, L; Stevens, V; Turok, DK | 1 |
| Lee, SC; Norman, WV | 1 |
| Amorim, G; Bernard, C; Bukusi, EA; Cohen, CR; Jakait, B; Mocello, AR; Musick, B; Patel, RC; Shepherd, BE; Stalter, RM; Wools-Kaloustian, K; Yiannoutsos, CT | 1 |
| Jensen, JT; Kroll, R; Lukkari-Lax, E; Schulze, A; Serrani, M; Wahdan, Y | 1 |
| Klein, DA; Landis, CA; Paradise, SL | 1 |
| Calaf Alsina, J; López González, G; Perelló Capó, J; Rius-Tarruella, J | 1 |
| Baker, CC; Creinin, MD | 1 |
| Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
| Catania, F; Centini, G; Exacoustos, C; Giorgi, M; Labanca, L; Lazzeri, L; Martire, FG; Zupi, E | 1 |
| Anab, E; Liambila, W; McCann, B; Mwanga, D; Odwe, G; Ramarao, S; Vandermark, J; Wanami, M | 1 |
| Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
| Alabaster, A; Anthony, MS; Armstrong, MA; Asiimwe, A; Chillemi, G; Chiu, VY; Fassett, MJ; Gatz, J; Getahun, D; Hunter, S; Ichikawa, L; Im, TM; Merchant, M; Peipert, JF; Pisa, F; Postlethwaite, D; Raine-Bennett, T; Reed, SD; Ritchey, ME; Rothman, KJ; Saltus, CW; Schoendorf, J; Shi, JM; Takhar, HS; Wahdan, Y; Wang, J; Xie, F; Zhou, X | 1 |
| Cao, D; Chen, J; Cheng, N; Peng, P; Shen, K; Wang, J; Yang, J; Yu, M; Zhang, Y; Zhou, H | 1 |
| Gawron, LM; Gero, A; Kaiser, JE; Sanders, JN; Simmons, RG; Turok, DK | 1 |
| Deng, C; Gu, Y; Jin, Y; Li, Y; Pan, L; Wang, H; Wang, W; Yin, J | 1 |
| Anjos, F; Bahamondes, L; Garcia, E; Laporte, M; Manhiça, SI; Paiva, LC; Viscola, M | 1 |
| Cohen, J; Reed, S; Shull, D | 1 |
| Bartz, D; Cleland, K; Salcedo, J; Thompson, I | 1 |
| Fouad, R; Zayed, M | 1 |
| Dong, Z; Guo, W; Ma, C; Pan, N; Wei, H; Xiong, G; Zhang, W | 1 |
| Beshear, D; Lebduska, E; Spataro, BM | 1 |
| Byakika-Kibwika, P; Chappell, CA; Cirrincione, LR; Cohn, SE; Fletcher, CV; Kyohairwe, I; Lamorde, M; Mackline, H; Nakalema, S; Owen, A; Pham, MM; Scarsi, KK; Siccardi, M; Winchester, L | 1 |
| Nogueira-Silva, C; Pereira da Silva, D; Plancha, M; Ramilo, I; Rolhas, A | 1 |
| Huguelet, PS; Moyer, G; Wilde, M | 1 |
| Anjos, FCQS; Bahamondes, L; Barbosa, PF; Espejo-Arce, X; Juliato, CT; Marcelino, AC; Pereira, PDC | 1 |
| He, C; He, X; Huirne, JAF; Ji, S; Liang, Y; Mol, BW; Tian, Y; Wang, Y; Xia, W; Xie, L; Yan, L; Zhang, J; Zhu, C; Zhu, Q | 1 |
| Atangana Mvodo, D; Fouedjio, J; Nkwabong, E | 1 |
| Lidegaard, Ø; Meaidi, A; Mørch, LS; Torp-Pedersen, C | 1 |
| Agarwal, R; González, JL; Hong, KM; Klar, M; Mandelbaum, RS; Matsuo, K; Obermair, A; Paulson, RJ; Roman, LD; Violette, CJ; Wright, JD | 1 |
| Bahamondes, L; Carmona, EV; Lopes-Garcia, EA; Monteiro, I | 1 |
| Arencibia Sánchez, O; Emergi Zhrigen, Y; Gil González, Y; Laseca Modrego, M; Martín Martínez, AI; Nieto Naya, MÁ; Ocón Padrón, L; Pérez Matos, C; Pérez Morales, ME; Sánchez Sánchez, V; Santana Suárez, MA | 1 |
| Chen, L; de Meritens, AB; Hershman, DL; Hou, JY; Khoury-Collado, F; Matsuo, K; Melamed, A; St Clair, CM; Suzuki, Y; Wright, JD | 1 |
| Barnhart, KT; Creinin, MD; Eisenberg, D; Gawron, LM; Jensen, JT; Mabey, RG | 1 |
| Caffe, S; Chandra-Mouli, V; de León, RGP; Espinola, N; Karolinski, A; Maceira, D; Oizerovich, S; Perrotta, G; Suarez, N | 1 |
| Boniface, E; Edelman, A; Han, L; Jensen, JT; Messerle-Forbes, M; O'Donnell, A; Schrote, K | 1 |
| Chen, X; Guan, J; Liao, J; Luo, X; Ma, F; Ning, C; Shan, W; Shao, W; Wu, P; Xu, Z; Yang, B; Zhang, H; Zhou, S; Zhu, Q | 1 |
| Hu, M; Ji, L; Jin, L; Shao, MJ; Xu, J | 1 |
| Actis, S; Biglia, N; Bounous, VE; Giorgi, M; Nappi, RE; Rosso, R; Tiranini, L | 1 |
| Ankomah, A; Boateng, A; Bruce, H; Essandoh, P; Kuffour, E; Liang, T; McCann, B; Ramarao, S; Vandermark Moore, J | 1 |
| Jugl, S; Winterstein, AG | 1 |
| Meaidi, A; Mørch, LS; Torp-Pedersen, C | 1 |
| Fong, CHY; Gemzell-Danielsson, K; Ho, PC; Li, RHW; Lo, SST; Ng, EHY | 1 |
| Ma, C; Pan, N; Wang, Y; Wei, H | 1 |
| Alisoltani, A; Ayele, H; Balle, C; Bosinger, SE; Brown, B; Burgener, AD; Gasper, MA; Gupta, PM; Heffron, R; Jaspan, HB; Nair, G; Nelson, SA; Noel-Romas, L; Onono, M; Palanee-Phillips, T; Passmore, JS; Tharp, GK | 1 |
| Barrera, D; Chirinos, M; García-Uribe, PÁ; Hernández-Pando, R; Hernández-Silva, G; Larrea, F; Vega, CC | 1 |
| Huang, J; Jiang, S; Li, C; Liu, X; Tang, K; Tian, Z; Zhang, W | 1 |
| Adamowicz, D; Cieslik, A; Jargielo, A; Kosieradzka, K; Lopuszynska, I; Meliksetian, A; Pazik, D; Rudzinski, P; Stanczyk, J; Wosinska, A | 1 |
| Blumenthal, PD; Stanton, TA | 1 |
| Keter, A; Orang'o, O; Shurie, S; Were, E | 1 |
| Abdelhakim, AM; Amin, AH; Nabil, H; Raslan, AN; Samy, A; Sunoqrot, M | 1 |
| Bryce, C; Sisk, K | 1 |
| Baraitser, P; Battison, C; Cameron, S; Cameron, ST; Cowle, K; Forrest, M; Gilson, R; Glasier, A; Goulao, B; Johnstone, A; McDaid, L; McDonald, A; Morelli, A; Norrie, J; Patterson, S; Radley, A; Sally, D; Stephenson, JM; Stewart, N; Trussell, J | 1 |
| Aghajanova, L; Dinehart, E; Lathi, RB | 1 |
| Creinin, MD; Gangestad, A; Keder, LM; Olariu, AI; Teal, SB; Westhoff, CL | 1 |
| De Martino, M; Govind, A | 1 |
| Gawron, LM; Gero, A; Kushner, KL; Sanders, JN; Turok, DK | 1 |
| Dietrich, JE; Hernandez, AMC | 1 |
| Bahamondes, L; Juliato, CT; Laporte, M; Marangoni, M; Miadaira, M; Surita, F | 1 |
| Castaño, PM; Westhoff, CL | 1 |
| Bahamondes, L; Faúndes, A; Miranda, L; Townsend, J | 1 |
| Bahamondes, L; Bahamondes, MV; Fernandes, A; Monteiro, I | 1 |
| Ärlemalm, A; Böttiger, Y; Brynhildsen, J; Carlsson, B; Fagerberg-Silwer, J; Ginstman, C; Kopp Kallner, H | 1 |
| Leelakanok, N; Methaneethorn, J | 1 |
| Diggs, AI; Gonzalez, J; Lunde, B; Overbey, J; Pan, S; Rana, R; Stimmel, S; Thomas, AG | 1 |
| Adam, MP; Amies Oelschlager, AM; Austin, JC; Fechner, PY; Hougen, HY; Ramsell, L; Seideman, CA; Shnorhavorian, M; Squire, A | 1 |
| Hong, JH; Kang, SB; Kim, MK; Park, DC; Roh, JW; Seong, SJ | 1 |
| Abdelhakim, AM; Hamza, M; Latif, D; Metwally, AA; Osman, OM; Samy, A | 1 |
| Llombart, B; Requena, C | 1 |
| Koskas, M; Maumy, L; Peigné, M | 1 |
| Anoka, NA; Lawrence, OA; Olufunmilayo, OM; Olufunto, BO | 1 |
| Carugno, J | 1 |
| Alexander, M; Breech, LL; Schwartz, BI | 1 |
| Bahamondes, L; de Nadai, MN; Ferreira, LS; Franceschini, SA; Juliato, CRT; Monteiro, IMU; Poli-Neto, OB; Vieira, CS | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Elliesen, J; Höchel, J; Kohnke, A; Mellinger, U; Nave, R; Schmitz, H | 1 |
| Bahamondes, L; Becerra, A; Castro, L; Espejo-Arce, X; Laporte, M; Veiga, N | 1 |
| Christianson, MS; Cordeiro Mitchell, CN; Garbose, RA; Gornet, ME; Hunkler, KF; Maher, JY; Whiting-Collins, LJ | 1 |
| Carr, BR; Creinin, MD; Eisenberg, DL; Gangestad, A; Olariu, A; Thomas, MA | 1 |
| Archer, J; Madden, T; Montoya, MN; Peipert, JF; Schultheis, P; Zhao, Q | 1 |
| He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
| Amos, N; Calabretto, H; Grzeskowiak, LE; Ilomaki, J; Mazza, D | 1 |
| Béliard, A; Chabbert-Buffet, N; Pintiaux, A | 1 |
| Brown, J; Cicali, B; Schmidt, S; Sunaga, T | 1 |
| Dorton, B; Heslin, K; Kram, JJF; Ostroot, MK; Tjoe, JA | 1 |
| Andreeva, YY; Krasnopolskaya, KV; Nosov, VB; Novikova, EG; Novikova, OV; Panov, VA; Shevchuk, AS | 1 |
| Gawron, LM; Gero, A; Kaiser, JE; Sanders, JN; Sexsmith, CD; Simmons, RG; Stoddard, GJ; Turok, DK | 1 |
| Caetano, C; Faustmann, T; Gemzell-Danielsson, K; Heikinheimo, O; Kubba, A; Lukkari-Lax, E | 1 |
| Beelen, P; Bongers, MY; Duijnhoven, RG; Geomini, PM; Herman, MC; van den Brink, MJ | 1 |
| Creinin, MD; Eisenberg, DL; Gilliam, ML; Jensen, JT; Olariu, A; Thomas, MA | 1 |
| Gichere, I; Makena, D; Warfa, K | 1 |
| Nguyen, NY | 1 |
| Boraas, CM; Sanders, JN; Schwarz, EB; Thompson, I; Turok, DK | 1 |
| Arends-Kuenning, M; Pullabhotla, HK; Shukla, P | 1 |
| Ali, M; Bahamondes, L; Laporte, M; Metelus, S | 1 |
| Crespi, S; Fabron, C; Farge, G; Lévy-Bachelot, L; Linet, T; Robert, J; Yang, JZ | 1 |
| Choi, YJ; Salcedo, J; Tschann, M; Vega, A | 1 |
| Ibisomi, L; Ohazurike, E; Olamijulo, JA; Olorunfemi, G; Oluwole, AA | 1 |
| Almeida, NM; Baêta, T; Barbosa, LR; Chaves, IA; Dolabella, GB; L Silva-Filho, A; Oliveira, EC; Oliveira, FR; Rocha, ALL | 1 |
| Benítez-Robredo, MT; Frutos-Balibrea, I; Haro-León, A; Pedrero-Pérez, EJ; Sánchez-Núñez, MI | 1 |
| BakenRa, AA; Clement, AC; Fay, KE; Gero, A; Kaiser, JE; Sanders, JN; Turok, DK | 1 |
| Pynnä, K; Räsänen, P; Roine, RP; Sintonen, H; Vuorela, P | 1 |
| Alharbi, S; Hussein, S; Khalil, A | 1 |
| McQuillan, SK; Rosenthal, MA | 1 |
| Andrade, TRM; Di Bella, ZIKJ; Farah, D; Fonseca, MCM; Girão, MJBC | 1 |
| Hacker, MR; Harvey, LFB; Hofler, LG; Modest, AM; Phillips, SJ; Wu, LH | 1 |
| Eggebroten, JL; Sanders, JN; Turok, DK | 1 |
| Bae, HS; Hwang, JY; Jung, YW; Kim, DH; Kim, MK; Kim, ML; Seong, SJ; Shin, E; Yun, BS | 1 |
| Brady, PC; Ginsburg, ES; Soiffer, RJ | 1 |
| Black, K; Bolnga, J; Gupta, S; Jenkins, G; Mola, G; Ramsay, P; Stein, W | 1 |
| Beasley, LM; Howard, DL | 1 |
| Gawron, LM; Royer, PA; Sanders, JN; Storck, KE; Thompson, IS; Turok, DK | 1 |
| Bateson, D; McNamee, K | 1 |
| Averbach, S; Byamugisha, J; Dehlendorf, C; Kakaire, O; Kayiga, H; Lester, F; Sokoloff, A; Steinauer, J | 1 |
| Heikinheimo, O; Korjamo, R; Mentula, M | 3 |
| Choi, YM; Kim, H; Kim, SH; Kim, SW; Ku, SY; Suh, CS | 1 |
| Nelson, AL | 2 |
| Lee, JK; Schwarz, EB | 1 |
| Che, Y; Chen, K; Cheng, L; Shen, J; Showell, E | 2 |
| Goldstein, SR; Lumsden, MA | 1 |
| Chen, H; Chu, Z; Ge, X; Huang, X; Huang, Y; Liu, Z; Lou, W; Lu, Q; Ruan, Q; Wang, X; Wang, Y; Xie, W; Yao, P; Zhang, Z; Zheng, D; Zhou, Y; Zou, Y | 1 |
| Goldthwaite, LM; Hyer, J; Sheeder, J; Teal, SB; Tocce, K | 1 |
| Bullock, H; Eggebroten, JL; Espey, E; Gawron, LM; Leeman, L; Sanders, JN; Singh, R; Thaxton, L; Turok, DK; Yonke, N | 1 |
| Apter, D; Gemzell-Danielsson, K; Lukkari-Lax, E; Roth, K; Serrani, M | 1 |
| Pandey, S | 1 |
| Creinin, MD; Cwiak, C; Darney, PD; Olariu, A; Stuart, GS; Thomas, MA | 1 |
| Ali, M; Bahamondes, L; Bahamondes, MV; Fernandes, A; Juliato, CT; Monteiro, I | 1 |
| Alegre-Del Rey, EJ; Díaz-Navarro, J; Fénix-Caballero, S | 1 |
| Abbas, AM; Hassen, SG; Mahmoud, HR; Shaaban, OM; Yones, EM; Zakherah, MS | 1 |
| Carayon-Lefebvre d'Hellencourt, F; Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M | 1 |
| Chen, J; Chen, X; Li, J; Li, Q; Luo, J; Lv, W; Shi, B; Wang, H; Wang, X | 1 |
| Caruso, S; Cianci, A; Cianci, S; Cutello, S; Fava, V; Vitale, SG | 1 |
| Jude, DC; Sinning, KM; Yoost, JL | 1 |
| Kaneshiro, B; McGuire, K; Salcedo, J; Soon, R | 1 |
| Blumenthal, PD; Creinin, MD; Keder, LM; Olariu, AI; Schreiber, CA; Teal, SB | 1 |
| Bogers, H; Duvekot, JJ; Hitzerd, E; Kianmanesh Rad, NA | 1 |
| Mouemba, DM; Moutchia-Suh, J; Ngwasiri, CA | 1 |
| Adeleye, AJ; Aghajanova, L; Cedars, MI; Kao, CN; Sauer, MV | 1 |
| Freye, R | 1 |
| Goldstuck, ND; Le, HP | 1 |
| Blumenthal, PD; Cahill, EP; Goldthwaite, LM; Voedisch, AJ | 1 |
| Adachi, S; Enomoto, T; Ishiguro, T; Kitani, Y; Kobayashi, A; Nishikawa, N; Sekine, M; Tamura, R; Ueda, H | 1 |
| Avila, K; Bryant, AG; Findley, MK; Levi, EE | 1 |
| Gemzell-Danielsson, K; Heikinheimo, O; Hognert, H; Lidegaard, Ø; Lindh, I; Milsom, I; Skjeldestad, FE | 1 |
| Bateson, D; Butcher, BE; Foran, T; Kovacs, G; O'Connor, V | 1 |
| Agostini, A; Cardinale, C; Hamdaoui, N | 1 |
| Cartault, A; Pienkowski, C | 1 |
| Endrikat, J; Filonenko, A; Gerlinger, C; Lynen, R; Vaitsiakhovich, T | 1 |
| Amat, L; Bulach, A; Leclercq, M; Mesrine, S; Scheffler, F; Scheffler, M; Sperandeo, D | 1 |
| Bayly, C; Bentley, RJ; Bingham, AL; Garrett, CC; Hocking, JS; Kavanagh, AM; Keogh, LA | 1 |
| Chen, BA; Creinin, MD; Kimble, T; Olariu, AI; Teal, SB; Turok, DK | 1 |
| Assouni Mindjah, YA; Dohbit, JS; Essiben, F; Foumane, P; Mboudou, ET | 1 |
| Kardos, L; Luczai, E; Magyar, G; Schváb, E | 1 |
| Alonso, MJ; Doval, JL; Lete, I; Pérez-Campos, E; Sánchez-Borrego, R; Sellers, G | 1 |
| He, XQ; Huang, HF; Huang, Z; Li, C; Liang, GL; Qi, H; Tang, X; Wang, XF; Wu, YT; Zhang, D; Zhang, HY; Zhang, J; Zhu, Q | 1 |
| Alterman, A; Hsu, R; Tavrow, P; Uysal, J | 1 |
| Graner, S; Kopp Kallner, H; Mc Taggart, J; Melander, E; Nordström, F; Widenberg, J | 1 |
| Chen, PH; Choudhury, T; Frondelli, M; Goldman, AR; Shimoni, N | 1 |
| Bueno Sanchez, JC; Gil, VC; Grant, H; Narváez, JF; Ocampo Duque, LF; Porras, J; Quintana-Castillo, JC; Sossa, RR | 1 |
| Bosco-Lévy, P; Gouverneur, A; Langlade, C; Miremont, G; Pariente, A | 1 |
| Gao, Y; Jiang, J; Li, D; Shan, S; Shi, B; Zhao, X | 1 |
| Black, KI; Bolnga, J; Gupta, S; Kelly-Hanku, A; McGeechan, K; Mola, G; Ramsay, P | 1 |
| Badmus, OO; Olatunji, LA | 1 |
| Bogani, G; Chiappa, V; Ditto, A; Dondi, G; Evangelista, MT; Ferrero, S; Leone Roberti Maggiore, U; Liberale, V; Martinelli, F; Raspagliesi, F | 1 |
| Fortin, J; Goldberg, AB; Janiak, E; Maurer, R; Roe, AH | 1 |
| Bullard, KA; Edelman, AB; Rodriguez, MI; Williams, SM | 1 |
| Ades, V; Hinz, EK; Murthy, A; Ryan, N; Wang, B | 1 |
| Kuang, Y; Liang, Z; Ma, M; Wang, Y; Yin, M | 1 |
| Gordon, C; Harken, T | 1 |
| Bistervels, IM; Hamulyák, EN; Middeldorp, S; Scheres, LJJ | 1 |
| Sakurai, S | 1 |
| Cameron, ST; Michie, L | 1 |
| Blockeel, C; De Munck, N; De Vos, M; Drakopoulos, P; Galvão, A; Karakus, G; Racca, A; Santos-Ribeiro, S; Tournaye, H; Verheyen, G | 1 |
| Cheng, L; Gemzell-Danielsson, K; Rabe, T | 1 |
| Gardner, DK; Gawronski, KM; Karaoui, LR; Koepf, ER; Lehman, KJ; McBane, S; McIntosh, J; Patel-Shori, NM; Rafie, S | 1 |
| Kahlenborn, C; Severs, WB | 1 |
| Chen, PL; Hubacher, D; Kiarie, J; Liku, J; Muiruri, P; Omwenga, J; Rakwar, J | 1 |
| Latta, R; Peleg, D | 1 |
| Czajkowski, K; Gardyszewska, A | 1 |
| Atti, A; Bahamondes, L; Bahamondes, MV; Hidalgo, MM; Monteiro, I; Santos, AR | 1 |
| Snel, M; Van Vliet, HA; Visser, J | 1 |
| Batur, P | 2 |
| Kolding, L; Majeed, HG | 1 |
| Hepp, H; Hillemanns, P | 1 |
| Black, KI; Mwalwanda, CS | 1 |
| Huang, C; Meng, C; Shi, W; Sun, L; Zhang, J; Zhang, M | 1 |
| Berger, C; Gemzell-Danielsson, K; Lalitkumar, PG | 1 |
| Ferriani, RA; Martins, WP; Nastri, CO; Raine-Fenning, N | 1 |
| Lech, MM; Ostrowska, L; Swiątek, E | 1 |
| Baldwin, MK; Jensen, JT | 1 |
| Coelingh Bennink, HJ; Ebes, F; Fauser, BC; Wouters, W; Zimmerman, Y | 1 |
| Kostev, K; Rashed, AN; Ziller, M; Ziller, V | 1 |
| Ameye, L; Hindryckx, A; Timmerman, D; Van den Bosch, T; Van Schoubroeck, D; Veldman, J; Werbrouck, E | 1 |
| Jais, X; Olsson, KM | 1 |
| Matthews, CM; Prescott, GM | 1 |
| Cade, TJ; Neesham, D; Quinn, MA; Rome, RM | 2 |
| Peck, SA | 1 |
| Caputo, TA; Gupta, D; Holcomb, KM; Kligman, I; Kudesia, R; Rosenwaks, Z; Singer, T | 1 |
| Apter, D; Gemzell-Danielsson, K; Hauck, B; Nelson, A; Rosen, K; Rybowski, S; Schmelter, T | 2 |
| Eggertson, L | 1 |
| Dermish, AI; Gurtcheff, S; Jacobson, JC; McFadden, M; Murphy, PA; Simonsen, SE; Turok, DK | 1 |
| Bahamondes, LG; Fine, PM; Ginde, SY; Halpern, V; Lendvay, A; Raymond, EG; Taylor, DJ; Wheeless, A | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL | 1 |
| Azmat, SK; Chen, M; Feldblum, PJ; Hameed, W; Kuria, S; Lendvay, A; Otieno-Masaba, R; Shaikh, BT; Steiner, MJ; Wheeless, A | 1 |
| Brant, R; Brooks, M; Kaczorowski, J; Majdzadeh, A; Norman, WV; Soon, JA | 1 |
| Endres, LK; Gilliam, ML; Mistretta, SQ; Whitaker, AK | 1 |
| Aoun, J; Dines, VA; Gomez-Lobo, V; Mete, M; Nelson, CB; Stovall, DW | 1 |
| Bahamondes, L | 1 |
| Howard, B; Hsieh, J; Kaunitz, AM; Portman, DJ; Ricciotti, N; Weiss, H | 1 |
| Andreasen, AK; Clark, JT; Clark, MR; Fabian, J; Friend, DR; Johnson, TJ; Kiser, PF; Nebeker, JS; Shelke, NB; Smith, EM | 1 |
| Craik, J; Melvin, L; Simpson, J | 1 |
| Al-Amin, MM; Rahman, MM; Reza, HM; Shohel, M; Uddin, MM; Zaman, A | 1 |
| LaGuardia, KD | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Westhoff, CL | 1 |
| Eissa, AA; Rantell, K; Stott, D; Tuck, SM | 1 |
| Baird, AS; Trussell, J; Webb, A | 1 |
| Cheng, L; Shen, L; Yang, Z; Ye, W; Yu, W; Zhang, L | 1 |
| Craik, J; Melvin, L; Scott, J | 1 |
| Andreeva, IuIu; Danilova, NV; Lozovaia, IuA; Novikova, EG; Novikova, OV; Podtetenev, DV; Pronin, SM; Rubtsova, NA; Vostrov, AN | 1 |
| Bahamondes, L; Bahamondes, MV; Bottura, BF; Correia, VM; Espejo-Arce, X; Fernandes, A; Gonçalves, MP; Monteiro, I; Sousa, MH | 1 |
| Effa, EE; Oduwole, O; Okusanya, BO | 1 |
| Hammond, C; Kiley, JW; Liu, D; Niznik, C; Rademaker, A; Shulman, LP | 1 |
| Eisenberg, DL; Madden, T; McNicholas, C; Peipert, JF; Secura, GM; Zhao, Q | 1 |
| Guthrie, K; Trussell, J | 1 |
| Dermish, AI; Jacobson, JC; Sanders, JN; Torres, LN; Turok, DK; Ward, K | 1 |
| Hendriks, E; Prine, L | 1 |
| Jatlaoui, T; Lathrop, E | 1 |
| Armstrong, AY; Heitmann, RJ; Hill, MJ; Mumford, SL | 1 |
| Buckel, CM; Madden, T; McNicholas, C; Mullersman, J; Peipert, JF; Secura, GM; Zhao, Q | 1 |
| Bimla Schwarz, E; Corbelli, J | 1 |
| Abitbol, JL; Gainer, E; Guillard, H; Kapp, N; Mathé, H; Scherrer, B; Ulmann, A | 1 |
| Bian, J; Fang, L; Li, H; Liu, H; Shao, H; Tao, M; Wang, L; Xing, C | 1 |
| Friedman, JO | 1 |
| Heinemann, K; Minh, TD; Moehner, S; Reed, S | 1 |
| Cao, SJ; Cheng, L; Huang, HF; Li, C; Ping, H; Qin, GJ; Xi, X; Zhang, J; Zhao, WH | 1 |
| Jamin, C | 1 |
| An, XP; Cao, BY; Gao, TY; Hou, JX; Lei, YN | 1 |
| Brynhildsen, J; Frisk, J; Ginstman, C; Ottosson, J | 1 |
| Goler, N; Lee, JW; Merchant, M; Raine-Bennett, T; Sinclair, F | 1 |
| Garrett, SM; Rose, SB; Stanley, J | 1 |
| Birgisson, NE; Madden, T; Peipert, JF; Secura, GM; Zhao, Q | 1 |
| Cheng, L; Li, C; Meng, CX; Sun, LL; Zhang, J; Zhang, M; Zhao, WH | 1 |
| Garrett, SM; Rose, SB | 1 |
| Creinin, MD; Eisenberg, DL; Schreiber, CA; Teal, SB; Turok, DK; Westhoff, CL | 1 |
| Elsedeek, MS | 1 |
| Cristobal, I; Lete, I; Neyro, JL | 1 |
| Filonenko, A; Hawes, C; Henry, N; Kallner, HK; Lekander, I; Lowin, J | 1 |
| Darney, PD; Goodman, S; Harper, CC; Morfesis, J; Rocca, CH; Speidel, JJ; Thompson, KM; Westhoff, CL | 1 |
| Aravantinou, M; Blanchard, J; Derby, N; Fernández-Romero, JA; Gettie, A; Grasperge, B; Kenney, J; Kizima, L; Kumar, N; Levendosky, K; Mizenina, O; Robbiani, M; Roberts, K; Rodriguez, A; Seidor, S; Ugaonkar, SR; Wesenberg, A; Wilk, J; Zhang, S; Zydowsky, TM | 1 |
| Diedrich, JT; Drey, EA; Harper, CC; Sokoloff, A; Steinauer, JE; Upadhyay, UD | 1 |
| Giljanovic, S; Howard, B; Lobo Abascal, P; Luzar-Stiffler, V; Trussell, J; Weiss, H | 1 |
| Bilgehan, F; Deveci, CD; Dilbaz, B; Karadag, B | 1 |
| Agostini, A; Asselin, I; Ben M'barek, I; Bettahar, K; Carbonne, B; David, P; Faucher, P; Fernandez, H; Fournet, P; Goffinet, F; Guilbaud, L; Hassoun, D; Jamin, C; Lachowsky, M; Letombe, B; Levy, G; Trignol-Viguier, N; Vayssiere, C; Vigoureux, S | 1 |
| Garrett, CC; Hocking, JS; Kavanagh, A; Keogh, LA; Tomnay, J | 1 |
| Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
| Gemzell-Danielsson, K; Kardos, L; von Hertzen, H | 1 |
| Jun, HS; Kim, MK; Kim, ML; Park, DS; Seong, SJ; Song, T; Yun, BS | 1 |
| Ali, M; Bahamondes, L; Brache, V; Habib, N; Landoulsi, S; Meirik, O | 1 |
| Schmid, R | 1 |
| Reiter, L; Westergren, T | 1 |
| Byamugisha, JK; Gemzell-Danielsson, K; Kakaire, O; Tumwesigye, NM | 1 |
| Arango, N; Cohen, R; Sheeder, J; Teal, SB; Tocce, K | 1 |
| Goldthwaite, LM; Shaw, KA | 1 |
| Curtis, KM; Jatlaoui, TC; Riley, H | 1 |
| Lotke, PS | 1 |
| Bullock, H; Salcedo, J | 1 |
| Back, DJ; Buzibye, A; Byakika-Kibwika, P; Cohn, SE; Darin, KM; Dilly Penchala, S; Else, LJ; Lamorde, M; Merry, C; Nakalema, S; Scarsi, KK | 1 |
| Najera, DB | 1 |
| Ma, J; Sun, J; Xia, W; Xue, RH; Yan, MX; Zhang, D; Zhang, J | 1 |
| Layman, K; Steele, BJ | 1 |
| Bahamondes, L; Bahamondes, MV; Bartfai, G; Bito, T; Festin, MP; Gosavi, A; Habib, N; Kapp, N; Nguyen, TM; Singh, K; Thamkhantho, M | 1 |
| Apter, D; Buhling, KJ; Dermout, SM; Gemzell-Danielsson, K; Lukkari-Lax, E; Montegriffo, E | 1 |
| Boccard, S; Farley, T; Landoulsi, S; Meirik, O; Peregoudov, A; Piaggio, G; Rowe, P | 1 |
| Eggebroten, J; Gawron, LM; Royer, PA; Sanders, JN; Thompson, IS; Turok, DK | 1 |
| Leung, VW; Levine, M; Lynd, LD; Marra, CA; Soon, JA | 1 |
| Apter, D; Briggs, P; Gemzell-Danielsson, K; Grunert, J; Lukkari-Lax, E; Rybowski, S; Tuppurainen, M | 1 |
| Royer, PA; Saltzman, HM; Sanders, JN; Turok, DK | 1 |
| Batur, P; Casey, PM; Kransdorf, LN | 1 |
| Cwiak, C; Howard, B; Hsieh, J; Ricciotti, N; Sucato, GS | 1 |
| Cetinkaya, N; Erkaya, S; Gungor, T; Yalcin, H; Zergeroglu, S | 1 |
| Howell, L; Saltzman, HM; Sanders, JN; Schwarz, EB; Thompson, IS; Turok, DK | 1 |
| Berry-Bibee, EN; Curtis, KM; Nanda, K; Pagano, HP; Zapata, LB | 1 |
| Madden, T; McNicholas, C; Mejia, M; Peipert, JF | 1 |
| Bóta, J; Csányi, A; Ducza, E; Falkay, G; Gáspár, R | 1 |
| Monastersky, R | 1 |
| Lohr, PA; Lyus, R; Prager, S | 1 |
| Cascella, M; Falcone, F; Gallo, MS; Granata, V; Greggi, S; Laurelli, G; Losito, S; Scala, F | 1 |
| Di Napoli, M; Falcone, F; Granata, V; Greggi, S; Laurelli, G; Losito, S | 1 |
| Blumenthal, PD; Fok, WK | 1 |
| Barnett, C; Dinger, J; Do Minh, T; Hagemann, C; Heinemann, K | 1 |
| Curtis, KM; Jatlaoui, TC; Riley, HEM | 1 |
| Heikinheimo, O; Mentula, M; Pohjoranta, E; Suhonen, S | 1 |
| Kiechle, M; Neuenfeldt, M | 1 |
| Fan, G; Kang, S; Lukkari-Lax, E; Ren, M; Roth, K; Shin, S; Weisberg, E | 1 |
| Michala, L; Patseadou, M | 1 |
| Huguelet, PS; Scott, S; Sheehan, C; Spitzer, RF | 1 |
| Goldstuck, ND; Jackers, G; Wildemeersch, D | 1 |
| McNicholas, C; Peipert, JF; Swor, E; Wan, L | 1 |
| Downing, D; Sanfilippo, J | 1 |
| Cheng, LN; Gemzell-Danielsson, K; Lalitkumar, PG; Meng, CX; Zhang, HJ; Zhang, L | 1 |
| Day, AS | 1 |
| Gold, MA; Johnson, LM | 1 |
| Doan, QV; Gricar, J; Lalla, AM; Pinto, L; Reyes, E; Trussell, J | 1 |
| Dadhwal, V; Deka, D; Ghosh, B; Mittal, S; Ramesan, CK | 1 |
| Loisel, C; Marpeau, L; Puscasiu, L; Roman, H; Sentilhes, L | 1 |
| Agudelo-Suarez, P; Creedon, DJ; El-Nashar, SA; Famuyide, AO; Hopkins, MR; Rose, CH | 1 |
| Baird, DT | 1 |
| Marshall, N; Simonsen, SE; Turok, DK | 1 |
| Chen, J; Cheng, L; Ren, F; Wang, Y; Yu, W; Zhang, L | 1 |
| Andrade, A; Janssens, D; Wildemeersch, D | 1 |
| Abell, S | 1 |
| Bonnema, R; McNamara, MC; Spencer, AL | 1 |
| Cabar, FR; Pereira, PP; Zugaib, M | 2 |
| Botros, G; Haddad, N | 1 |
| Huang, Y; Teng, Z; Wu, H; Xin, X; Yuan, P; Zhang, J | 1 |
| Kroll, R; Margolis, M; Reape, KZ | 1 |
| Dowd, MD; Miller, MK; Patel, S | 1 |
| Alanbay, I; Baser, I; Duru, NK; Ercan, CM; Karasahin, KE; Sakinci, M | 1 |
| Leung, VW; Levine, M; Soon, JA | 3 |
| Blithe, DL; Cameron, ST; Casale, W; Fine, PM; Gainer, E; Glasier, AF; Jaspart, A; Logan, SJ; Mathe, H; Scherrer, B; Sogor, L; Ulmann, A; Van Horn, J | 1 |
| Cheng, L; Dorflinger, L; Farley, TM; Grimes, DA; Lopez, LM; Shelton, J; Steiner, MJ; Trussell, J | 1 |
| Andrade, A; Wildemeersch, D | 1 |
| Langston, A | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Lohr, P; Lyus, R; Prager, S | 1 |
| Pittrof, R; Rubenstein, P; Sauer, U | 1 |
| Byamugisha, JK; Faxelid, E; Gemzell-Danielsson, K; Mirembe, FM; Tumwesigye, NM | 1 |
| Weisberg, E | 1 |
| Bor, P; Højgaard, A; Mikkelsen, MS | 1 |
| Cheng, L; Cleland, K; Raymond, E; Trussell, J; Zhu, H | 2 |
| Grimes, DA; Lopez, LM; Schulz, KF; Stanwood, NL | 1 |
| Handasyde, KA; Hynes, EF; Renfree, MB; Shaw, G | 1 |
| Cosmi, E; Mozzanega, B | 1 |
| Cansino, C; Curtis, KM; Jamieson, DJ; Paulen, ME; Zapata, LB | 1 |
| Medard, LM; Ostrowska, L | 1 |
| Brown, SA; Lawton, BA; Rose, SB | 1 |
| Dada, OA; Godfrey, EM; Piaggio, G; von Hertzen, H | 1 |
| Bocciolone, L; Boveri, S; Casadio, C; Franchi, D; Minig, L; Sideri, M | 1 |
| Chen, BA; Creinin, MD; Hayes, JL; Hohmann, HL; Perriera, LK; Reeves, MF | 2 |
| Cameron, S; Schmid, R; Thomas, CM | 1 |
| Fine, PM | 2 |
| Newman, A | 1 |
| Beiner, M; Ben-Baruch, G; Ferenczy, A; Friedman, E; Gotlieb, WH; Korach, J; Meirow, D; Perri, T | 1 |
| Alabi-Isama, L; Eke, AC | 1 |
| Bakken, RT; Kozinszky, Z; Lieng, M | 1 |
| Kapp, N; Piaggio, G; von Hertzen, H | 1 |
| Schreiber, CA; Tennant, C | 1 |
| Chen, QJ; Cheng, LN; Kang, JZ; Luo, YF; Wang, RP; Xiang, WP; Zhang, DK | 1 |
| Dueñas-Garcia, OF; Young, C | 1 |
| Apen, K; Kapoor, S | 1 |
| Thaler, CJ; Wiegratz, I | 1 |
| Cook, J; Martin, A; Tan, TL; Warren, O | 1 |
| Amir, LH; Chapman, CB; Hobbs, MK; Hussainy, SY; Shelley, JM; Smith, AM; Stewart, K; Taft, AJ | 1 |
| Blithe, D; Cameron, ST; Gainer, E; Glasier, A; Levy, D; Mathe, H; Scherrer, B; Ulmann, A | 1 |
| Gemzell-Danielsson, K; Inki, P; Jensen, JT; Mansour, D | 1 |
| Croxatto, HB; Morales, G; Muñoz, C; Noé, G; Retamales, A; Reyes, V; Salvatierra, AM; Villarroel, C | 1 |
| Chen, BA; Creinin, MD; Reeves, MF; Schwarz, EB | 1 |
| Bahamondes, L; Bahamondes, MV; Hidalgo, MM; Monteiro, I | 1 |
| Lidegaard, Ø; Løkkegaard, E; Nielsen, LH; Skjeldestad, FE; Skovlund, CW | 1 |
| Hait, HI; Reape, KZ; Westhoff, CL | 1 |
| Trussell, J | 2 |
| Brahmi, D; Curtis, KM; Gaffield, ME; Renner, RM; Steenland, MW | 1 |
| Sarkar, NN | 2 |
| Steinbrook, R | 1 |
| Apter, D; Gemzell-Danielsson, K; Schellschmidt, I | 1 |
| Willyard, C | 1 |
| Liu, M; Qu, J; Wang, Y; Wang, Z; Yang, M; Zhang, Y; Zhang, Z | 1 |
| Ali, AA; Kazal, O | 1 |
| Chen, J; Jin, Q; Liang, Y; Wang, XJ | 1 |
| Randel, A | 1 |
| Jagasia, N; Maher, P; McCarthy, EA; Robinson, M | 1 |
| Piancatelli, R; Piccione, E; Pietropolli, A; Ruggeri, V; Sesti, F | 1 |
| de Waure, C; Di Pietro, ML; Noia, G; Puccetti, R; Riccardi, M | 1 |
| Bahamondes, L; Bahamondes, MV | 1 |
| Karowicz-Bilińska, A; Niemiec, T; Nowak-Markwitz, E; Oszukowski, P; Poreba, R; Spaczyński, M | 1 |
| Cheng, L; Cleland, K; Goldstuck, N; Trussell, J; Zhu, H | 1 |
| Alton, TM; Brock, GN; Hertweck, SP; Loveless, MB; Wilking, DA; Yang, D | 1 |
| Chen, PL; Hubacher, D; Kiarie, J; Manduku, C; Olawo, A | 1 |
| Bahamondes, L; Cho, S; Gemzell-Danielsson, K; Inki, P; Mansour, D; Reid, R | 1 |
| Dunn, S; Guilbert, É | 1 |
| Bayer, LL; Caughey, AB; Edelman, AB; Rodriguez, MI | 2 |
| Glasier, A | 2 |
| Degu, G; Takele, A; Yitayal, M | 1 |
| Berger, C; Gemzell-Danielsson, K; P G L, L | 1 |
| Dvořák, J; Toman, A | 1 |
| Gelli, MC; La Sala, GB; Mandato, VD; Nucera, G; Palomba, S | 1 |
| Guo, Y; Lv, X; Shi, D | 1 |
| Compaore, G; Filippi, V; Meda, N; Pittrof, R; Somé, DA | 1 |
| Polis, CB; Raymond, EG; Trussell, J | 1 |
| Hussein, AF; Selim, MF | 1 |
| Aggarwal, A; Bernardin, J; Burnett, M; Clark, V; Davis, V; Dempster, J; Dunn, S; Fisher, W; Guilbert, É; MacKinnon, K; Pellizzari, R; Polomeno, V; Rutherford, M; Sabourin, J; Senikas, V; Wagner, MS | 1 |
| Schwartz, JL | 1 |
| Li, N; Wang, Z; Xu, K | 1 |
| Coulson, G; Nave, CD; Poiani, A; Renfree, MB; Shaw, G; Short, RV | 1 |
| El-kabarity, H; El-zenieny, AH; Fikry, MF; Hafiz, MA | 1 |
| Prema, K | 1 |
| Haspels, AA; Van Santen, MR | 1 |
| Abed, A; Chelli, H; Habibi, H; Khrouf, M; Messaad, J; Ouerghemmi, R; Rouis, M; Sfar, E; Zouari, F | 2 |
| Dennis, J; Hampton, N | 1 |
| Blacksell, S; Cox, M; Tripp, J | 1 |
| Aguilar García, MD; Garmendia Leiza, JR | 1 |
| Adekunle, AO; Arowojolu, AO; Okewole, IA | 1 |
| Cox, M; Richardson, S | 1 |
| Dolan, LM; Mulholland, M; Price, J | 1 |
| Lo, SS | 1 |
| Hattotuwa, K; Tasker, M | 1 |
| Furlong, LA | 1 |
| Mikolajczyk, RT; Stanford, JB | 1 |
| Abu, JI; Emembolu, JO; Wandless, GM | 1 |
| Baldaszti, E; Löschke, K; Wimmer-Puchinger, B | 1 |
| Harrison-Woolrych, M; Woolley, J | 1 |
| Giersig, C; Lück, HJ; Rollnik, JD | 1 |
| Taylor, B | 1 |
| Gamzu, R; Lessing, JB; Maslovitch, S; Pauzner, D; Sheffer-Mimouni, G | 1 |
| Lam, LY; Stiber, A; Wan, LS | 1 |
| Luukkainen, T; Pakarinen, P; Toivonen, J | 3 |
| Vinson, DR | 1 |
| Allaire, C; Arneja, J; Beaudoin, F; Birch, C; Cherniak, D; Dunn, S; Fortier, M; Grant, L; Guilbert, E; Jeffrey, J; Lefebvre, G; Pellizzari, R; Sadownik, L; Saraf-Dhar, R; Turnbull, V; Vilos, G; Wagner, MS | 1 |
| Anderson, FD; Hait, H | 1 |
| Alvarez, F; Brache, V; Faúndes, A | 1 |
| Cook, RJ; Dickens, BM | 1 |
| Wu, SC; Xiao, BL | 1 |
| Benagiano, G; Primiero, FM | 1 |
| Guillebaud, J | 1 |
| Hedley, A; Raymond, E; Trussell, J | 1 |
| Croxatto, HB; Müller, AL; Ortiz, ME | 1 |
| Piaggio, G; von Hertzen, H | 1 |
| Dudderidge, TJ; Haynes, SV | 1 |
| Raymond, E; Steiner, MJ; Taylor, D; Trussell, J | 1 |
| Harrison-Woolrych, M | 1 |
| Gainer, E; Méry, C; Ulmann, A | 1 |
| Hassan, MA; Killick, SR | 1 |
| Backman, T; Huhtala, S; Koskenvuo, M; Rauramo, I | 1 |
| Bigrigg, A; Gallagher, J; Hesketh, C; Loftus-Granberg, B; Shochet, T; Tyrer, A; Webb, A | 1 |
| Jian, Z; Linan, C | 1 |
| Larimore, WL | 1 |
| Kayahan, A; Tugrul, S; Yavuzer, B; Yildirim, G | 1 |
| Croxatto, HB; Fuentes, MA; Ortiz, ME; Ortiz, RE; Parraguez, VH | 1 |
| Berlanda, N; Fedele, L | 1 |
| Nelson, R | 1 |
| Orellana, C | 1 |
| Chernev, T; Dimitrov, A; Kamenov, Z; Kolarov, G; Nikolov, A; Sirakov, M | 1 |
| Smith, KA | 1 |
| Crockett, SA; Hager, WD; Stanford, JB | 1 |
| Croxatto, HB; d'Arcangues, C; Fuentealba, B; Massai, MR; Pavez, M | 1 |
| Puzey, M | 3 |
| Benedetto, C; de Melo, NR; Dieben, TO; Leifels-Fischer, B; Oddsson, K; Verhoeven, CH; Wiel-Masson, D | 1 |
| Cheng, L; Ding, J; Fan, S; Ho, PC; Jing, X; Li, S; Ng, EH; Ngai, SW | 1 |
| Affandi, B; Critchley, HO; Hannan, NJ; Jones, RL; Kovacs, GJ; Rogers, PA; Salamonsen, LA | 1 |
| Cédrin-Durnerin, I | 1 |
| Shentov, B; Tanchev, S | 1 |
| Mena, P | 1 |
| Curlin, FA; Hall, DE | 1 |
| Amant, F; Berteloot, P; De Greef, I; Deprest, J; Timmerman, D | 1 |
| Valenzuela, CY | 1 |
| Castle, PE; Schiffman, M; Walker, JL; Wheeler, CM | 1 |
| Akande, V; Gordon, UD; Kailasam, C | 1 |
| Basu, A; Candelier, C | 1 |
| Carducci, B; Caruso, A; Cavaliere, AF; De Santis, M; Straface, G | 1 |
| Farnham, J | 1 |
| McCutcheon, G | 1 |
| Cantin, L | 1 |
| Ready, T | 1 |
| Luukkainen, T; Pakarinen, P | 1 |
| Gale, E; Lloyd, K | 1 |
| Merkatz, RB | 1 |
| Eggertson, L; Sibbald, B | 1 |
| Cravioto, MD; Jiménez-Santana, L; Lara-Reyes, P; Mestanza-Peralta, M; Sánchez-Guerrero, J; Seuc, AH; Uribe, AG | 1 |
| Cabar, FR; Pereira, PP; Raiza, LC; Roncaglia, MT; Zugaib, M | 1 |
| Quindlen, A | 1 |
| Croxatto, HB; Fernández, SD | 1 |
| Benjawang, W; Geater, A; Krisanapan, O; Pinjaroen, S; Soonthornpun, K | 1 |
| Mubaraki, M | 1 |
| Shorto, R | 1 |
| Bassas, L; Calaf, J; Espinós-Gómez, JJ; Mata, A; Senosiain, R; Vanrell, C | 1 |
| Jordan, B; Trussell, J | 1 |
| Frezieres, RG; Walsh, TL | 1 |
| Laakariseuran, S | 1 |
| Rabinovici, J; Stewart, EA | 1 |
| Raymond, E | 1 |
| Disu, S; Gordon-Wright, H; Kalu, E; Pisal, N | 1 |
| Aschenbrenner, DS | 1 |
| Gilliam, M | 1 |
| Archer, DF; Creinin, MD; Frezieres, R; Higgins, J; Rosenberg, M; Schlaff, W; Thomas, M; Wan, L | 1 |
| Croxatto, HB; Fraser, IS; Novikova, N; Stanczyk, FZ; Weisberg, E | 1 |
| Hynes, EF; Nave, CD; Renfree, MB; Shaw, G | 1 |
| Ekabua, JE; Itam, IH | 1 |
| Budiman, H; Friese, K; Kümper, C; Mylonas, I; Thaler, CJ; Weissenbacher, ER | 1 |
| Hansen, KA; Ziebarth, A | 1 |
| Hubacher, D; Kimani, J; Ndugga, MB; Solomon, M; Steiner, MJ | 1 |
| Haynes, KA | 1 |
| Darney, PD; Prager, S | 1 |
| Ikarashi, H; Matsushita, H; Takayanagi, T | 1 |
| Fernandez, H; Gervaise, A | 1 |
| Constantine, GD; Davis, AR; Grubb, GS; Kroll, R; Soltes, B; Zhang, N | 1 |
| Cherchi, C; Concas, A; Follesa, P; Panzanelli, P; Perazzini, AZ; Porcu, P; Sassoè-Pognetto, M; Sogliano, C | 1 |
| Murphy, TF | 1 |
| Boonyarangkul, A; Taneepanichskul, S | 1 |
| Stanford, JB | 1 |
| Saraví, FD | 1 |
| Greene, MF | 1 |
| Ensom, MH; Fielding, DW; Levine, M; Marciante, KD; Meckley, LM; Soon, JA | 1 |
| Arbo, E; Cunha-Filho, JS; de Freitas, FM; Jiménez, MF; Vetori, D | 1 |
| Duan, Y; Li, Y; Qi, X; Zhao, W | 1 |
| Misfar, N; Pilkington, A; Polson, DW | 1 |
| Barnhart, K; Constantine, G; Grubb, G; Mirkin, S | 1 |
| Besio, M; Santos, M; Ventura-Juncá, P | 1 |
| Ehnholm, C; Kostiainen, E; Nilsson, CG | 1 |
| Andersen, NB; Andersen, RF; Bredesgaard, P; Cullberg, G; Ernerot, H; Fanøe, E; Fylling, P; Haack-Sørensen, PE; Klottrup, P; Pedersen, JH; Samsioe, G; Sandager, T | 1 |
| de Visser, J; van der Vies, J | 1 |
| Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M | 1 |
| Tatum, HJ | 1 |
| Allonen, H; Diaz, J; Luukkainen, T; Nilsson, CG | 1 |
| Haspels, AA | 2 |
| Moggia, AV | 1 |
| Casado, ME; Croxatto, HB; Díaz, S; Durán, E; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM | 3 |
| Coutinho, E; Diaz, S; Holma, P; McDonald, O; Robertson, DN; Sanchez, FA; Sivin, I; Stern, J | 1 |
| Briggs, M | 1 |
| Kurunmäki, H | 1 |
| Guillebaud, J; Kubba, AA | 1 |
| Bialy, G; Blye, RP; Enever, RP; Lindberg, MC; Naqvi, RH | 1 |
| Agnihotri, A; Kamboj, VP; Srivastava, AK; Tandon, P | 1 |
| Duda, MJ; Krauss, RM; Lacarra, M; Mishell, DR; Robertson, DN; Roy, S | 1 |
| Salah, M; Shaaban, MM | 1 |
| Beier, S; Düsterberg, B | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Ahrendt, HJ; Ahrendt, S; Canzler, E | 1 |
| Kurunmäki, H; Lähteenmäki, PL; Luukkainen, T; Toivonen, J | 1 |
| Alvarez, F; Brache, V; Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Pavez, M; Sivin, I | 1 |
| Ahren, T; Akinla, O; Alvarez-Sanchez, F; Brache, V; Brenner, PF; Coutinho, E; Darze, E; Diaz, J; Diaz, S; Fasan, MO; Faundes, A; Gama daSilva, JC; Giwa-Osagie, OF; Jackanicz, TM; Mishell, DR; Nash, HA; Nielsen, NC; Pavez, M; Pyorala, T; Roy, S; Sivin, I; Stern, J; Victor, A; Zausner-Guelman, B | 2 |
| Hesse, G; Kurischko, A; Löw, O; Oettel, M; Tkocz, H | 1 |
| Boccardo, E; Larosa, E; Ragni, N; Viglino, S | 1 |
| Jemilev, ZA; Komor, A; Oettel, M; Schubert, K; Strecke, J | 1 |
| Adatia, A; Andolsek, L; Ayeni, S; Belsey, MA; Hall, PE; Jain, U; Li Hoi Foo, C; Parker, RA; Patankar, S; Pinol, A; Pretnar-Darovec, A; Sharma, S; Sheth, A | 1 |
| Nilsson, CG | 1 |
| Heikkilä, M; Luukkainen, T | 1 |
| Kühl, C; Mølsted-Pedersen, L; Skouby, SO | 1 |
| El Mahgoub, S | 1 |
| Heikkilä, M | 1 |
| Goncharov, NP; Komor, A; Oettel, M | 1 |
| Hillesheim, HG; Hoffmann, H; Oettel, M; Strecke, J | 1 |
| Heikkilä, M; Lähteenmäki, P; Luukkainen, T | 1 |
| Heikkilä, M; Luukkainen, T; Nylander, P | 1 |
| Noerpramana, NP | 1 |
| Sudik, R | 1 |
| Dinerman, LM; Duggan, AK; Joffe, A; Wilson, MD | 1 |
| Chatterjee, M; Kasnic, T; Nevils, R | 1 |
| Ammerman, SD | 1 |
| Allen-Davis, J; Stevens-Simon, C; Wallis, J | 1 |
| Toivonen, J | 1 |
| Bardin, CW | 1 |
| Chi, IC; Farr, G | 1 |
| Post, SG | 1 |
| Fritzemeier, KH; Hegele-Hartung, C; Krattenmacher, R; Kuhnz, W | 1 |
| Buckshee, K; Chatterjee, P; Dhall, GI; Hazra, MN; Kodkany, BS; Lalitha, K; Logambal, A; Manchanda, P; Nanda, UK; RaiChoudhury, G | 1 |
| Sivin, I | 2 |
| van Amerongen, D | 1 |
| Blumenthal, PD; Cullins, VE; Huggins, GR; Remsburg, RE; Wilson, LE | 1 |
| Salzetti, RG; Shihata, AA | 1 |
| Beilenson, PL; Farmer, M; Miola, ES | 1 |
| Du, M; Gu, S; Liu, Y; Sivin, I; Wang, S; Zhang, L | 1 |
| Baldwin, CJ; Bosu, WT; Dubielzig, RR; Peter, AT | 1 |
| Forke, C; Polaneczky, M; Rappaport, A; Slap, G; Sondheimer, S | 1 |
| Fayrer-Hosken, RA; Warren, RJ; White, LM | 1 |
| Hemminki, E; Ollila, E; Sihvo, S | 1 |
| Carrizo, DG; Deis, RP; Tellería, CM | 1 |
| Dawson, G | 1 |
| Andersson, K; Odlind, V; Rybo, G | 2 |
| Hemal, AK; Hemal, U; Kriplani, A; Wadhwa, SN | 1 |
| Du, MK; Gu, SJ; Liu, YL; Sivin, I; Wang, SH; Zhang, LD | 1 |
| Blumenthal, PD; Cullins, VE; Huggins, GR; Remsburg, RE | 1 |
| Beier, S; Kuhnz, W | 1 |
| Bateman, L; Cornin, LM; Cox, CA; Frank, ML; Poindexter, AN | 1 |
| Sivin, I; Stern, J | 1 |
| Rowlands, S | 1 |
| Aguayo, EL; Calventi, V; de Silva, P; Dunson, TR; Gerais, AS; McLaurin, VL; Serani, RG | 1 |
| Akhter, H; Amatya, RN; Begum, K; Chowdhury, T; Dighe, N; Dunson, TR; Krueger, SL; Rahman, S | 1 |
| Alvarez, F; Bassol, S; Brache, V; Coutinho, EM; da Silva, AR; de Acosta, OM; de Souza, JC; Garza Flores, J; Santo, R; Vasquez-Estrada, L | 1 |
| Webb, A | 1 |
| Díaz, J; Díaz, M; Faúndes, A; Marchi, N | 1 |
| Ho, PC; Kwan, MS | 1 |
| Ahmed, AG; Ghaneimah, SA; Khalifa, EA; Salem, HT; Segal, S; Shaaban, MM | 1 |
| Brown, MD | 1 |
| Alvarez, F; Díaz, J; Faúndes, A | 1 |
| Croxatto, HB | 1 |
| Gu, SJ; Shi, SQ; Wang, SL; Xiao, BL; Zhu, PD | 1 |
| Shaaban, MM | 1 |
| Lähteenmäki, P | 1 |
| Chi, IC | 2 |
| Du, M; Gao, Y; Gu, S; He, X; Meng, F; Sivin, I; Wang, P; Wu, S; Ying, L; Zhang, L | 1 |
| Battin, MP | 1 |
| Betrabet, SS; Kombo, I; Kulkarni, RD; Patel, SB; Saxena, BN; Toddywalla, VS | 1 |
| Rizk, DE | 1 |
| Luukkainen, T; Toivonen, J | 1 |
| Bundren, JC; McKinney, S; Shirley, B | 1 |
| Biro, FM; Hillard, PJ; Kollar, LM; Rauh, JL; Rosenthal, SL | 1 |
| Anderson, NG; Grubb, GS; Moore, D | 1 |
| Spaulding, C | 1 |
| Chompootaweep, S; Dusitsin, N; Kochagarn, E; Sirisumpan, S; Tang-usaha, J; Theppitaksak, B | 1 |
| Barzelatto, J | 1 |
| Chuang, SM; Ko, TM; Lee, TY; Tseng, LH; Yang, YS | 1 |
| Cushman, LF; Davidson, AR; Heartwell, S; Kalmuss, D; Rulin, M | 1 |
| Huimin, F; Shuhua, Q; Zenger, E | 1 |
| Davey, A; Graham, J; Peers, T; Stevens, JE | 1 |
| Segal, SJ | 1 |
| Biro, FM; Harel, Z; Kollar, LM; Rauh, JL | 1 |
| Elomaa, K; Lähteenmäki, P; Luukkainen, T; Pakarinen, P; Ratsula, K; Tuominen, J; Venesmaa, P | 1 |
| Bygdeman, M; Johannisson, E; Swahn, ML; Westlund, P | 1 |
| Bass, JD; Cooper, KR; Hampton, HL; Morrison, JC; Pryor, JA; Rock, WA | 1 |
| Amatya, RN; Balogh, S; Bhatta, A; Chetri, M; Dunson, TR; Lama, H; McMahan, JH; Spivey, S | 1 |
| Amatya, RN; Dunson, TR; Krueger, SL | 1 |
| Lähteenmäki, P; Suvisaari, J | 1 |
| Delvigne, A; Paesmans, M; Vekemans, M | 2 |
| Anant, MP; Campodonico, I; Diaz, S; el din Abdalla, K; Holma, P; Kiriwat, O; Koetsawang, S; Pavez, M; Sivin, I; Stern, J; Viegas, O; Wan, L | 1 |
| Alvarez, F; Bilhareus, P; Brache, V; Darney, P; Diaz, S; Klaisle, C; Koetsawang, S; Lacarra, M; LaGuardia, K; Lähteenmäki, P; Mishell, DR; Nash, H; Pavez, M; Piya-Anant, M; Ranta, S; Sivin, I; Stern, J; Viegas, OA; Wan, L | 1 |
| Berenson, AB; McCombs, SL; Rickerr, VI; Wiemann, CM | 1 |
| Archer, DF; DelConte, A; Maheux, R; O'Brien, FB | 1 |
| Hemminki, E; Ollila, E | 1 |
| Chaturachinda, K; Intaraprasert, S; Phuapradit, W; Taneepanichskul, S | 1 |
| Duminy, PC | 1 |
| Fan, H; Han, L; Meng, F | 1 |
| Fang, H; Qiu, S; Smith, HL; Tu, P | 1 |
| Bardin, CW; Elomaa, K; Haukkamaa, M; Kivijärvi, A; Kuukankorpi, A; Lähteenmäki, P; Tuominen, J; Venhola, M | 1 |
| Cisse, CT; Cisse, ML; Diadhiou, F; Diallo, D; Faye, EO; Kerby, K; Moreira, P; N'Dong, I; O'Connor, C | 1 |
| Hediger, ML; Kramer, JP; Martin, SS; Mears, CJ; Scholl, TO | 1 |
| Nyman, T; Rutanen, EM; Salmi, A | 1 |
| Chiou, V; DuRant, RH; Emans, SJ; Middleman, AB; Robertson, LM | 1 |
| Ratnam, SS; Singh, K | 1 |
| DiMaria, C; Frank, ML | 1 |
| Albring, M; Bannemerschult, R; Brill, K; Fox, P; Hanker, JP; Wünsch, C | 1 |
| Evans, MP; Jacobsen, SJ; Manolis, AL; Simmons, PS; Suman, VJ; Van Winter, JT | 1 |
| Dias, PJ; O'Mara, N | 1 |
| Cameron, IT; Campbell, S; Church, HJ; Irvine, GA; Kohnen, G; MacLachlan, F; Titterington, M | 1 |
| Balfour, JA; Coukell, AJ | 1 |
| Ba Gueye, M; Diadhiou, F; Israël, A; Moreau, JC; Sangaré, M; Sokal, D | 1 |
| Baird, D; Glasier, A | 1 |
| Alfthan, H; Lehtovirta, P; Stenman, UH; Vartiainen, J | 1 |
| Odlind, V | 2 |
| Gard, PR; Malhi, JS; Ostad, SN | 1 |
| Bono, CA; Clarke, LL; Miller, MK; Schmitt, K; Steele, J | 1 |
| Berg-Kelly, KS; Cromer, BA; Ruusuvaara, L; Seimer, BS; Van Groningen, JP | 1 |
| Christ, M; Darney, P; Mishell, DR; Sivin, I; Wan, L | 1 |
| Cutner, A; Ojutiku, D; Rymer, J | 1 |
| Kelly, L; Stevens-Simon, C | 1 |
| Faragó, K | 1 |
| Houston, A | 1 |
| Donaldson, PJ; Noble, J; Tuladhar, J | 1 |
| Chukudebelu, W; Ozumba, B; Snow, R | 1 |
| McMullen, JP; Schooff, M | 1 |
| von Hertzen, H | 1 |
| Chompootaweep, S; Dusitsin, N; Kochagarn, E; Tang-Usaha, J; Theppitaksak, B | 1 |
| Couchenour, RL; Strayer, SM | 1 |
| Alvarez, F; Brache, V; Darney, P; Klaisle, C; Lacarra, M; Mishell, DR; Sivin, I; Stern, J; Wan, L | 1 |
| Anant, MP; Biswas, A; Campodonico, I; Diaz, S; el din Abdalla, K; Holma, P; Kiriwat, O; Pavez, M; Sivin, I; Stern, J; Viegas, O; Wan, L | 1 |
| Ebacher, R; Prior, S; Valdini, A | 1 |
| Grimes, DA; Piaggio, G; Van Look, PF; von Hertzen, H | 1 |
| Critchley, HO; Gebbie, AE; Glasier, AF; Riley, SC; Skinner, JL | 1 |
| Cromer, BA; Hayes, J; Zibners, A | 1 |
| Bannemerschult, R; Brill, K; Fox-Kuchenbecker, P; Hite, RC; Turck, R | 1 |
| Armengol, J; Aura, M; Calaf, J; Cuberas, N; Espinós, JJ; Senosiain, R; Vanrell, C | 1 |
| Nawroth, F; Sudik, R | 1 |
| Bromham, DR; Kirkman, RJ; O'Connor, TP; Sahota, JE | 1 |
| Odlind, V; Rönnerdag, M | 1 |
| Cromer, B; Harel, Z | 1 |
| Ahued-Ahued, JR; de la Jara Díaz, J; Lara Ricalde, RJ; Rodríguez-Bosch, MR; Torres Ramírez, A | 1 |
| Ba, MG; Dao, B; Diadhiou, F; Dunson, R; Kouedou, D; Moreau, JC; Sokal, D | 1 |
| Chaudhary, I; Inayatullah, A; Rehan, N | 1 |
| Aura, M; Calaf, J; Espinós, JJ; Gispert, M; Rodríguez-Espinosa, J; Senosiain, R; Vanrell, C; Vega, C | 1 |
| Backman, T; Blom, T; Huhtala, S; Koskenvuo, M; Luoto, R; Rauramo, I | 1 |
| Duffy, S; Hawe, J; Rogerson, L | 1 |
| Balogh, G; Bardin, CW; Csörgei, J; Dancsi, A; Dukát-Abrók, V; Falkay, G; Francsics-Czinege, E; Koide, SS; Kumar, N; Molnár, C; Sundaram, K; Tuba, Z | 1 |
| O'Brien, PA | 1 |
| Kelly, L; Stevens-Simon, C; Wallis, J | 1 |
| Abdalla, K; Alvarez, F; Biswas, A; Brache, V; Campodonico, I; Darney, P; Diaz, S; Holma, P; Kiriwat, O; Mishell, DR; Pasquale, S; Pavez, M; Schechter, J; Sivin, I; Wan, L | 1 |
| Kirch, W; Siepmann, M | 1 |
| Bártfai, G | 1 |
| Blacksell, S; Cox, M | 1 |
| Sherfey, MA | 1 |
| Cowan, FM; French, RS; Guillebaud, J; Hughes, D; Mansour, DJ; Morris, S; Procter, T; Robinson, A | 1 |
| Achiron, R; Kreizer, D; Soriano, D; Zalel, Y | 1 |
| Akers, R; Cheng, H; Macaluso, M | 1 |
| LaValleur, J | 1 |
| Affandi, B; Critchley, HO; Findlay, JK; Jones, RL; Rogers, PA; Salamonsen, LA | 1 |
| Barnes, PM; Bradley, JL; Kirkman, RJ; Mansfield, E; Sahota, J | 1 |
| Nave, CD; Renfree, MB; Shaw, G; Short, RV | 1 |
| Bashir, MI; Laway, BA; Masoodi, SR; Salahuddin, M; Wani, AI; Zargar, AH | 1 |
| McCarthy, M | 1 |
| Csillag, C | 1 |
| Grant, EC | 1 |
| Croxatto, HB; Devoto, L; Durand, M; Ezcurra, E; Larrea, F; Nagle, C; Ortiz, ME; Vantman, D; Vega, M; von Hertzen, H | 1 |
| Hannaford, P | 1 |
| Kelly, L; Kulick, R; Stevens-Simon, C | 1 |
| Cepický, P; Koryntová, D; Zivný, J | 1 |
| Bonati, G; Lech, MM | 1 |
| Agren, U; Dieben, T; Kivelä, A; Ruuskanen, M | 1 |
| Falk, G; Falk, L; Hanson, U; Milsom, I | 1 |
| Alvarez, F; Anant, MP; Biswas, A; Brache, V; Darney, P; Diaz, S; Kiriwat, O; Klaisle, C; Mishell, DR; Pavez, M; Ranta, S; Schechter, J; Sivin, I; Wan, L | 1 |
| Persels, J | 1 |
| Roberts, DE | 1 |
| Heller, S; Mertus, J | 1 |
| Ballard, T | 1 |
| Rutherford, C | 1 |
| Bernier, BL | 1 |
| Henley, M | 1 |
| Coney, P; DiGiovanna, JJ; Harrison, DD; Langley, RG; Washenik, K | 1 |
| Bulut, A; Ortayli, N; Sahin, T; Sivin, I | 1 |
| Grimes, D; Helmerhorst, F; Schulz, K; Van Vliet, H | 1 |
| Creasy, GW; Fisher, AC; Lenihan, JP; Meador, ML; Shangold, GA; Smallwood, GH | 1 |
| Darney, PD; Meckstroth, KR | 1 |
| Piaggio, G; Pinol, AP | 1 |
| Couchenour, RL; Wanner, MS | 1 |
| Grimes, DA; Hubacher, D | 1 |
| Kahlenborn, C; Larimore, WL; Stanford, JB | 1 |
| Bahamondes, L; Dantas-Monteiro, C; Diaz, J; Hidalgo, M; Perrotti, M; Petta, C | 1 |
| Weng, L; Zhang, L | 1 |
| Ashok, PW; Flett, GM; Melvin, L; Stalder, C; Templeton, A; Wagaarachchi, PT | 1 |
| Ngu, A; Trivedi, AN | 1 |
| Elstein, M; Russell, J; Webb, AM | 1 |
| Andersson, K; Batar, I; Rybo, G | 1 |
| Chen, JH; Gao, J; Wang, SL; Wu, SC; Xin, XM | 1 |
| Alvarez, F; Brache, V; Diaz, S; Holma, P; Lacarra, M; McCarthy, T; Mishell, DR; Pavéz, M; Sivin, I; Stern, J | 1 |
| Fong, YF; Ratnam, SS; Singh, K; Viegas, OA | 1 |
| Klaisle, CM; Wysocki, S | 1 |
| Cleveland, WW | 1 |
| Burton, R | 1 |
| Bopp, BL; Fielding, M; Mishell, DR; Shoupe, D | 1 |
| Huggins, GR; Wentz, AC | 1 |
| Croxatto, HB; Díaz, S; Sivin, I | 1 |
| Darney, PD | 1 |
| Andrade, AT; Cuadros, A; Dhall, GI; Ji, G; Khan, T; Koetsawang, S; Kononova, ES; Krishna, U; Rodriquez la Puenta, J; Wyss, R | 2 |
| Juchem, M; Pollow, K | 1 |
| Baveja, R; Bichille, LK; Coyaji, KJ; Engineer, AD; Gogoi, MP; Hazra, MN; Kochhar, M; Lahiri, BC; Manuel, M; Nanda, UK | 1 |
| Ratsula, K | 2 |
| Apelo, R; Osteria, T; Ramos, R; Vilar, E | 1 |
| Mishell, DR; Shoupe, D | 1 |
| Alvarado, A; Darney, PD; Klaisle, CM; Monroe, SE | 1 |
| Plotka, ED; Seal, US | 1 |
| Fitz, R; Grünberger, W; Vytiska-Binstorfer, E | 1 |
| Becker, C; Higgins, JE; McCann, MF; Moggia, AV; Potts, M | 1 |
| Croxatto, HB; Díaz, S; Miranda, P; Pavez, M; Quinteros, E | 1 |
| Laird, M; Monier, M | 1 |
| Nilsson, B; von Schoultz, B | 1 |
| Daw, E; Paraskevaides, EC | 1 |
| Keller, PJ | 1 |
| Winzer, M; Wolff, HH | 1 |
| Belsey, EM; Carlson, N; d'Arcangues, C | 1 |
| Hertz, R; Spiro, I; Zook, BC | 1 |
| Rådberg, G; Svanvik, J | 1 |
| Allonen, H; Haukkamaa, M; Lähteenmäki, P; Luukkainen, T; Nilsson, CG; Toivonen, J | 1 |
| Odlind, V; Olsson, SE | 2 |
| Amatayakul, K; Bamji, MS; Belsey, MA; Hall, P; Joshi, UM; Parker, RA; Prema, K; Singkamani, R; Virkar, KD; Whitehead, TP | 1 |
| Croxatto, HB; Díaz, S; Herreros, C; Johansson, ED; Pavez, M | 1 |
| Lopez, G; Rengifo, J; Rodriguez, A; Sivin, I | 1 |
| Haukkamaa, M | 1 |
| Betrabet, SS; Datey, S; Patel, DM; Saxena, BN; Shikary, ZK; Toddywala, WS | 1 |
| Alvarez, F; Belhadj, H; Brache, V; Breaux, H; Diaz, S; Mishell, DR; Pavez, M; Shoupe, D; Sivin, I; Tejada, AS | 1 |
| Dhaliwal, LK; Gulati, K; Gupta, AN | 1 |
| Andersen, O; Kühl, C; Saurbrey, N; Skouby, SO | 1 |
| Affandi, B; Karmadibrata, S; Lubis, F; Prihartono, J; Samil, RS | 1 |
| Johansson, ED; Nordström, ML; Odlind, V; Olsson, SE | 1 |
| Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Mattos, CE; Pavez, M; Sivin, I; Stern, J | 1 |
| Kung, AW; Lam, KS; Li, DF; Ma, HK; Ma, JT; Ng, MM; Wang, CC; Wong, VC; Young, RT | 1 |
| Betrabet, SS; Patel, D; Saxena, BN; Shikary, ZK; Toddywalla, SP; Toddywalla, VS | 1 |
| Abo-Eloyoun, M; Ahmed, AG; Salah, M; Shaaban, MM | 1 |
| Croxatto, HB; Díaz, S; Johansson, ED; Miranda, P; Pavez, M | 1 |
| Cárdenas, H; Croxatto, HB; Díaz, S; Pavez, M | 1 |
| Segal, S | 1 |
| Bártfai, G; Bhattacharjee, SK; Boukhris, R; Kononova, ES; Prasad, RN; Pretnar-Darovec, A; Romeo, J; Saraya, L; Shi, YE; Van Look, PF | 1 |
| Brandeis, V; Cruz, RI; Kelly, S; Pasquale, SA; Sweeney, M | 1 |
| Affandi, B; Hadisaputra, W; Lubis, F; Moeloek, FA; Prihartono, J; Samil, RS; Santoso, SS | 2 |
| Johansson, ED; Odlind, V; Olsson, SE; Sivin, I | 1 |
| Christaens, GC; Haspels, AA; Scholten, PC | 1 |
| Husain, FA; Khan, T | 1 |
| Dai, MZ; Li, LZ; Liu, CQ; Liu, GM; Shen, SR; Zhu, JY | 1 |
| Du, MG; Gao, YL; Gu, SJ; Liu, YL; Wang, PZ; Wang, SH; Wu, SL; Xu, MF; Yuan, DY; Zhang, LD | 1 |
| Chaudhury, N; Gupta, AN; Hazra, MN; Hingorani, V; Kochhar, M; Kodkany, BS; Logambal, A; Nanda, UK; Rai Choudhary, G; Raja Ram, P | 1 |
| Alvarez-Sanchez, F; Brache, V; Coutinho, E; Croxatto, HB; Diaz, S; Faundes, A; Holma, P; Lacarra, M; Mishell, DR; Robertson, DN | 1 |
| Koch, M; Peschke, T; Stracke, R | 1 |
| Casado, ME; Croxatto, HB; Díaz, S; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM | 1 |
| Christensen, MS; Kühl, C; Mølsted-Pedersen, L; Petersen, K; Skouby, SO | 1 |
| Abdulla, KA; Elwan, SI; Salem, HS; Shaaban, MM | 1 |
| Aedo, AR; Diczfalusy, E; Johannisson, E; Landgren, BM; Xing, S | 1 |
| Abdullah, KA; Salem, HT; Shaaban, MM | 1 |
| Croxatto, HB; Díaz, S; Herreros, C; Juez, G; Peralta, O | 1 |
135 review(s) available for levonorgestrel and Pregnancy
| Article | Year |
|---|---|
Uterine sparing management in patients with endometrial cancer: a narrative literature review.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Levonorgestrel; Pregnancy; Uterus | 2022 |
Effect of levonorgestrel emergency contraception on implantation and fertility: A review.
Topics: Abortion, Spontaneous; Contraception, Postcoital; Female; Fertility; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2022 |
Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Precancerous Conditions; Pregnancy; Pregnancy Outcome | 2022 |
Long-Acting Reversible Contraception.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Long-Acting Reversible Contraception; Pregnancy; United States | 2022 |
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
Unilateral hydroureteronephrosis after introduction of a levonorgestrel-releasing intrauterine system: a case report and literature review.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2023 |
Society of Family Planning Clinical Recommendation: Emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Family Planning Services; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy | 2023 |
Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis.
Topics: Carcinoma, Endometrioid; Child, Preschool; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy | 2023 |
Abnormal Uterine Bleeding.
Topics: Contraceptives, Oral; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Pregnancy; Uterine Hemorrhage | 2023 |
Role of hysteroscopy during conservative management of atypical endometrial hyperplasia and early-stage endometrial cancer in patients who desire pregnancy.
Topics: Conservative Treatment; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2022 |
No-daily hormonal contraception today: general overview and application in specific clinical settings.
Topics: Adolescent; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Female; Hormonal Contraception; Humans; Levonorgestrel; Pregnancy; Progestins | 2023 |
Emergency contraception - A review.
Topics: Contraception; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unplanned | 2023 |
Postpartum hormonal contraception in breastfeeding women.
Topics: Breast Feeding; Contraception; Contraceptive Agents; Delayed-Action Preparations; Female; Gynecology; Health Knowledge, Attitudes, Practice; Hormonal Contraception; Humans; Infant; Infant, Newborn; Intrauterine Devices; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Milk, Human; Postpartum Period; Practice Guidelines as Topic; Pregnancy | 2019 |
The effect of early vs. delayed postpartum insertion of the LNG-IUS on breastfeeding continuation: a systematic review and meta-analysis of randomised controlled trials.
Topics: Adult; Breast Feeding; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Postpartum Period; Pregnancy; Randomized Controlled Trials as Topic; Time Factors | 2019 |
Levonorgestrel IUD: is there a long-lasting effect on return to fertility?
Topics: Contraceptive Agents, Hormonal; Female; Fertilization; Humans; Infertility, Female; Intrauterine Devices; Levonorgestrel; Pregnancy | 2020 |
Long-acting reversible contraceptive (LARCs) methods.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Unplanned | 2020 |
A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.
Topics: Contraceptive Agents, Hormonal; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Pregnancy | 2020 |
Oral Contraceptives in Dermatology.
Topics: Contraceptives, Oral; Dermatology; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Progesterone | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Pooled incidence of continuation and pregnancy rates of four contraceptive methods in young women: a meta-analysis.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Young Adult | 2022 |
The safety of available and emerging options for emergency contraception.
Topics: Animals; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy | 2017 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Unsafe Sex | 2017 |
Abnormal uterine bleeding in perimenopause.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Contraceptives, Oral, Combined; Diagnostic Imaging; Endometrial Hyperplasia; Endometrium; Female; Genital Neoplasms, Female; Humans; Hysteroscopy; Leiomyoma; Levonorgestrel; Middle Aged; Perimenopause; Pregnancy; Quality of Life; Uterine Hemorrhage | 2017 |
Delivery of progestins via the subdermal versus the intrauterine route: comparison of the pharmacology and clinical outcomes.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Pregnancy; Progestins | 2018 |
Postpartum intrauterine devices: clinical and programmatic review.
Topics: Breast Feeding; Cesarean Section; Clinical Competence; Contraceptive Agents, Female; Contraindications, Procedure; Delivery, Obstetric; Female; Health Care Costs; Health Services Accessibility; Humans; Insurance, Health; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Long-Acting Reversible Contraception; Postnatal Care; Pregnancy; Time Factors; Ultrasonography; Uterus | 2018 |
Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Migration; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Observational Studies as Topic; Pain, Procedural; Parity; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Retrospective Studies; Young Adult | 2018 |
[Emergency contraception: CNGOF Contraception Guidelines].
Topics: Contraception, Postcoital; Female; France; Humans; Intrauterine Devices, Copper; Levonorgestrel; MEDLINE; Norpregnadienes; Pregnancy; Pregnancy Tests; Unsafe Sex | 2018 |
[Contraception for adolescent : CNGOF Contraception guidelines].
Topics: Adolescent; Adolescent Health; Body Height; Body Mass Index; Body Weight; Calcification, Physiologic; Condoms; Contraception; Contraceptives, Oral, Hormonal; Female; France; Health Education; Humans; Levonorgestrel; Male; Papillomavirus Infections; Papillomavirus Vaccines; Pregnancy; Pregnancy, Unplanned; Sex Education; Sexually Transmitted Diseases | 2018 |
Levonorgestrel emergency contraception and bodyweight.
Topics: Body Weight; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Obesity; Pregnancy; Pregnancy Rate | 2019 |
Interventions for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mifepristone; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Unsafe Sex | 2019 |
Controversies in family planning: intrauterine device placement in solid organ transplant patients.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Liver Transplantation; Patient Preference; Pregnancy; Pregnancy, Unplanned; Transplant Recipients; Young Adult | 2019 |
Sex matters: Practice 5P's when treating young women with venous thromboembolism.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low-Molecular-Weight; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Risk Factors; Sex Factors; Stockings, Compression; Thrombophilia; Thrombophlebitis; Tranexamic Acid; Travel; Uterine Hemorrhage; Venous Thromboembolism; Young Adult | 2019 |
Emergency contraception and impact on abortion rates.
Topics: Abortion, Induced; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unplanned | 2020 |
Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
Topics: Blood Glucose; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipid Metabolism; Pregnancy; Progestins; Randomized Controlled Trials as Topic | 2013 |
Immediate post-partum initiation of intrauterine contraception and implants: a review of the safety and guidelines for use.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Postpartum Period; Practice Guidelines as Topic; Pregnancy | 2013 |
Contraception during the perimenopause.
Topics: Contraception; Contraceptive Agents, Female; Contraindications; Estrogens; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Perimenopause; Pregnancy; Pregnancy, Unplanned; United States | 2013 |
Birth control and pregnancy management in pulmonary hypertension.
Topics: Abortion, Therapeutic; Antihypertensive Agents; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Diuretics; Endothelin Receptor Antagonists; Familial Primary Pulmonary Hypertension; Female; Heart Failure; Humans; Hypertension, Pulmonary; Intrauterine Devices, Medicated; Levonorgestrel; Phosphodiesterase 5 Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Progestins; Prostaglandins I; Sterilization, Reproductive | 2013 |
Long-acting reversible contraception: a review in special populations.
Topics: Age Factors; Animals; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Risk Factors; Sexually Transmitted Diseases | 2014 |
A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Treatment Outcome | 2014 |
Jaydess® levonorgestrel intrauterine system.
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Equipment Failure Analysis; Equipment Safety; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Risk Assessment; United Kingdom; Uterine Hemorrhage | 2014 |
Immediate postabortal insertion of intrauterine devices.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Randomized Controlled Trials as Topic; Time Factors | 2014 |
Contraception for women with chronic medical conditions: an evidence-based approach.
Topics: Chronic Disease; Contraception; Contraceptive Agents, Female; Drug Implants; Evidence-Based Medicine; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy, Unplanned | 2014 |
Emergency contraception: a review.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Nonprescription Drugs; Norpregnadienes; Patient Education as Topic; Pregnancy | 2014 |
Emergency contraception. Widely available and effective but disappointing as a public health intervention: a review.
Topics: Adolescent; Adult; Coitus; Contraception; Contraception, Postcoital; Contraceptive Agents; Contraceptives, Postcoital; Female; Fertility; Humans; Levonorgestrel; Middle Aged; Ovulation; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Public Health; Young Adult | 2015 |
[Emergency contraception: efficacy difference between levonorgestrel and ulipristal acetate depending on the follicular size at the time of an unprotected sexual intercourse].
Topics: Coitus; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Norpregnadienes; Organ Size; Ovarian Follicle; Ovulation; Pregnancy; Time Factors; Unsafe Sex | 2015 |
The new LNG-releasing IUS: a new opportunity to reduce the burden of unintended pregnancy.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Satisfaction; Pregnancy; Pregnancy, Unplanned | 2015 |
Practice Bulletin No. 152: Emergency Contraception.
Topics: Adult; Contraception, Postcoital; Contraceptives, Postcoital; Emergency Treatment; Evidence-Based Medicine; Female; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Levonorgestrel; Practice Guidelines as Topic; Pregnancy; Publications | 2015 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraception, Postcoital; Double-Blind Method; Female; Humans; Levonorgestrel; Middle Aged; Overweight; Pregnancy; Randomized Controlled Trials as Topic; World Health Organization; Young Adult | 2015 |
Immediate postpartum provision of long-acting reversible contraception.
Topics: Adult; Cesarean Section; Contraception; Cost-Benefit Analysis; Delivery, Obstetric; Family Planning Services; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Levonorgestrel; Patient Acceptance of Health Care; Postpartum Period; Pregnancy; Treatment Outcome | 2015 |
Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception.
Topics: Breast Feeding; Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Lactation; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Outcome; Treatment Failure | 2016 |
Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
Topics: Adolescent; Adolescent Behavior; Adult; Contraceptive Agents, Female; Directive Counseling; Family Planning Services; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Pregnancy; Pregnancy, Unplanned; United States | 2015 |
Emergency Contraception: Do Your Patients Have a Plan B?
Topics: Adult; Contraception, Postcoital; Directive Counseling; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Patient Education as Topic; Pregnancy; Time Factors; United States | 2015 |
Emergency contraception: Focus on the facts.
Topics: Contraception; Contraception, Postcoital; Contraceptives, Oral, Hormonal; Cyclooxygenase Inhibitors; Female; Health Services Accessibility; Humans; Intrauterine Devices; Levonorgestrel; Meloxicam; Mifepristone; Norpregnadienes; Ovulation Inhibition; Pregnancy; Thiazines; Thiazoles | 2016 |
Emergency Contraception.
Topics: Administration, Oral; Attitude of Health Personnel; Body Mass Index; Breast Feeding; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Copper; Levonorgestrel; Nonprescription Drugs; Norpregnadienes; Ovulation; Patient Education as Topic; Pregnancy; Prescription Drugs | 2016 |
Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review.
Topics: Bipolar Disorder; Contraceptives, Oral; Depressive Disorder; Equipment Safety; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Psychiatric Status Rating Scales; Risk Assessment | 2016 |
Update on emergency contraception.
Topics: Adult; Contraception; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Obesity; Pregnancy | 2016 |
The safety of intrauterine devices among young women: a systematic review.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Randomized Controlled Trials as Topic; Risk Assessment; Young Adult | 2017 |
Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2017 |
Intrauterine devices and adolescents.
Topics: Adolescent; Contraceptive Agents; Endometriosis; Equipment Design; Female; Humans; Inflammation; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pregnancy; Pregnancy in Adolescence | 2008 |
Emergency contraception: how does it work?
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Pregnancy | 2009 |
Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
Topics: Adult; Clinical Trials as Topic; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Counseling; Desogestrel; Evidence-Based Medicine; Family Planning Services; Family Practice; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Levonorgestrel; Medroxyprogesterone Acetate; Ovulation Inhibition; Practice Guidelines as Topic; Pregnancy; Risk Factors; Women's Health; World Health Organization | 2009 |
Mechanisms of action of hormonal emergency contraceptives.
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Models, Biological; Models, Statistical; Ovulation; Pregnancy; Pregnancy, Unwanted; Reproduction; Treatment Outcome | 2010 |
Sino-implant (II)--a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials.
Topics: Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Patient Satisfaction; Pregnancy; Prostheses and Implants; Randomized Controlled Trials as Topic | 2010 |
Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Middle Aged; Pregnancy; Uterine Perforation | 2010 |
Emergency contraception: update and review.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Patient Education as Topic; Pregnancy; United States | 2010 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Ectopic pregnancy and emergency contraceptive pills: a systematic review.
Topics: Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2010 |
Immediate postabortal insertion of intrauterine devices.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Randomized Controlled Trials as Topic; Time Factors | 2010 |
How do levonorgestrel-only emergency contraceptive pills prevent pregnancy? Some considerations.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Embryo Implantation; Female; Humans; Levonorgestrel; Ovulation; Pregnancy; Signal Transduction; Tablets | 2011 |
Contraceptive use among women with a history of bariatric surgery: a systematic review.
Topics: Bariatric Surgery; Contraceptives, Oral; Female; Gastric Bypass; Gastroplasty; Humans; Levonorgestrel; Obesity; Pregnancy; PubMed; Weight Loss | 2010 |
[Hormonal (levonorgestrel) emergency contraception--effectiveness and mechanism of action].
Topics: Contraception Behavior; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Levonorgestrel; Poland; Pregnancy; Pregnancy, Unwanted; Reproductive Health Services; Women's Health | 2010 |
Update on emergency contraception.
Topics: Administration, Oral; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Norpregnadienes; Ovulation Inhibition; Pregnancy; Pregnancy, Unwanted; Product Surveillance, Postmarketing; Time Factors; Treatment Outcome; Unsafe Sex | 2011 |
Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Time Factors; World Health Organization | 2011 |
Fertility after discontinuation of contraception: a comprehensive review of the literature.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Fertility; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome | 2011 |
Pregnancy outcomes with an IUD in situ: a systematic review.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy Outcome | 2012 |
The emergency contraceptive drug, levonorgestrel: a review of post-coital oral and peri-coital vaginal administration for prevention of pregnancy.
Topics: Administration, Intravaginal; Administration, Oral; Coitus; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy | 2011 |
Measuring and reporting of the treatment effect of hormonal emergency contraceptives.
Topics: Clinical Trials as Topic; Contraceptives, Postcoital; Female; Follow-Up Studies; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Treatment Outcome | 2012 |
Ultrasound-guided hysteroscopy to remove a levonorgestrel intrauterine system in early pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Contraceptive Agents, Female; Female; Gestational Age; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Ultrasonography; Ultrasonography, Prenatal | 2012 |
The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience.
Topics: Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Cost-Benefit Analysis; Databases, Factual; Female; History, 20th Century; History, 21st Century; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Time Factors | 2012 |
Emergency contraception: clinical outcomes.
Topics: Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Rate; Risk-Taking; Treatment Outcome | 2013 |
Emergency contraception -- mechanisms of action.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Corpus Luteum; Embryo Implantation; Endometrium; Fallopian Tubes; Female; Fertilization; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Norpregnadienes; Ovarian Follicle; Ovulation; Pregnancy; Spermatozoa | 2013 |
Emergency contraception: separating fact from fiction.
Topics: Abortion, Induced; Contraception, Postcoital; Counseling; Crime Victims; Female; Hospitals; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Nonprescription Drugs; Norpregnadienes; Obesity; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unplanned; Sex Offenses; United States | 2012 |
Release of progestin-only emergency contraception.
Topics: Contraception; Contraceptive Agents, Female; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fertilization; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Ovulation; Pregnancy | 2001 |
IUDs: which device?
Topics: Consumer Product Safety; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Patient Selection; Pregnancy; Progesterone Congeners; Technology Assessment, Biomedical | 2002 |
Ectopic pregnancy risk when contraception fails. A review.
Topics: Clinical Trials as Topic; Contraceptive Agents; Contraceptives, Oral, Synthetic; Drug Approval; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norethindrone; Norgestrel; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Progesterone; Treatment Failure; United States; United States Food and Drug Administration | 2002 |
Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects.
Topics: Cervix Mucus; Endometrium; Fallopian Tubes; Female; Fertilization; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; MEDLINE; Oocytes; Pregnancy; Pregnancy, Ectopic; Sperm Transport | 2002 |
Emergency contraception--clinical and ethical aspects.
Topics: Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Emergency Medical Services; Ethics, Medical; Female; Health Services Accessibility; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted | 2003 |
Seventy-five microgram desogestrel minipill, a new perspective in estrogen-free contraception.
Topics: Adult; Clinical Trials as Topic; Contraception; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Female; Follow-Up Studies; Humans; Italy; Levonorgestrel; Middle Aged; Multicenter Studies as Topic; Pregnancy; Pregnancy Rate; Progesterone Congeners | 2003 |
The levonorgestrel intrauterine system: a clinical perspective from the UK.
Topics: Adult; Contraception; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pelvic Infection; Pregnancy; Pregnancy Rate; Risk Assessment; United Kingdom; Uterine Hemorrhage | 2003 |
Mechanisms of action of emergency contraception.
Topics: Animals; Contraception; Contraceptives, Postcoital; Embryo, Mammalian; Endometrium; Ethinyl Estradiol; Female; Fertilization; Haplorhini; Humans; Levonorgestrel; Male; Pregnancy; Rats; Sperm Motility; Spermatozoa; Steroids; Time Factors | 2003 |
Levonorgestrel and mifepristone in emergency contraception.
Topics: Clinical Trials as Topic; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Mifepristone; Pregnancy; Pregnancy Rate; Pregnancy, Unwanted; Random Allocation; Time Factors | 2003 |
Levonorgestrel as an emergency contraceptive drug.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Postcoital, Synthetic; Drug Administration Schedule; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Pregnancy; Treatment Failure | 2003 |
Emerging drugs for endometriosis.
Topics: Adult; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Contraceptives, Oral, Hormonal; Cytokines; Danazol; Endometriosis; Estradiol; Estrogen Receptor Modulators; Female; Gestrinone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormone Replacement Therapy; Humans; Infertility, Female; Levonorgestrel; Mifepristone; Ovary; Ovulation; Pregnancy; Progestins; Randomized Controlled Trials as Topic | 2004 |
New interventional techniques for adenomyosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Danazol; Diagnosis, Differential; Embolization, Therapeutic; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Pregnancy; Uterine Diseases; Uterine Neoplasms | 2006 |
Over-the-counter access to emergency contraception.
Topics: Adolescent; Adult; Age Factors; Contraception, Postcoital; Contraceptives, Postcoital; Drug Approval; Drug Labeling; Drug Prescriptions; Endometrium; Female; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Ovulation; Pregnancy; Pregnancy, Unplanned; Time Factors; United States; United States Food and Drug Administration | 2006 |
Hormonal emergency contraception: a clinical primer.
Topics: Abortion, Induced; Adolescent; Adult; Clinical Trials as Topic; Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Female; Health Care Costs; Humans; Levonorgestrel; Nonprescription Drugs; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unwanted; Risk-Taking; Sexual Behavior; Time Factors; United States; United States Food and Drug Administration; World Health Organization | 2007 |
An update on emergency contraception use in adolescents.
Topics: Adolescent; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Drug Utilization; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Information Services; Internet; Levonorgestrel; Pregnancy; Pregnancy in Adolescence | 2007 |
The levonorgestrel intrauterine system in nulliparous women.
Topics: Abortion, Induced; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Satisfaction; Pelvic Inflammatory Disease; Pregnancy | 2007 |
[Dysfunctionnal uterin bleedings].
Topics: Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Pregnancy; Premenopause; Tranexamic Acid; Uterine Hemorrhage | 2007 |
[Emergency contraception with levonorgestrel].
Topics: Clinical Trials as Topic; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Fallopian Tubes; Female; Fertilization; Humans; Intrauterine Devices; Levonorgestrel; Ovulation; Pregnancy; Pregnancy, Ectopic | 2007 |
The use of Norplant and Depo Provera in adolescents.
Topics: Adolescent; Contraception; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Pregnancy in Adolescence; Sexually Transmitted Diseases | 1995 |
The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic | 1994 |
Contraception with NORPLANT implants.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Fertility; Humans; Levonorgestrel; Menstruation; Pregnancy; Pregnancy Outcome | 1994 |
NORPLANT: levonorgestrel-releasing contraceptive implant.
Topics: Body Weight; Drug Implants; Female; Forearm; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Pregnancy | 1993 |
NORPLANT and the levonorgestrel IUD in Chinese family planning programmes.
Topics: Amenorrhea; China; Drug Implants; Family Planning Policy; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pregnancy | 1993 |
Experience with NORPLANT in Egypt.
Topics: Adult; Contraception Behavior; Developing Countries; Drug Implants; Egypt; Female; Humans; Lactation; Levonorgestrel; Pregnancy; Time Factors | 1993 |
Postabortal contraception.
Topics: Abortion, Induced; Contraception; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Ovulation; Pregnancy; Risk Factors; Thromboembolism | 1993 |
The TCu-380A (AG), MLCu375, and Nova-T IUDs and the IUD daily releasing 20 micrograms levonorgestrel--four pillars of IUD contraception for the nineties and beyond?
Topics: Evaluation Studies as Topic; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Uterine Perforation | 1993 |
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Pregnancy, Ectopic | 1995 |
Consensus statement on emergency contraception.
Topics: Contraceptives, Oral; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Italy; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1995 |
The progestin-only pills and the levonorgestrel-releasing IUD: two progestin-only contraceptives.
Topics: Administration, Oral; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Progesterone Congeners | 1995 |
Emergency postcoital contraception.
Topics: Contraception; Contraceptives, Postcoital; Danazol; Embryo Implantation; Emergencies; Ethinyl Estradiol; Female; Fertilization; Humans; Intrauterine Devices; Levonorgestrel; Ovulation; Pregnancy; Pregnancy, Unwanted | 1997 |
Levonorgestrel subdermal implants. Contraception on trial.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Cost-Benefit Analysis; Drug Implants; Family Planning Services; Female; Humans; Levonorgestrel; Pregnancy; Product Surveillance, Postmarketing; Risk Factors | 1997 |
Norplant failure: an adolescent case study and review of the literature.
Topics: Adolescent; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Risk Factors; Weight Gain | 1998 |
Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Implants; Drug Interactions; Female; Humans; Infant, Newborn; Levonorgestrel; Patient Satisfaction; Pregnancy; Pregnancy Outcome; Progesterone Congeners; Skin Absorption | 1998 |
Long-term experience of a levonorgestrel-releasing intrauterine system.
Topics: Contraceptive Agents, Female; Equipment Failure; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk Factors; Uterine Hemorrhage | 1996 |
Research on mifepristone and levonorgestrel in comparison with the Yuzpe regimen.
Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Therapy, Combination; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Mifepristone; Norgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; World Health Organization | 1998 |
The use of long-acting contraceptives in adolescents.
Topics: Adolescent; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Progesterone Congeners | 1999 |
Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Drug Implants; Female; Humans; Injections, Subcutaneous; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction; Pregnancy; Prospective Studies; Technology Assessment, Biomedical; Treatment Outcome | 2000 |
Emergency contraception.
Topics: Androgens; Contraceptives, Postcoital; Contraindications; Drug Costs; Estradiol Congeners; Female; Hormone Antagonists; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Progesterone; Progestins; United States | 2000 |
Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature.
Topics: Animals; Contraceptives, Postcoital; Estrogens; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Pregnancy; Progestins | 2001 |
[Contraception with depot gestagens].
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy | 2001 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Pregnancy; Randomized Controlled Trials as Topic | 2001 |
Progestin-releasing intrauterine systems.
Topics: Acne Vulgaris; Clinical Trials as Topic; Contraceptive Agents, Female; Depression; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Progesterone; Progesterone Congeners; Uterine Hemorrhage; Uterine Perforation; Weight Gain | 2001 |
Implant contraception.
Topics: Cervix Mucus; Clinical Trials as Topic; Contraceptive Agents, Female; Counseling; Desogestrel; Drug Implants; Endometrium; Female; Humans; Levonorgestrel; Megestrol; Norprogesterones; Ovulation; Patient Satisfaction; Pregnancy; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Vinyl Compounds | 2001 |
Therapeutic use of the LNG IUS, and counseling.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contraceptive Agents, Female; Counseling; Endometriosis; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Premenstrual Syndrome | 2001 |
Hormonal emergency contraception.
Topics: Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Danazol; Drug Administration Schedule; Female; Humans; Levonorgestrel; Mifepristone; Nausea; Pregnancy; Vomiting | 2002 |
Noncontraceptive health benefits of intrauterine devices: a systematic review.
Topics: Endometrial Neoplasms; Female; Genital Diseases, Female; Hormone Replacement Therapy; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Progesterone Congeners | 2002 |
Postfertilization effect of hormonal emergency contraception.
Topics: Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Ovulation; Pregnancy | 2002 |
Subdermal progestin implant contraception.
Topics: Biodegradation, Environmental; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Pregnancy; Pregnancy, Ectopic | 1991 |
Norplant: subdermal implant system for long-term contraception.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Intrauterine steroid contraceptives.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy | 1987 |
180 trial(s) available for levonorgestrel and Pregnancy
| Article | Year |
|---|---|
Comparing levonorgestrel intrauterine system versus hysteroscopic resection in patients with postmenstrual spotting related to a niche in the caesarean scar (MIHYS NICHE trial): protocol of a randomised controlled trial.
Topics: Cesarean Section; Child; China; Cicatrix; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Randomized Controlled Trials as Topic; Uterus | 2021 |
Effectiveness, safety and overall satisfaction of early postpartum placement of hormonal IUD compared with standard procedure: An open-label, randomized, multicenter study.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Personal Satisfaction; Postpartum Period; Pregnancy | 2022 |
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
Topics: Cohort Studies; Demography; Dysmenorrhea; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Risk Factors | 2022 |
One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Utah | 2023 |
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
Topics: Adolescent; Adult; Benzoxazines; Contraceptive Agents, Female; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged; Pregnancy; Young Adult | 2023 |
Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
Topics: Adolescent; Adult; Brazil; Copper; Dysmenorrhea; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Young Adult | 2023 |
Comparing levonorgestrel intrauterine system with hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open-label, controlled trial.
Topics: China; Cicatrix; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Metrorrhagia; Pelvic Pain; Pregnancy; Uterus | 2023 |
Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Prospective Studies; Treatment Outcome | 2023 |
Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
Topics: Contraception; Contraceptive Agents, Female; Curcumin; Female; Humans; Levonorgestrel; Metrorrhagia; Pregnancy; Uterine Hemorrhage | 2023 |
Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study.
Topics: China; Endometrial Hyperplasia; Female; Fertility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Pregnancy; Prospective Studies | 2023 |
Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial.
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Cyclooxygenase Inhibitors; Female; Humans; Levonorgestrel; Piroxicam; Pregnancy | 2023 |
Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD.
Topics: Contraceptive Agents; Copper; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Systems Analysis | 2023 |
Pragmatic cluster randomised cohort cross-over trial to determine the effectiveness of bridging from emergency to regular contraception: the Bridge-It study protocol.
Topics: Abortion, Induced; Adult; Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Cross-Over Studies; Desogestrel; Female; Humans; Levonorgestrel; Pharmacy; Pilot Projects; Pragmatic Clinical Trials as Topic; Pregnancy; Pregnancy, Unplanned; Progestins; Surveys and Questionnaires; Young Adult | 2019 |
Postplacental placement of intrauterine devices: A randomized clinical trial.
Topics: Adolescent; Adult; Brazil; Contraceptive Agents, Female; Delivery, Obstetric; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Logistic Models; Multivariate Analysis; Obstetrics; Postnatal Care; Pregnancy; Risk Factors; Time Factors; Young Adult | 2020 |
Benefits of vaginal dinoprostone administration prior to levonorgestrel-releasing intrauterine system insertion in women delivered only by elective cesarean section: a randomized double-blinded clinical trial.
Topics: Adult; Cesarean Section; Contraceptive Agents, Hormonal; Dinoprostone; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Oxytocics; Pregnancy; Prospective Studies | 2020 |
Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.
Topics: Adult; Contraceptive Agents, Female; Dysmenorrhea; Female; Gravidity; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lidocaine; Pain Measurement; Pregnancy | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation.
Topics: Contraceptive Agents, Female; Female; Fertilization; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Pregnancy | 2021 |
Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Pregnancy Tests; Unsafe Sex; Young Adult | 2021 |
Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years.
Topics: Cesarean Section; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Pregnancy | 2021 |
Risk of Pregnancy With Levonorgestrel-Releasing Intrauterine System Placement 6-14 Days After Unprotected Sexual Intercourse.
Topics: Contraception, Postcoital; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Prospective Studies; United States | 2021 |
Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
Topics: Contraception, Postcoital; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate | 2021 |
Immediate versus delayed postpartum use of levonorgestrel contraceptive implants: a randomized controlled trial in Uganda.
Topics: Adult; Birth Intervals; Contraceptive Agents, Female; Drug Implants; Female; Goals; Humans; Levonorgestrel; Postpartum Period; Pregnancy; Pregnancy, Unwanted; Time Factors; Uganda; Young Adult | 2017 |
Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy - 1 year continuation rates: a randomised controlled trial.
Topics: Abortion, Induced; Adult; Contraceptive Agents, Female; Female; Gestational Age; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Prospective Studies; Time-to-Treatment; Treatment Outcome; Young Adult | 2017 |
Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of late first- and second-trimester pregnancy: a randomised controlled trial.
Topics: Abortion, Induced; Adult; Contraceptive Agents, Female; Feasibility Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Safety; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Time Factors; Treatment Outcome; Young Adult | 2017 |
Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial.
Topics: Adolescent; Adult; Breast Feeding; Contraceptive Agents, Female; Equivalence Trials as Topic; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Parturition; Postpartum Period; Pregnancy; Prosthesis Implantation; Time Factors; Young Adult | 2017 |
Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Multivariate Analysis; Parity; Pregnancy; Regression Analysis; Time Factors; Young Adult | 2018 |
Counseling and in-advance provision of levonorgestrel emergency contraceptive pills decrease the rate of unplanned pregnancy during breastfeeding: a randomized controlled trial.
Topics: Adult; Breast Feeding; Contraception, Postcoital; Contraceptives, Postcoital; Counseling; Egypt; Female; Humans; Levonorgestrel; Postpartum Period; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Young Adult | 2019 |
Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial.
Topics: Adolescent; Adult; Depression; Dysmenorrhea; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; London; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Research Design; Sexual Dysfunction, Physiological; South Africa; Young Adult | 2017 |
Immediate Versus Delayed Insertion of the Levonorgestrel Intrauterine Device in Postpartum Adolescents: A Randomized Pilot Study.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Feasibility Studies; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pilot Projects; Postpartum Period; Pregnancy; Treatment Outcome; Young Adult | 2018 |
Bleeding patterns for the Liletta
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Parity; Pregnancy; Prospective Studies; Time Factors; Young Adult | 2018 |
Placement of Levonorgestrel Intrauterine Device at the Time of Cesarean Delivery and the Effect on Breastfeeding Duration.
Topics: Adult; Breast Feeding; Cesarean Section; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Lactation; Levonorgestrel; Outcome and Process Assessment, Health Care; Postpartum Period; Pregnancy | 2018 |
Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy Rate; United States; Young Adult | 2019 |
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Topics: Adolescent; Adult; Eswatini; Family Planning Services; Female; HIV Infections; Humans; Incidence; Intention to Treat Analysis; Intrauterine Devices, Copper; Kenya; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; South Africa; Young Adult; Zambia | 2019 |
Endometrial scratching performed in the non-transfer cycle and outcome of assisted reproduction: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Hormonal; Endometrium; Estradiol; Estrogens; Female; Humans; Infertility, Female; Levonorgestrel; Live Birth; Ovulation Induction; Pain; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Ultrasonography | 2013 |
The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
Topics: Adult; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Testosterone | 2013 |
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
Topics: Adolescent; Adult; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Uterine Perforation; Young Adult | 2013 |
A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel.
Topics: Adolescent; Adult; Brazil; Coitus; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Middle Aged; Pregnancy; Prospective Studies; United States; Young Adult | 2014 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
What proportion of Canadian women will accept an intrauterine contraceptive at the time of second trimester abortion? Baseline data from a randomized controlled trial.
Topics: Abortion, Induced; Adult; Canada; Educational Status; Female; Humans; Income; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Pregnancy Trimester, Second | 2014 |
Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial.
Topics: Academic Medical Centers; Adult; Cesarean Section; Chicago; Contraceptive Agents, Female; Early Termination of Clinical Trials; Female; Follow-Up Studies; Hospitals, Urban; Humans; Intention to Treat Analysis; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Lost to Follow-Up; Patient Satisfaction; Postnatal Care; Pregnancy; Time Factors; Young Adult | 2014 |
Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Pregnancy; Treatment Outcome; Young Adult | 2014 |
[Hormone therapy alone for pre-cancerous conditions and early endometrial cancer: pros and cons].
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Goserelin; Humans; Levonorgestrel; Neoplasm Recurrence, Local; Precancerous Conditions; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Rate; Treatment Outcome | 2014 |
We should really keep in touch: predictors of the ability to maintain contact with contraception clinical trial participants over 12 months.
Topics: Adolescent; Adult; Clinical Trials as Topic; Communication Barriers; Continuity of Patient Care; Contraception, Postcoital; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Levonorgestrel; Lost to Follow-Up; Patients; Pregnancy; Socioeconomic Factors; Telecommunications; Young Adult | 2014 |
Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception.
Topics: Body Mass Index; Body Weight; Contraceptives, Postcoital; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Ireland; Levonorgestrel; Models, Biological; Overweight; Pregnancy; Pregnancy Rate; Pregnancy, Unwanted; Risk; United Kingdom; United States | 2015 |
Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Topics: Abortion, Spontaneous; Adult; Biopsy; China; Embryo Implantation; Embryo Transfer; Endometrial Hyperplasia; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prospective Studies; Time Factors; Treatment Outcome | 2015 |
Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Ectopic; Pregnancy, Unplanned; Proportional Hazards Models; Prospective Studies; Treatment Outcome; Young Adult | 2015 |
Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Parity; Pelvic Infection; Pregnancy; Pregnancy Rate; Time Factors; Uterine Hemorrhage; Young Adult | 2015 |
Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial.
Topics: Adolescent; Adult; Cluster Analysis; Contraception; Contraceptive Agents, Female; Directive Counseling; Drug Implants; Family Planning Services; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; United States; Young Adult | 2015 |
Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
Topics: Abortion, Induced; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Young Adult | 2015 |
The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial.
Topics: Adolescent; Adult; Age Factors; Body Mass Index; Consumer Behavior; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Parity; Pregnancy; Safety; Young Adult | 2015 |
A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Outcome Assessment, Health Care; Pregnancy; Pregnancy, Unplanned; Time Factors; Young Adult | 2015 |
Intrauterine Contraception Among Women Living With Human Immunodeficiency Virus: A Randomized Controlled Trial.
Topics: Adult; Contraceptive Agents, Female; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Patient Compliance; Pregnancy; Young Adult | 2015 |
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Levonorgestrel; Nevirapine; Pregnancy; Pregnancy, Unplanned; Reverse Transcriptase Inhibitors; Time Factors; Uganda | 2016 |
A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
Topics: Adolescent; Adult; Coitus; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Middle Aged; Pregnancy; Sexual Behavior | 2016 |
A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.
Topics: Adolescent; Child; Contraceptive Agents, Female; Device Removal; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Satisfaction; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Pregnancy, Unplanned; Uterine Perforation | 2016 |
Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Device Removal; Female; Hemorrhage; Humans; Intrauterine Devices, Copper; Levonorgestrel; Patient Safety; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Time Factors | 2016 |
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Patient Satisfaction; Pregnancy; Pregnancy, Unplanned; Time Factors; Treatment Outcome; Young Adult | 2016 |
Long-Term Oncologic and Reproductive Outcomes in Young Women With Early Endometrial Cancer Conservatively Treated: A Prospective Study and Literature Update.
Topics: Adult; Endometrial Neoplasms; Female; Fertility; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Organ Sparing Treatments; Pregnancy; Prospective Studies | 2016 |
Intrauterine contraception after medical abortion: factors affecting success of early insertion.
Topics: Abortion, Induced; Adult; Aftercare; Contraception; Contraceptive Agents; Female; Finland; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Logistic Models; Misoprostol; Pregnancy; Pregnancy Trimester, First; Time Factors; Young Adult | 2017 |
A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.
Topics: Adolescent; Adult; Australia; China; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Pregnancy Rate; Republic of Korea; Treatment Outcome; Young Adult | 2017 |
Expressions of steroid receptors and Ki67 in first-trimester decidua and chorionic villi exposed to levonorgestrel used for emergency contraception.
Topics: Adult; Cell Proliferation; Chorionic Villi; Contraception, Postcoital; Contraceptive Agents, Female; Decidua; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Ki-67 Antigen; Levonorgestrel; Pregnancy; Pregnancy Trimester, First; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone | 2009 |
The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate | 2010 |
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
Topics: Adult; Coitus; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstrual Cycle; Meta-Analysis as Topic; Middle Aged; Norpregnadienes; Ovulation; Pregnancy; Treatment Outcome | 2010 |
A randomized clinical trial of two emergency contraceptive pill regimens in a Ugandan population.
Topics: Adolescent; Adult; Attitude to Health; Chi-Square Distribution; Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Developing Countries; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levonorgestrel; Logistic Models; Pregnancy; Reference Values; Risk Assessment; Treatment Outcome; Uganda; Young Adult | 2010 |
A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria.
Topics: Adult; Contraception, Postcoital; Contraceptives, Postcoital, Synthetic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levonorgestrel; Logistic Models; Nigeria; Pregnancy; Time Factors; Young Adult | 2010 |
Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Postpartum Period; Pregnancy; Time Factors | 2010 |
Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial.
Topics: Adolescent; Adult; China; Contraception, Postcoital; Female; Humans; Levonorgestrel; Middle Aged; Nonprescription Drugs; Pregnancy; Pregnancy Rate; Tablets, Enteric-Coated | 2011 |
Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration.
Topics: Adult; Breast Feeding; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Postpartum Period; Pregnancy; Treatment Outcome | 2011 |
Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
Topics: Abortion, Induced; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors; Young Adult | 2012 |
Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult | 2012 |
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.
Topics: Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pregnancy; Pregnancy, Unplanned; Time Factors; Treatment Outcome; Young Adult | 2012 |
Levonorgestrel-releasing intrauterine system versus laparoscopic supracervical hysterectomy for the treatment of heavy menstrual bleeding: a randomized study.
Topics: Adult; Body Mass Index; Female; Hemoglobins; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Outcome Assessment, Health Care; Pain, Postoperative; Parity; Pregnancy; Quality of Life; Rome; Surveys and Questionnaires | 2012 |
Assessment of the use of two new low-dose levonorgestrel-releasing intrauterine systems as contraceptives.
Topics: Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Pregnancy, Unplanned; Time Factors; Treatment Outcome | 2012 |
Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report.
Topics: Adult; Device Removal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Rate; Progesterone Congeners; United Kingdom; Uterine Hemorrhage | 2002 |
Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians.
Topics: Abdominal Pain; Adult; Contraceptives, Postcoital; Double-Blind Method; Female; Headache; Humans; Levonorgestrel; Menorrhagia; Nausea; Nigeria; Placebos; Pregnancy; Safe Sex; Vomiting | 2002 |
Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up.
Topics: Abortion, Induced; Adult; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pain; Pelvic Inflammatory Disease; Pregnancy; Uterine Hemorrhage | 2003 |
A multicenter, randomized study of an extended cycle oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Patient Compliance; Pregnancy | 2003 |
[Development of serial clinical study on mifepristone used as contraception].
Topics: Adult; Contraception; Contraceptives, Oral; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Mifepristone; Pregnancy; Pregnancy Rate | 2003 |
Effect of hormonal emergency contraception on bleeding patterns.
Topics: Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Interviews as Topic; Levonorgestrel; Menstruation; Menstruation Disturbances; Norethindrone; Pregnancy; Pregnancy, Unwanted; Safe Sex; Time Factors; Treatment Outcome | 2004 |
Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levonorgestrel; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2004 |
Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Menstrual Cycle; Patient Compliance; Pregnancy; Pregnancy Rate; Uterine Hemorrhage | 2005 |
A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception.
Topics: Adult; China; Coitus; Contraceptives, Postcoital, Synthetic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levonorgestrel; Male; Pregnancy; Time Factors | 2005 |
[Antagonist protocols: residual LH levels and the value of exogenous LH supplementation].
Topics: Adult; Anovulation; Biological Availability; Clinical Protocols; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies | 2004 |
Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
Topics: Contraceptive Agents, Female; Contraceptives, Oral; DNA, Viral; Female; Humans; Injections; Levonorgestrel; Logistic Models; Papanicolaou Test; Papillomaviridae; Parity; Pregnancy; Prospective Studies; Risk Factors; Uterine Cervical Dysplasia; Vaginal Smears | 2005 |
Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Device Removal; Endometrium; Equipment Design; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Ultrasonography; Uterine Hemorrhage | 2005 |
A trial of contraceptive methods in women with systemic lupus erythematosus.
Topics: Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Lupus Erythematosus, Systemic; Pregnancy; Severity of Illness Index; Single-Blind Method | 2005 |
Patterns of emergency contraception use by age and ethnicity from a randomized trial comparing advance provision and information only.
Topics: Adolescent; Adult; Age Factors; Contraception, Postcoital; Contraceptives, Postcoital; Ethnicity; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Middle Aged; Pregnancy; Risk-Taking; Surveys and Questionnaires | 2006 |
Progesterone receptor modulator for emergency contraception: a randomized controlled trial.
Topics: Adolescent; Adult; Contraceptives, Postcoital; Double-Blind Method; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Rate | 2006 |
Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study.
Topics: Administration, Oral; Adolescent; Adult; Australia; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovulation; Pilot Projects; Pregnancy; Pregnancy Rate; Progesterone | 2007 |
Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years.
Topics: Administration, Cutaneous; Adult; Age Factors; Contraceptive Agents; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Pregnancy; Thailand; Time Factors | 2007 |
The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow.
Topics: Adult; Age Factors; Arteries; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Luteal Phase; Microvessels; Odds Ratio; Parity; Pregnancy; Prospective Studies; Regional Blood Flow; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Pulsed; Uterus | 2008 |
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Topics: Adolescent; Adult; Blood Proteins; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Denmark; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Norway; Pregnancy; Sex Hormone-Binding Globulin; Sweden; Transcortin | 1982 |
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand | 1984 |
Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Topics: Adolescent; Adult; Brazil; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Finland; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Outpatient Clinics, Hospital; Pain; Pregnancy; Random Allocation; Uterine Hemorrhage | 1983 |
Clinical experience with a low-dose contraceptive agent. European studies.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Digestive System; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Latin America; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth.
Topics: Adult; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Three-year experience with NORPLANT subdermal contraception.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Implants; Female; Hemoglobins; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Norgestrel; Norgestrienone; Pain; Patient Dropouts; Pregnancy | 1983 |
Plasma lipids in women using progestogen-only oral contraceptives.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Female; Humans; Lactation; Levonorgestrel; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Norethindrone; Norgestrel; Pregnancy; Triglycerides | 1983 |
Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
Topics: Adolescent; Adult; Capsules; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Silicone Elastomers; Uterine Hemorrhage | 1984 |
Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1984 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemoglobins; Humans; Levonorgestrel; Norgestrel; Pregnancy; Vagina | 1981 |
A randomized, double-blind study of six combined oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Random Allocation | 1982 |
A randomized, double-blind study of two combined and two progestogen-only oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norgestrel; Pregnancy; Random Allocation | 1982 |
Long-term intracervical contraception with a levonorgestrel device.
Topics: Adult; Biopsy; Cervix Mucus; Cervix Uteri; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation; Norgestrel; Pain; Pregnancy; Vaginal Smears | 1982 |
Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device.
Topics: Adult; Breast Feeding; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Metrorrhagia; Middle Aged; Migraine Disorders; Norgestrel; Postpartum Period; Pregnancy | 1982 |
The non-contraceptive effects of the levonorgestrel-releasing intrauterine device.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic | 1994 |
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
A five-year evaluation of NORPLANT II implants in China.
Topics: Adult; Cardiovascular Diseases; China; Drug Implants; Female; Hematologic Diseases; Humans; Levonorgestrel; Pregnancy | 1994 |
Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
Topics: Adult; Amenorrhea; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 1994 |
A 5-year evaluation of NORPLANT contraceptive implants in China.
Topics: Adult; China; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Prospective Studies; Thrombocytopenia | 1994 |
Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR).
Topics: Adolescent; Adult; Chi-Square Distribution; Female; Genital Diseases, Female; Health Status; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menstruation; Patient Dropouts; Patient Satisfaction; Pregnancy; Prospective Studies | 1994 |
A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
Topics: Adolescent; Adult; Chile; Contraceptives, Oral, Combined; Dominican Republic; Ecuador; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Sri Lanka; Sudan | 1993 |
A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
Topics: Adolescent; Adult; Bangladesh; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Surveys and Questionnaires | 1993 |
Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
Topics: Adolescent; Adult; Body Weight; Drug Implants; Family Characteristics; Female; Follow-Up Studies; Foreign-Body Migration; Humans; Infections; Levonorgestrel; Menstruation Disturbances; Patient Dropouts; Patient Satisfaction; Pregnancy | 1993 |
Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Topics: Administration, Intravaginal; Adolescent; Adult; Desogestrel; Developing Countries; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Patient Acceptance of Health Care; Pregnancy; Random Allocation; Vagina | 1993 |
Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil.
Topics: Adult; Brazil; Evaluation Studies as Topic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Pregnancy; Time Factors | 1993 |
A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception.
Topics: Adolescent; Adult; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Hong Kong; Humans; Levonorgestrel; Norgestrel; Pregnancy; Prospective Studies | 1993 |
A Latin American experience with levonorgestrel IUD.
Topics: Adult; Amenorrhea; Brazil; Developing Countries; Dominican Republic; Female; Ferritins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Luteal Phase; Pregnancy | 1993 |
Effectiveness of Norplant implants through seven years: a large-scale study in China.
Topics: Adult; Age Factors; Body Weight; China; Cohort Studies; Drug Implants; Female; Humans; Levonorgestrel; Life Tables; Pregnancy; Pregnancy Rate; Time Factors | 1995 |
Subdermal levonorgestrel implants. Three years' experience in Cairo, Egypt.
Topics: Administration, Cutaneous; Adult; Amenorrhea; Contraceptive Agents, Female; Drug Implants; Egypt; Family Planning Policy; Female; Headache; Humans; Hypertension; Incidence; Levonorgestrel; Longitudinal Studies; Pregnancy; Pregnancy Rate | 1995 |
Effectiveness of Norplant implants among Thai women in Bangkok.
Topics: Acne Vulgaris; Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Drug Implants; Female; Headache; Humans; Levonorgestrel; Life Tables; Melanosis; Menstrual Cycle; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Pregnancy Rate; Thailand | 1996 |
A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal.
Topics: Adolescent; Adult; Cohort Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Patient Dropouts; Pregnancy; Pregnancy, Ectopic; Progesterone Congeners; Prospective Studies; Treatment Refusal; Uterus | 1996 |
Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle.
Topics: Administration, Oral; Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic; Danazol; Drug Combinations; Endometrium; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstruation; Pregnancy; Pregnanediol | 1996 |
Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Topics: Abortion, Induced; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pregnancy; Progesterone Congeners; Retrospective Studies; Software; Time Factors | 1996 |
Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls.
Topics: Adolescent; Adult; Analysis of Variance; Capsules; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Finland; Humans; Incidence; Levonorgestrel; Menstruation Disturbances; Pregnancy; Pregnancy Rate; Singapore; Thailand; United States | 1997 |
Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Time Factors | 1997 |
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Headache; Humans; Incidence; Levonorgestrel; Life Tables; Menstruation; Metrorrhagia; Middle Aged; Patient Compliance; Patient Dropouts; Pregnancy; Pregnancy Rate; Safety; Uterine Cervical Neoplasms; Uterine Hemorrhage | 1997 |
A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Patient Compliance; Pregnancy; Uterine Hemorrhage | 1997 |
[Contraception by subcutaneous Norplant implants. 300 cases].
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Prurigo; Senegal | 1998 |
The effects of self-administering emergency contraception.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Postcoital, Hormonal; Drug Prescriptions; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Self Administration | 1998 |
Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Double-Blind Method; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Nausea; Pregnancy; Pregnancy, Unwanted; Risk; Time Factors; Vomiting | 1998 |
Levonorgestrel capsule implants in the United States: a 5-year study.
Topics: Adult; Capsules; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Time Factors; United States | 1998 |
Experience of Thai women in Bangkok with Norplant-2 implants.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Pregnancy; Socioeconomic Factors; Thailand | 1998 |
Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
Topics: Adolescent; Adult; Analysis of Variance; Chi-Square Distribution; Contraceptive Agents, Female; Dominican Republic; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; United States | 1998 |
The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Treatment Outcome | 1998 |
A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progest
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Pregnancy; Progesterone Congeners; Safety; Time Factors | 1998 |
Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Patient Satisfaction; Pregnancy; Prospective Studies; Treatment Outcome; United Kingdom | 1999 |
Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
Topics: Adult; Contraceptive Agents, Female; Drug Monitoring; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Pelvic Inflammatory Disease; Postmenopause; Pregnancy; Regression Analysis | 1999 |
A 5-year clinical evaluation of Norplant implants in Senegal.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Prospective Studies; Senegal | 1999 |
Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study.
Topics: Adolescent; Adult; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Proportional Hazards Models; Sterilization, Tubal; Time Factors | 2000 |
Initial UK experience of the levonorgestrel-releasing contraceptive intravaginal ring.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Menstruation; Patient Satisfaction; Pregnancy; United Kingdom | 1999 |
The effects of two progrestogen-only pills containing either desogestrel (75 microgram/day) or levonorgestrel (30 microgram/day) on carbohydrate metabolism and adrenal and thyroid function.
Topics: Adolescent; Adrenal Glands; Adult; Carbohydrate Metabolism; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Female; Finland; Humans; Levonorgestrel; Middle Aged; Pregnancy; Reference Values; Thyroid Gland | 2001 |
Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Pregnancy | 2001 |
Efficacy and safety of a transdermal contraceptive system.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy | 2001 |
Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years.
Topics: Adolescent; Adult; Amenorrhea; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Oligomenorrhea; Patient Satisfaction; Pregnancy; Prospective Studies; Uterine Hemorrhage | 2002 |
[Clinical study on women with amenorrhea after levonorgestrel intrauterine system].
Topics: Adult; Amenorrhea; Consumer Product Safety; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices; Levonorgestrel; Menstruation; Pregnancy; Progesterone Congeners; Time Factors | 2001 |
A randomised study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital, Synthetic; Emergencies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Mifepristone; Ovulation; Patient Satisfaction; Pregnancy; Treatment Outcome | 2002 |
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Danazol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Middle Aged; Mifepristone; Nausea; Pregnancy; Treatment Outcome; Vomiting | 1992 |
Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
Topics: Female; Fertility; Fertilization; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Male; Pregnancy; Pregnancy Outcome; Time Factors | 1992 |
Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative study.
Topics: Adult; Amenorrhea; Contraception; Drug Implants; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Menstruation; Patient Satisfaction; Pregnancy | 1992 |
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Topics: Administration, Intravaginal; Contraception; Contraception Behavior; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Pessaries; Pregnancy | 1990 |
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Topics: Administration, Intravaginal; Body Weight; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Pregnancy | 1990 |
Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Indian Council of Medical Research Task Force on IUD.
Topics: Adolescent; Adult; Female; Humans; Infections; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Uterine Perforation | 1989 |
A comparative analysis of three different dose combinations of oral contraceptives.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Nausea; Norethindrone; Norgestrel; Patient Compliance; Philippines; Pregnancy | 1989 |
Norplant: subdermal implant system for long-term contraception.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
Clinical evaluation of the Capronor contraceptive implant: preliminary report.
Topics: Administration, Cutaneous; Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Random Allocation | 1989 |
The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breast-feeding.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Infant; Infant Nutritional Physiological Phenomena; Lactation; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
Microdose intrauterine levonorgestrel for contraception. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy, Ectopic; Random Allocation | 1987 |
Five years' experience with levonorgestrel-releasing IUDs.
Topics: Adult; Amenorrhea; Female; Humans; Infections; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Random Allocation | 1986 |
Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task For
Topics: Adolescent; Adult; Avitaminosis; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy; Social Class; Vitamins | 1986 |
Two-year prospective study in Colombia of Norplant implants.
Topics: Adolescent; Adult; Clinical Trials as Topic; Colombia; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Pregnancy; Prospective Studies; Stereoisomerism | 1986 |
Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device.
Topics: Adult; Clinical Trials as Topic; Female; Fertility; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Prospective Studies; Random Allocation | 1986 |
Clinical performance with contraceptive vaginal rings containing levonorgestrel.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy | 1986 |
Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Estradiol; Female; Half-Life; Humans; Kinetics; Levonorgestrel; Norgestrel; Pregnancy; Sex Hormone-Binding Globulin | 1987 |
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pain; Pelvic Inflammatory Disease; Pregnancy; Random Allocation | 1987 |
ICMR Task Force Study on hormonal contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Infant; Lactation; Levonorgestrel; Milk, Human; Norethindrone; Norgestrel; Pregnancy | 1987 |
Long-term follow-up of women treated with Norplant implants.
Topics: Adult; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Time Factors | 1987 |
A new delivery system for contraceptive steroids.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1987 |
Norplant contraceptive implants: rods versus capsules.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Pregnancy; Random Allocation | 1987 |
Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Pregnancy; Sweden | 1988 |
Clinical trial of a post-coital contraceptive pill.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Postcoital; Endometrium; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1988 |
Contraception with long-acting subdermal implants. A five-year clinical trial with Silastic covered rod implants containing levonorgestrel. The International Committee for Contraception Research (ICCR) of the Population Council.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Pregnancy; Time Factors | 1985 |
Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth.
Topics: Adolescent; Adult; Breast Feeding; Child Development; Clinical Trials as Topic; Drug Implants; Female; Humans; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Menstruation Disturbances; Milk, Human; Norgestrel; Pregnancy | 1985 |
A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Models, Biological; Norgestrel; Pregnancy; Progesterone; Silicone Elastomers; Stereoisomerism; Vagina | 1985 |
Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Intrauterine Devices; Lactation; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism | 1985 |
573 other study(ies) available for levonorgestrel and Pregnancy
| Article | Year |
|---|---|
The effect of a hysteroscopic niche resection compared with Levonorgestrel-releasing intrauterine device on postmenstrual spotting in patients with a symptomatic niche in the uterine cesarean scar: A prospective cohort study.
Topics: Child; China; Cicatrix; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Prospective Studies | 2021 |
Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Pregnancy | 2022 |
Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena
Topics: Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Personal Satisfaction; Pregnancy; Prospective Studies | 2021 |
Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
Topics: Adult; Contraceptive Agents, Female; Delivery, Obstetric; Female; Health Policy; Humans; Inpatients; Intrauterine Devices; Levonorgestrel; Long-Acting Reversible Contraception; Ohio; Postpartum Period; Pregnancy; Pregnancy Rate; Retrospective Studies | 2021 |
Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia.
Topics: Abortion, Spontaneous; Adult; Cohort Studies; Endometrial Hyperplasia; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Rate; Prospective Studies; Reproductive Techniques, Assisted; Treatment Outcome | 2021 |
Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Megestrol; Norpregnadienes; Pregnancy; Pregnancy, Unplanned | 2021 |
Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones.
Topics: Absorbable Implants; Anti-Retroviral Agents; Female; HIV Infections; Hormones; Humans; Levonorgestrel; Pregnancy | 2021 |
Levonorgestrel intrauterine system for the treatment of intermenstrual spotting in patients with previous cesarean delivery scar defect.
Topics: Cicatrix; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Pregnancy; Retrospective Studies | 2022 |
The Intrauterine Device Experience Among Transgender and Gender-Diverse Individuals Assigned Female at Birth.
Topics: Contraception; Female; Humans; Infant, Newborn; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Transgender Persons | 2021 |
Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome.
Topics: Adolescent; Adult; Child; Contraceptive Agents, Female; Ehlers-Danlos Syndrome; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Retrospective Studies; Young Adult | 2022 |
Early contraceptive implants removal and its associated factors among women using implants at a National Referral Hospital, Kampala Uganda.
Topics: Contraceptive Agents, Female; Cross-Sectional Studies; Drug Implants; Female; Hospitals; Humans; Levonorgestrel; Pregnancy; Referral and Consultation; Uganda | 2021 |
Reasons reported by women for choosing the levonorgestrel intrauterine system as a contraceptive method.
Topics: Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Pregnancy | 2022 |
Perspectives of health care providers regarding the levonorgestrel-releasing intrauterine system.
Topics: Contraceptive Agents, Female; Female; Health Personnel; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2022 |
A Cost Effectiveness Model of Long-Acting Reversible Contraceptive Methods in the Brazilian National Health System.
Topics: Adolescent; Contraception; Contraceptive Agents; Contraceptive Devices; Cost-Benefit Analysis; Female; Humans; Levonorgestrel; Pregnancy | 2022 |
Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France.
Topics: Adolescent; Adult; Communicable Disease Control; Contraception; Contraception, Postcoital; Contraceptive Agents, Female; COVID-19; Female; Humans; Infant; Levonorgestrel; Pandemics; Pregnancy; SARS-CoV-2; Young Adult | 2022 |
Adenomyosis: Diagnosis and Management.
Topics: Adenomyosis; Adult; Contraceptive Agents, Hormonal; Endometriosis; Female; Humans; Hysterectomy; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Pelvic Pain; Pregnancy; Risk Factors; Ultrasonography | 2022 |
Fertility-preserving treatment in patients with early-stage endometrial cancer: A protocol for systematic review and meta-analysis.
Topics: Contraceptive Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Meta-Analysis as Topic; Pregnancy; Progestins; Systematic Reviews as Topic | 2021 |
Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Spain | 2022 |
The impact of awareness and attitudes towards long-action reversible contraceptives on the intention to use: a survey among youth with unintended pregnancies.
Topics: Adolescent; Attitude; China; Contraceptive Agents; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intention; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Unplanned | 2022 |
Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation.
Topics: Contraception; Copper; Female; Humans; Levonorgestrel; Pelvic Pain; Pregnancy; Retrospective Studies; Sterilization, Tubal; United States | 2022 |
Patient acceptability, continuation and complication rates with immediate postpartum levonorgestrel intrauterine device insertion at caesarean section and vaginal birth.
Topics: Cesarean Section; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Postpartum Period; Pregnancy; Retrospective Studies | 2022 |
Effect of Hysteroscopic Polypectomy Combined with Mirena Placement on Postoperative Adverse Reactions and Recurrence Rate of Endometrial Polyps: Based on a Large-Sample, Single-Center, Retrospective Cohort Study.
Topics: Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Polyps; Pregnancy; Retrospective Studies; Uterine Neoplasms | 2022 |
Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.
Topics: Adolescent; Adult; Amenorrhea; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Young Adult | 2022 |
Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
Topics: Contraception; Contraceptive Agents, Female; Female; Hormonal Contraception; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Progestins | 2022 |
Delayed pregnancy detection and return to fertility with extended levonorgestrel-containing oral contraceptives: A real world setting cohort study.
Topics: Cohort Studies; Contraceptives, Oral, Combined; Female; Fertility; Humans; Levonorgestrel; Pregnancy; Retrospective Studies | 2023 |
Evaluation of the Efficacy and Adverse Reactions of Mirena Combined with Hysteroscopic Surgery When Treating AUB: Based on a Retrospective Cohort Study.
Topics: Case-Control Studies; Female; Humans; Hysteroscopy; Levonorgestrel; Mastodynia; Nausea; Pregnancy; Quality of Life; Retrospective Studies; Uterine Hemorrhage | 2022 |
Use of Two Levonorgestrel Intrauterine Devices in a Patient with a Uterus Didelphys: A Case Report.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Uterus; Young Adult | 2022 |
The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2022 |
Cost of providing family planning services & management of pregnancy outcomes at public health facilities in India.
Topics: Family Planning Services; Female; Health Facilities; Humans; India; Levonorgestrel; Pregnancy; Pregnancy Outcome | 2022 |
The impact of caller characteristics on levonorgestrel emergency contraception access in West Virginia community pharmacies.
Topics: Adolescent; Contraception, Postcoital; Cross-Sectional Studies; Female; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Pharmacies; Pregnancy; West Virginia | 2022 |
Oral Emergency Contraception Provision in the Veterans Health Administration: a Retrospective Cohort Study.
Topics: Adult; Contraception, Postcoital; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Retrospective Studies; Veterans Health | 2022 |
Emergency contraception subsidy in Canada: a comparative policy analysis.
Topics: Contraception, Postcoital; Female; Humans; Levonorgestrel; Policy; Policy Making; Pregnancy; Pregnancy, Unplanned | 2022 |
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis.
Topics: Adolescent; Adult; Alkynes; Benzoxazines; Contraceptive Agents; Cyclopropanes; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged; Nevirapine; Pregnancy; Retrospective Studies; Young Adult | 2022 |
Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Metrorrhagia; Pregnancy | 2022 |
Evidence-Based Contraception: Common Questions and Answers.
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Gender Identity; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Pregnancy; Testosterone; United States | 2022 |
Real-world satisfaction and menstrual bleeding pattern with available LNG-IUD among Spanish young women.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Personal Satisfaction; Pregnancy; Prospective Studies; Young Adult | 2022 |
Feasibility of e-commerce pharmacy provision and acceptability of levonorgestrel 1.5 mg for pericoital use in urban and peri-urban settings in Kenya: a prospective cohort study.
Topics: Commerce; Feasibility Studies; Female; Humans; Kenya; Levonorgestrel; Pharmacy; Pregnancy; Prospective Studies | 2023 |
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia.
Topics: Aromatase Inhibitors; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Letrozole; Levonorgestrel; Male; Pregnancy; Progestins; Retrospective Studies | 2022 |
Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year exper
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovulation Induction; Pregnancy; Retrospective Studies; Tertiary Care Centers | 2023 |
Single-visit long-acting reversible contraception provision and pregnancy rates within 3 months.
Topics: Brazil; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Long-Acting Reversible Contraception; Pregnancy; Pregnancy Rate; Prospective Studies | 2023 |
Co-delivery of an HIV prophylactic and contraceptive using PGSU as a long-acting multipurpose prevention technology.
Topics: Contraceptive Agents, Female; Diazonium Compounds; Female; HIV Infections; Humans; Levonorgestrel; Pregnancy | 2023 |
Levonorgestrel-Releasing Intrauterine System: A Promising Choice after Uterovaginal Anastomosis in Patients with Cervical Dysgenesis.
Topics: Adolescent; Anastomosis, Surgical; Contraceptive Agents, Female; Dysmenorrhea; Female; Hematometra; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Retrospective Studies | 2023 |
User satisfaction with an intrauterine system containing 52 mg levonorgestrel: a Portuguese study.
Topics: Dysmenorrhea; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Personal Satisfaction; Portugal; Pregnancy; Prospective Studies | 2023 |
Use of the Levonorgestrel Intrauterine Device in an Adolescent with Type IV Vascular Ehlers-Danlos Syndrome and Heavy Menstrual Bleeding, a Case Report.
Topics: Adolescent; Contraceptive Agents, Female; Ehlers-Danlos Syndrome; Ehlers-Danlos Syndrome, Type IV; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Treatment Outcome | 2023 |
Risk factors for ectopic pregnancy in a sub-Saharan African country.
Topics: Africa South of the Sahara; Case-Control Studies; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Risk Factors | 2023 |
Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
Topics: Contraceptive Agents, Female; Female; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2023 |
The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research.
Topics: Adult; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Female; Fertility Preservation; Glucagon-Like Peptide-1 Receptor; Humans; Levonorgestrel; Obesity; Polycystic Ovary Syndrome; Pregnancy; Progestins | 2023 |
Assessment of pain and ease of intrauterine device placement according to type of device, parity, and mode of delivery.
Topics: Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Male; Pain; Pain Measurement; Parity; Pregnancy | 2023 |
Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
Topics: Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Progestins; Uterine Neoplasms; Venous Thromboembolism | 2023 |
Acceptability and continuation of use of the subdermal contraceptive implant among adolescents and young women in Argentina: a retrospective cohort study.
Topics: Adolescent; Adult; Argentina; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Retrospective Studies; Young Adult | 2023 |
Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.
Topics: Carotid Intima-Media Thickness; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteinizing Hormone; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 2023 |
Feasibility and Acceptability of LNG 1.5 mg as an On-Demand Pericoital Contraceptive in Ghana.
Topics: Contraception, Postcoital; Contraceptive Agents; Contraceptive Agents, Female; Feasibility Studies; Female; Ghana; Humans; Levonorgestrel; Pregnancy; Prospective Studies | 2023 |
Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
Topics: Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Risk | 2023 |
Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems-Reply.
Topics: Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Risk | 2023 |
Segmented in vitro fertilization and frozen embryo transfer in levonorgestrel-releasing intrauterine device treated patients with endometrial cancer.
Topics: Adult; Carcinoma, Endometrioid; Embryo Transfer; Endometrial Neoplasms; Female; Fertilization in Vitro; Humans; Intrauterine Devices; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Rate; Retrospective Studies | 2023 |
Gene Expression Changes in the Ovary Mediate Non-Anovulatory Mechanisms of Contraception with Levonorgestrel.
Topics: Animals; Contraception; Contraceptive Agents; Female; Gene Expression; Humans; Levonorgestrel; Ovary; Pregnancy; Rats; Rats, Wistar | 2023 |
Hysteroscopic suture of levonorgestrel-releasing intrauterine system: learning curve for in vitro simulation training.
Topics: Female; Humans; Hysteroscopy; Learning Curve; Levonorgestrel; Male; Pregnancy; Simulation Training; Sutures | 2023 |
Levonorgestrel only emergency contraceptive use and risk of ectopic pregnancy in Eldoret Kenya: a case-control study.
Topics: Adolescent; Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptives, Postcoital; Female; Humans; Kenya; Levonorgestrel; Logistic Models; Pregnancy; Pregnancy, Ectopic; Risk Factors; Surveys and Questionnaires; Young Adult | 2018 |
Progestin Therapy Not Likely to Be Harmful in Women with First Trimester Bleeding.
Topics: Contraceptive Agents, Female; Female; Hemorrhage; Humans; Levonorgestrel; Pregnancy; Pregnancy Trimester, First; Progestins | 2019 |
Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy Rate; Time Factors; Young Adult | 2020 |
SCAD: a gendered cardiac threat.
Topics: Adult; Clomiphene; Contraception; Contraceptives, Oral; Coronary Vessel Anomalies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Complications, Cardiovascular; Progesterone; Vascular Diseases | 2020 |
Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Hormonal; Contraceptives, Postcoital; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Tests; Risk Assessment; Time Factors; Unsafe Sex; Young Adult | 2020 |
Gynecologic Management of Pediatric and Adolescent Patients with Ehlers-Danlos Syndrome.
Topics: Adolescent; Contraceptive Agents, Hormonal; Dysmenorrhea; Ehlers-Danlos Syndrome; Female; Gynecology; Humans; Levonorgestrel; Menorrhagia; Pregnancy; Referral and Consultation; Retrospective Studies | 2020 |
Experience with same-day placement of the 52 mg levonorgestrel-releasing intrauterine system.
Topics: Abortion, Induced; Adolescent; Adult; Checklist; Cohort Studies; Contraception, Postcoital; Contraceptive Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteal Phase; Pregnancy; Pregnancy Tests; Retrospective Studies; Risk Assessment; Time Factors; Young Adult | 2020 |
The benefits and limitations of donating new contraceptive technology: The case of the International Contraceptive Access (ICA) Foundation and the LNG IUS Program in Brazil.
Topics: Adult; Brazil; Contraception; Contraceptive Agents, Female; Female; Health Care Costs; Health Services Accessibility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Unplanned | 2020 |
Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls.
Topics: Adolescent; Adult; Body Mass Index; Female; Gastric Bypass; Humans; Levonorgestrel; Obesity, Morbid; Pregnancy; Sweden; Young Adult | 2020 |
Ultrasound location of intrauterine devices placed at cesarean section over the first year postpartum.
Topics: Adult; Cesarean Section; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; New York City; Postpartum Period; Pregnancy; Prospective Studies; Time Factors; Ultrasonography; Uterus | 2020 |
Congenital virilization of female infants recognized after pregnancies with retained levonorgestrel intrauterine devices.
Topics: Female; Humans; Infant; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Virilism | 2020 |
Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study.
Topics: Adolescent; Adult; Biopsy, Needle; Curettage; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Progestins; Prospective Studies; Republic of Korea; Young Adult | 2020 |
A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Attitude of Health Personnel; Conservative Treatment; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; France; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Male; Middle Aged; Patient Education as Topic; Pregnancy; Progestins; Reproductive Medicine; Surveys and Questionnaires | 2020 |
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
Topics: Animals; Contraceptives, Oral, Combined; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Glucocorticoids; Glucosephosphate Dehydrogenase; Insulin Resistance; Levonorgestrel; Maternal-Fetal Exchange; Myocardium; Pregnancy; Progestins; Rats, Wistar | 2020 |
Post-placental intra-abdominal placement of levonorgestrel 52 mg intrauterine system: A case report.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2020 |
Levonorgestrel Intrauterine Device Use for Medical Indications in Nulliparous Adolescents and Young Adults.
Topics: Adolescent; Child; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Parity; Pregnancy; Retrospective Studies; Young Adult | 2021 |
Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure.
Topics: Contraception; Contraceptive Agents, Female; Contraceptive Effectiveness; Female; Humans; Intrauterine Devices, Medicated; Japan; Levonorgestrel; Patient Compliance; Pregnancy | 2020 |
Evaluation of clinical performance when intrauterine devices are inserted by different categories of healthcare professional.
Topics: Adolescent; Adult; Brazil; Child; Contraceptive Agents, Female; Delivery of Health Care; Female; Health Personnel; Hemorrhage; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Retrospective Studies; Young Adult | 2021 |
Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
Topics: Adult; Carcinoma in Situ; Conservative Treatment; Contraceptive Agents, Female; Dilatation and Curettage; Endometrial Neoplasms; Female; Gynatresia; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Risk | 2021 |
Contraception and ectopic pregnancy risk: a prospective observational analysis.
Topics: Cohort Studies; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Delayed-Action Preparations; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Ectopic; Proportional Hazards Models; Prospective Studies; Transdermal Patch | 2021 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Changes in use of hormonal long-acting reversible contraceptive methods in Australia between 2006 and 2018: A population-based study.
Topics: Adolescent; Adult; Australia; Contraception; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Retrospective Studies; Young Adult | 2021 |
[Emergency contraception : practical guideline].
Topics: Belgium; Contraception, Postcoital; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy; Unsafe Sex | 2020 |
Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system.
Topics: Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Effectiveness; Cytochrome P-450 CYP3A; Desogestrel; Drug Implants; Drug Interactions; Female; Humans; Levonorgestrel; Pharmaceutical Preparations; Pregnancy | 2021 |
Breast cancer recurrence risk after hormonal contraceptive use in survivors of reproductive age.
Topics: Adolescent; Adult; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Survivors; Young Adult | 2021 |
Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Middle Aged; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2021 |
Thirty years of mirena: A story of innovation and change in women's healthcare.
Topics: Adult; Diffusion of Innovation; Female; History, 20th Century; History, 21st Century; Humans; Levonorgestrel; Pregnancy; Women's Health | 2021 |
Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
Topics: Cesarean Section; Child; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Netherlands; Pregnancy | 2021 |
Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report.
Topics: Adult; Fallopian Tubes; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Pregnancy, Tubal; Salpingectomy | 2021 |
Discussing pregnancy prevention with bariatric surgery patients.
Topics: Bariatric Surgery; Ethinyl Estradiol; Female; Gastric Bypass; Humans; Levonorgestrel; Obesity, Morbid; Pregnancy | 2021 |
Choosing Plan B Over Plan A: Risk Compensation Theory and Contraceptive Choice in India.
Topics: Condoms; Contraception; Contraceptive Agents; Female; Humans; India; Levonorgestrel; Pregnancy | 2021 |
Major differences in the characteristics of users of the copper intrauterine device or levonorgestrel intrauterine system at a clinic in Campinas, Brazil.
Topics: Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Retrospective Studies | 2022 |
Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Desogestrel; Drug Administration Routes; Female; France; Humans; Levonorgestrel; Long-Acting Reversible Contraception; Middle Aged; Models, Economic; Pregnancy; Young Adult | 2021 |
Over-the-counter access to levonorgestrel emergency contraception in South Texas: Does Over-the-counter mean ready to buy?
Topics: Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Nonprescription Drugs; Pregnancy; Texas | 2021 |
Predictors of Discontinuation of Subdermal Levonorgestrel Implants (Jadelle) at the Lagos University Teaching Hospital, Lagos, Nigeria: An Analytic Cohort Study.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Drug Implants; Female; Humans; Kaplan-Meier Estimate; Levonorgestrel; Long-Acting Reversible Contraception; Middle Aged; Nigeria; Patient Acceptance of Health Care; Pregnancy | 2020 |
Pain scores at the insertion of the 52 MG levonorgestrel-releasing intrauterine system among nulligravidas and parous women.
Topics: Administration, Intravaginal; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Drug Delivery Systems; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pain; Pain Management; Pain Measurement; Parity; Pregnancy; Prospective Studies; Young Adult | 2021 |
[Long-acting reversible contraception methods in women under 26 years of age].
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Long-Acting Reversible Contraception; Pregnancy; Retrospective Studies; Young Adult | 2021 |
Where does the money go to? Cost analysis of gynecological patients with a benign condition.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2021 |
Knowledge and attitude about intrauterine contraceptive devices among patients attending the National Guard Hospital in Jeddah, Saudi Arabia: a cross-sectional study.
Topics: Attitude; Cross-Sectional Studies; Female; Hospitals; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Saudi Arabia | 2022 |
Adolescent contraception.
Topics: Adolescent; Bone Density; Canada; Contraception; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Sexually Transmitted Diseases | 2021 |
Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study.
Topics: Adult; Age Factors; Cohort Studies; Ethnicity; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Satisfaction; Pregnancy; Proportional Hazards Models; Retrospective Studies; Time Factors | 2017 |
Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
Topics: Adolescent; Adult; Contraception; Delivery, Obstetric; Female; Hospitals; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Postpartum Period; Pregnancy; Prenatal Care; Prospective Studies; Young Adult | 2017 |
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.
Topics: Administration, Oral; Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2017 |
Continuation of a Levonorgestrel Intrauterine Device During Hematopoietic Stem Cell Transplant: A Case Report.
Topics: Adult; Contraceptive Agents, Female; Female; Gravidity; Hematopoietic Stem Cell Transplantation; Humans; Intrauterine Devices, Medicated; Leukemia, Myeloid, Acute; Levonorgestrel; Menstruation; Pregnancy; Prognosis; Young Adult | 2017 |
Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Papua New Guinea; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Pregnancy Rate; Rural Population; Surveys and Questionnaires; Young Adult | 2017 |
Pregnant with a perforated levonorgestrel intrauterine system and visible threads at the cervical os.
Topics: Adult; Cervix Uteri; Equipment Failure; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2017 |
One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Treatment Outcome; Young Adult | 2017 |
Perimenopausal contraception: A practice-based approach.
Topics: Adult; Aniline Compounds; Contraception; Contraceptive Devices; Drug Therapy, Combination; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Perimenopause; Pregnancy; Pregnancy, Unplanned; Progesterone | 2017 |
A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Cryopreservation; Embryo Transfer; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Letrozole; Levonorgestrel; Live Birth; Megestrol Acetate; Neoplasm Recurrence, Local; Nitriles; Pregnancy; Pregnancy Outcome; Triazoles | 2018 |
LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years.
Topics: Contraception; Contraceptive Agents, Female; Cost-Benefit Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2017 |
Prenatal levonorgestrel exposure induces autism-like behavior in offspring through ERβ suppression in the amygdala.
Topics: Amygdala; Animals; Autism Spectrum Disorder; Behavior, Animal; Contraceptive Agents, Female; Disease Models, Animal; DNA Methylation; Estrogen Receptor beta; Female; Gene Expression; Levonorgestrel; Male; Maternal Exposure; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Promoter Regions, Genetic; Rats; Reactive Oxygen Species | 2017 |
Postplacental intrauterine device expulsion by 12 weeks: a prospective cohort study.
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Parturition; Postpartum Period; Pregnancy; Prospective Studies; Prosthesis Implantation; Young Adult | 2017 |
Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter® in a majority nulliparous population.
Topics: Adolescent; Adult; Child; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Patient Satisfaction; Pregnancy; Young Adult | 2017 |
Re: Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy - 1-year continuation rates: a randomised controlled trial: Levonorgestrel-releasing intrauterine system following medic
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate | 2018 |
Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil.
Topics: Adolescent; Brazil; Contraception Behavior; Contraceptive Agents, Female; Drug Administration Schedule; Female; Humans; Intrauterine Devices, Medicated; Kaplan-Meier Estimate; Levonorgestrel; Pregnancy; Pregnancy Outcome; Retrospective Studies; Time Factors; Withholding Treatment; Young Adult | 2018 |
[Controversies about the mechanism of postcoital levonorgestrel: evidences according to the decrease of pregnancies].
Topics: Adult; Contraception, Postcoital; Contraceptives, Postcoital, Hormonal; Female; Humans; Levonorgestrel; Pregnancy | 2017 |
Authors' reply re: Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy - 1-year continuation rates: a randomised controlled trial.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate | 2018 |
Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Dysmenorrhea; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Prospective Studies; Young Adult | 2018 |
Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy.
Topics: Abortion, Induced; Adolescent; Adult; Contraceptive Agents, Female; Dysmenorrhea; Dyspareunia; Female; Humans; Intrauterine Devices, Medicated; Italy; Levonorgestrel; Pain Measurement; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Quality of Life; Sexual Behavior; Surveys and Questionnaires; Women's Health; Young Adult | 2018 |
Postinsertional Pain after Intrauterine Device Placement among Nulliparous Adolescents.
Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Pain Measurement; Parity; Pregnancy; Prospective Studies; Young Adult | 2018 |
A viable caesarean scar pregnancy in a woman using a levonorgestrel-releasing intrauterine device: a case report.
Topics: Adult; Cesarean Section; Cicatrix; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Abdominal | 2018 |
Occurrence of anembryonic pregnancy with use of levonorgestrel subdermal implant (JADELLE®): a case report.
Topics: Adult; Contraceptive Agents, Female; Dilatation and Curettage; Drug Implants; Embryo Loss; Female; Gestational Sac; Humans; Levonorgestrel; Pelvic Pain; Pregnancy; Ultrasonography | 2018 |
Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes.
Topics: Adult; Contraceptive Agents, Female; Drug Liberation; Female; Humans; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Oocyte Donation; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies; Treatment Outcome | 2018 |
[In process].
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Contraceptives, Postcoital; Drug Interactions; Enterohepatic Circulation; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Rifampin; Risk Factors | 2016 |
Ectopic pregnancy following oral levonorgestrel emergency contraception use.
Topics: Adult; Contraception, Postcoital; Contraceptive Agents, Female; Endometriosis; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2019 |
Ecological study on the use of hormonal contraception, abortions and births among teenagers in the Nordic countries.
Topics: Abortion, Induced; Adolescent; Birth Rate; Condoms; Contraception Behavior; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Databases, Factual; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Scandinavian and Nordic Countries; Young Adult | 2018 |
Cross design analysis of randomized and observational data - application to continuation rates for a contraceptive intra uterine device containing Levonorgestrel in adolescents and adults.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Parity; Pregnancy; Randomized Controlled Trials as Topic; Young Adult | 2018 |
[Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ovarian Cysts; Ovarian Neoplasms; Pregnancy | 2018 |
The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008-2012.
Topics: Adolescent; Adult; Age Factors; Australia; Contraceptive Agents, Female; Drug Prescriptions; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Unplanned; Pregnancy, Unwanted; Young Adult | 2018 |
Risk factors for ectopic pregnancy in a population of Cameroonian women: A case-control study.
Topics: Adolescent; Adult; Cameroon; Case-Control Studies; Contraception, Postcoital; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Odds Ratio; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk Factors; Young Adult | 2018 |
Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.
Topics: Adult; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Cross-Sectional Studies; Female; Humans; Levonorgestrel; Models, Theoretical; Norpregnadienes; Pregnancy; Pregnancy, Unplanned; Spain; Young Adult | 2019 |
TRPV4 is involved in levonorgestrel-induced reduction in oviduct ciliary beating.
Topics: Animals; Calcium; Cell Line; Cilia; Contraception, Postcoital; Contraceptive Agents, Hormonal; Contraceptive Effectiveness; Contraceptives, Postcoital; Down-Regulation; Epithelial Cells; Fallopian Tubes; Female; Humans; Levonorgestrel; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Oviducts; Pregnancy; Pregnancy, Tubal; Progesterone; Receptors, Progesterone; TRPV Cation Channels | 2019 |
Availability and Accessibility of Emergency Contraception to Adolescent Callers in Pharmacies in Four Southwestern States.
Topics: Adolescent; Contraception, Postcoital; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Pharmacies; Pregnancy; Pregnancy in Adolescence; Southwestern United States; Young Adult | 2019 |
Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Sweden | 2019 |
Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Multivariate Analysis; New Jersey; Pregnancy; Pregnancy, Unplanned; Regression Analysis; Time Factors; Uterine Hemorrhage; Young Adult | 2019 |
Assessment of endocrine disruptor effects of levonorgestrel and its photoproducts: Environmental implications of released fractions after their photocatalytic removal.
Topics: Catalysis; Cell Line; Endocrine Disruptors; Female; Humans; Levonorgestrel; Photochemical Processes; Pregnancy; Water Pollutants, Chemical | 2019 |
Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study.
Topics: Adult; Anxiety; Cause of Death; Cohort Studies; Contraceptive Agents, Female; Databases, Factual; Device Removal; Female; France; Hospitalization; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Mortality; Pregnancy; Pregnancy, Ectopic; Risk Assessment; Survival Analysis; Uterine Perforation | 2019 |
Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis.
Topics: Adenomyosis; Adult; CA-125 Antigen; Contraceptive Agents, Female; Dysmenorrhea; Female; Gynecologic Surgical Procedures; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Organ Size; Pain Measurement; Postoperative Period; Pregnancy; Uterus | 2019 |
Impact of the contraceptive implant on maternal and neonatal morbidity and mortality in rural Papua New Guinea: a retrospective observational cohort study.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Infant; Infant Mortality; Infant, Newborn; Levonorgestrel; Maternal Mortality; Middle Aged; Morbidity; Papua New Guinea; Parity; Postpartum Hemorrhage; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Prenatal Care; Retrospective Studies; Rural Population; Young Adult | 2019 |
Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Topics: Animals; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Glucose; Glucosephosphate Dehydrogenase; Levonorgestrel; Lipid Metabolism; Liver; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Progestins; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2019 |
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies | 2019 |
Prevalence and predictors of initiation of intrauterine devices and subdermal implants immediately after surgical abortion.
Topics: Abortion, Induced; Adolescent; Adult; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Long-Acting Reversible Contraception; Massachusetts; Pregnancy; Prevalence; Retrospective Studies; Young Adult | 2019 |
Ulipristal acetate compared to levonorgestrel emergency contraception among current oral contraceptive users: a cost-effectiveness analysis.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Cost-Benefit Analysis; Female; Humans; Levonorgestrel; Models, Theoretical; Norpregnadienes; Obesity; Pregnancy; Pregnancy, Unplanned; United States; Young Adult | 2019 |
A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
Topics: Adult; Cesarean Section; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Logistic Models; Multivariate Analysis; New York City; Postnatal Care; Pregnancy; Prospective Studies; Time Factors | 2019 |
Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis.
Topics: Adenomyosis; Adult; Case-Control Studies; China; Cohort Studies; Embryo Transfer; Embryo, Mammalian; Female; Fertilization in Vitro; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Preconception Care; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Retrospective Studies; Time Factors; Treatment Outcome; Vitrification | 2019 |
Pregnancy rate after emergency contraception with single-dose oral levonorgestrel in Japanese women.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Japan; Levonorgestrel; Pregnancy; Pregnancy Rate; Young Adult | 2019 |
Oocyte donation in donors with levonorgestrel intrauterine device: a good match?
Topics: Adult; Birth Rate; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Male; Oocyte Donation; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Retrospective Studies; Tissue Donors; Young Adult | 2019 |
Emergency contraception.
Topics: China; Contraception, Postcoital; Contraceptive Agents; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; European Union; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Norpregnadienes; Ovulation; Pregnancy; Pregnancy, Ectopic; Receptors, Progesterone; Time Factors | 2013 |
Over-the-counter access to emergency contraception without age restriction: an opinion of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
Topics: Adolescent; Age Factors; Contraception, Postcoital; Contraceptives, Postcoital; Drug Administration Schedule; Female; Government Regulation; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Patient Education as Topic; Pharmaceutical Services; Pregnancy; Pregnancy in Adolescence; Societies, Pharmaceutical; United States; Women's Health Services | 2013 |
Emergency contraception.
Topics: Contraception, Postcoital; Female; Humans; Levonorgestrel; Practice Patterns, Physicians'; Pregnancy | 2013 |
Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya.
Topics: Adolescent; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Contraceptive Agents; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Pregnancy; Prospective Studies; Young Adult | 2013 |
Removal of an intraabdominal levonorgestrel-releasing intrauterine device during pregnancy.
Topics: Abdominal Wall; Adult; Device Removal; Female; Hand-Assisted Laparoscopy; Humans; Intrauterine Device Migration; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2013 |
[Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].
Topics: Adult; Contraceptive Agents, Female; Female; Foreign-Body Migration; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome; Pregnancy, Unplanned | 2012 |
Pain at insertion of the levonorgestrel-releasing intrauterine system in nulligravida and parous women with and without cesarean section.
Topics: Adult; Brazil; Cesarean Section; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Materials Testing; Pain Measurement; Parity; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Prospective Studies; Young Adult | 2013 |
Emergency contraception: in reply.
Topics: Contraception, Postcoital; Female; Humans; Levonorgestrel; Practice Patterns, Physicians'; Pregnancy | 2013 |
[Reasons for removal of intrauterine devices among women in general practice].
Topics: Contraceptive Agents, Female; Device Removal; Female; General Practice; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 2013 |
Letter to the Editor: K. Gemzell-Danielsson et al. Emergency contraception - mechanisms of action. Contraception 87 (2013) 300-308.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Norpregnadienes; Pregnancy | 2013 |
Expressions of candidate molecules in the human fallopian tube and chorionic villi of tubal pregnancy exposed to levonorgestrel emergency contraception.
Topics: Adult; Chi-Square Distribution; Chorionic Villi; Contraception, Postcoital; Estrogen Receptor alpha; Fallopian Tubes; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Leukemia Inhibitory Factor; Levonorgestrel; Nitric Oxide Synthase Type II; Pregnancy; Pregnancy, Tubal; Receptor, Cannabinoid, CB1; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2013 |
Reply. Letter to the editor. Hillemanns Peter, Hepp Hermann, Letter to the Editor: K. Gemzell-Danielsson et al. Emergency contraception - mechanisms of action.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Male; Norpregnadienes; Pregnancy | 2013 |
Emergency contraception in a country with restricted access to contraceptives and termination of pregnancy, a prospective follow-up study.
Topics: Abortion, Legal; Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Female; Drug Administration Schedule; Female; Follow-Up Studies; Health Care Surveys; Humans; Levonorgestrel; Poland; Pregnancy; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2013 |
The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis.
Topics: Adolescent; Androstenes; Child; Chlormadinone Acetate; Contraceptive Agents; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Germany; Gynecology; Humans; Levonorgestrel; Menstruation Disturbances; Practice Patterns, Physicians'; Pregnancy; Pregnancy in Adolescence; Retrospective Studies | 2013 |
Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion.
Topics: Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Parity; Pregnancy; Prospective Studies; Ultrasonography; Uterus | 2013 |
Long-term outcomes after progestogen treatment for early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Medroxyprogesterone Acetate; Pregnancy; Progestins; Time Factors; Young Adult | 2013 |
Long-acting reversible contraception.
Topics: Adolescent; Adult; Choice Behavior; Contraception; Contraception Behavior; Contraceptive Devices, Female; Contraindications; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unplanned; Risk Factors; United States; Women's Health; Young Adult | 2013 |
Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome; Progesterone; Retrospective Studies; Treatment Outcome | 2014 |
Plan B emergency contraceptive may be ineffective for heavier women.
Topics: Canada; Contraceptives, Postcoital; Drug Labeling; Female; Humans; Levonorgestrel; Obesity; Pregnancy; Treatment Failure | 2014 |
Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy Rate; Treatment Outcome; Young Adult | 2014 |
Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Kenya; Levonorgestrel; Pakistan; Patient Satisfaction; Pregnancy; Prospective Studies; Young Adult | 2014 |
Effects of age, parity, and device type on complications and discontinuation of intrauterine devices.
Topics: Adolescent; Adult; Age Factors; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Acceptance of Health Care; Pelvic Inflammatory Disease; Pregnancy; Retrospective Studies; Young Adult | 2014 |
In reply.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate | 2014 |
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate | 2014 |
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
Topics: Algorithms; Animals; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Delivery Systems; Elasticity; Female; HIV Infections; Humans; Levonorgestrel; Models, Theoretical; Polyurethanes; Pregnancy; Pregnancy, Unwanted; Rabbits; Tensile Strength | 2014 |
Quick starting contraception after emergency contraception: have clinical guidelines made a difference?
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Drug Utilization; Female; Follow-Up Studies; Humans; Levonorgestrel; Medical Audit; Patient Preference; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Rate; Retreatment; Retrospective Studies; Risk Assessment; Scotland; Time Factors; Treatment Outcome; Young Adult | 2014 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy | 2014 |
In reply.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy | 2014 |
Trends in family planning and counselling for women with sickle cell disease in the UK over two decades.
Topics: Adolescent; Adult; Aged; Anemia, Sickle Cell; Contraception Behavior; Contraceptive Agents, Female; Counseling; Cross-Sectional Studies; Family Planning Services; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; London; Middle Aged; Pregnancy; Pregnancy, Unplanned; Surveys and Questionnaires | 2015 |
Use of ulipristal acetate and levonorgestrel for emergency contraception: a follow-up study.
Topics: Contraception, Postcoital; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Pregnancy; Retrospective Studies | 2015 |
Physical and mental development of children after levonorgestrel emergency contraception exposure: a follow-up prospective cohort study.
Topics: Abnormalities, Drug-Induced; Child Development; Child, Preschool; China; Cohort Studies; Contraception, Postcoital; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intelligence; Levonorgestrel; Male; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies | 2014 |
Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Topics: Brazil; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Pregnancy; Pregnancy, Unplanned; Quality-Adjusted Life Years; Retrospective Studies; Time Factors | 2014 |
Postpartum glucose tolerance in women with gestational diabetes using levonorgestrel intrauterine contraception.
Topics: Adult; Chicago; Contraceptive Agents, Female; Diabetes, Gestational; Female; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Hospitals, University; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Postpartum Period; Prediabetic State; Pregnancy; Risk; Sterilization, Tubal; Young Adult | 2015 |
Association of age and parity with intrauterine device expulsion.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Chi-Square Distribution; Cohort Studies; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Kaplan-Meier Estimate; Levonorgestrel; Middle Aged; Multivariate Analysis; Parity; Pregnancy; Pregnancy Rate; Proportional Hazards Models; Prospective Studies; Risk Assessment; Time Factors; Young Adult | 2014 |
Lessons from the contraceptive CHOICE project: the Hull long-acting reversible contraception (LARC) initiative.
Topics: Choice Behavior; Contraception; Cost-Benefit Analysis; Female; Humans; Information Dissemination; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Program Evaluation; United Kingdom | 2015 |
Reduced effectiveness of emergency contraception in women with increased BMI.
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Women's Health Services | 2014 |
Estimated economic impact of the levonorgestrel intrauterine system on unintended pregnancy in active duty women.
Topics: Abortion, Induced; Contraceptive Agents, Female; Cost Savings; Cost-Benefit Analysis; Decision Trees; Delivery, Obstetric; Female; Financing, Government; Humans; Intrauterine Devices; Levonorgestrel; Military Personnel; Pregnancy; Pregnancy, Unplanned; Pregnancy, Unwanted; Sensitivity and Specificity; United States | 2014 |
Provision of no-cost, long-acting contraception and teenage pregnancy.
Topics: Abortion, Induced; Adolescent; Birth Rate; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Prospective Studies; United States; Young Adult | 2014 |
Intrauterine contraception.
Topics: Contraindications; Education, Nursing, Continuing; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; United Kingdom | 2014 |
Factors associated with contraceptive satisfaction in adolescent women using the IUD.
Topics: Adolescent; Chi-Square Distribution; Contraception; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menstruation; New York City; Parity; Patient Satisfaction; Pregnancy; Surveys and Questionnaires; Young Adult | 2015 |
Emergency contraception in overweight women: an IUD is preferable.
Topics: Contraception, Postcoital; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnadienes; Overweight; Pregnancy; Pregnancy Rate | 2014 |
Association between levonorgestrel emergency contraception and the risk of ectopic pregnancy: a multicenter case-control study.
Topics: Adolescent; Adult; Case-Control Studies; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Ectopic; Risk; Young Adult | 2015 |
Polymorphism and DNA methylation in the promoter modulate KISS1 gene expression and are associated with litter size in goats.
Topics: Alleles; Animals; Binding Sites; Computational Biology; DNA Methylation; Female; Genomics; Goats; Granulosa Cells; Kisspeptins; Levonorgestrel; Litter Size; Polymorphism, Single Nucleotide; Pregnancy; Promoter Regions, Genetic; Protein Binding; Transcriptome | 2015 |
Contraceptive Use Before and After Gastric Bypass: a Questionnaire Study.
Topics: Adult; Contraception; Contraceptive Agents; Female; Gastric Bypass; Humans; Levonorgestrel; Obesity, Morbid; Pregnancy; Surveys and Questionnaires; Sweden; Young Adult | 2015 |
Reproductive health outcomes of insured adolescent and adult women who access oral levonorgestrel emergency contraception.
Topics: Adolescent; Adult; California; Chlamydia Infections; Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Implants; Drug Prescriptions; Female; Gonorrhea; Humans; Insurance, Health; Intrauterine Devices; Levonorgestrel; Office Visits; Pregnancy; Pregnancy Rate; Reproductive Health; Retrospective Studies; Telephone; Young Adult | 2015 |
Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Topics: Abortion, Induced; Adolescent; Adult; Aftercare; Contraception; Contraceptive Agents, Female; Female; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; New Zealand; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult | 2015 |
Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
Topics: Abortion, Induced; Adolescent; Adult; Choice Behavior; Contraception; Contraceptive Agents, Female; Equipment Failure; Female; Humans; Intrauterine Devices; Levonorgestrel; Middle Aged; Missouri; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unplanned; Prospective Studies; Young Adult | 2015 |
Reduced prevalence of chronic tubal inflammation in tubal pregnancies after levonorgestrel emergency contraception failure.
Topics: Adult; Chronic Disease; Contraception, Postcoital; Contraceptive Agents, Female; Female; Gestational Age; Humans; Levonorgestrel; Pregnancy; Pregnancy, Tubal; Prevalence; Retrospective Studies; Salpingitis; Treatment Failure | 2015 |
Post-abortion initiation of long-acting reversible contraception in New Zealand.
Topics: Abortion, Induced; Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intrauterine Devices; Levonorgestrel; New Zealand; Pregnancy; Retrospective Studies; Young Adult | 2015 |
Five-year follow-up of two types of contraceptive device fitted during elective cesarean delivery.
Topics: Adult; Cesarean Section; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Surveys and Questionnaires | 2015 |
Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.
Topics: Adolescent; Adult; Cohort Studies; Contraceptives, Oral; Cost Savings; Cost-Benefit Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Models, Economic; Pregnancy; Pregnancy, Unplanned; Sweden; Young Adult | 2015 |
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Topics: Administration, Intravaginal; Animals; Antiviral Agents; Carrageenan; Cell Line; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Delivery Systems; Equipment Design; Female; HeLa Cells; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Reverse Transcriptase; HIV-1; Human papillomavirus 16; Humans; Levonorgestrel; Macaca mulatta; Papillomavirus Infections; Pregnancy; Pyridines; Urea; Zinc Acetate | 2015 |
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Topics: Abortion, Induced; Adolescent; Adult; Body Weight; Choice Behavior; Contraception; Contraceptive Agents, Female; Decision Making; Desogestrel; Drug Implants; Educational Status; Female; Humans; Intimate Partner Violence; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Racial Groups; Stress, Psychological; Young Adult | 2015 |
Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Topics: Contraception Behavior; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Medication Adherence; Patient Satisfaction; Pregnancy; United States | 2016 |
[Emergency contraceptions: Propositions of the Orthogenics Commission of the French National College of Gynecology and Obstetrics].
Topics: Contraception, Postcoital; Female; France; Gynecology; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Obstetrics; Pregnancy; Unsafe Sex | 2015 |
Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
Topics: Adolescent; Adolescent Behavior; Australia; Contraception; Contraceptive Agents, Female; Counseling; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unplanned; Qualitative Research | 2015 |
Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Topics: Adenomyosis; Adult; Cohort Studies; Device Removal; Dysmenorrhea; Female; Follow-Up Studies; Gestational Age; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Pregnancy; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Ultrasonography | 2015 |
The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France.
Topics: Adolescent; Contraceptives, Oral, Hormonal; Costs and Cost Analysis; Female; France; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unwanted | 2015 |
[Emergency prevention in overweight--to be trusted?].
Topics: Body Mass Index; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Obesity; Pregnancy | 2015 |
Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Postpartum Period; Pregnancy; Time Factors; Young Adult | 2016 |
Association between knowledge about levonorgestrel emergency contraception and the risk of ectopic pregnancy following levonorgestrel emergency contraception failure: a comparative survey.
Topics: Adult; Contraception, Postcoital; Contraceptives, Postcoital; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Patient Education as Topic; Pregnancy; Pregnancy, Ectopic; Surveys and Questionnaires; Treatment Failure; Young Adult | 2016 |
Ectopic Pregnancy After Plan B Emergency Contraceptive Use.
Topics: Abortifacient Agents, Nonsteroidal; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Methotrexate; Pregnancy; Pregnancy, Ectopic; Young Adult | 2016 |
Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstrual Cycle; Patient Preference; Pregnancy; Prospective Studies; Utah; Young Adult | 2016 |
Population-based evaluation of the effectiveness of two regimens for emergency contraception.
Topics: Adolescent; Adult; British Columbia; Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Multivariate Analysis; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult | 2016 |
Choice of Emergency Contraceptive and Decision Making Regarding Subsequent Unintended Pregnancy.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Decision Making; Female; Humans; Intention; Intrauterine Devices, Copper; Levonorgestrel; Outcome Assessment, Health Care; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Prospective Studies; Surveys and Questionnaires; Utah; Visual Analog Scale; Young Adult | 2016 |
Sexual and Contraceptive Behaviors among Adolescents Requesting Emergency Contraception.
Topics: Adolescent; Age Factors; Chi-Square Distribution; Condoms; Contraception; Contraception Behavior; Contraception, Postcoital; Contraceptives, Oral; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; United States; Unsafe Sex | 2016 |
Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Incidental Findings; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Retrospective Studies; Turkey | 2016 |
Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
Topics: Adolescent; Adult; Coitus; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Rate; Prospective Studies; Time Factors; Unsafe Sex; Young Adult | 2016 |
Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
Topics: Abortion, Induced; Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menorrhagia; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; United States; Young Adult | 2016 |
The Effects of Female Sexual Hormones on the Expression of Aquaporin 5 in the Late-Pregnant Rat Uterus.
Topics: Animals; Aquaporin 5; Clomiphene; Estradiol; Estrogens; Female; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Progesterone; Progestins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tamoxifen; Uterus | 2016 |
Obama's science legacy: uneven progress on scientific integrity.
Topics: Federal Government; Female; Humans; Levonorgestrel; Ozone; Policy Making; Politics; Pregnancy; Science; United States; United States Environmental Protection Agency; United States Food and Drug Administration | 2016 |
Use of intrauterine devices in nulliparous women.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Equipment Failure; Female; Fertility; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Patient Satisfaction; Pregnancy; Risk Factors; United States; Young Adult | 2017 |
Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Megestrol Acetate; Pregnancy; Progestins; Prospective Studies; Young Adult | 2017 |
Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Europe; Female; Fertility; Follow-Up Studies; Humans; Levonorgestrel; Medication Adherence; Nandrolone; Pregnancy; Pregnancy Rate; Pregnancy, Unplanned; Prospective Studies; United States; Withholding Treatment; Young Adult | 2017 |
Experience with oral emergency contraception since the OTC switch in Germany.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral; Female; Germany; Humans; Levonorgestrel; Middle Aged; Nonprescription Drugs; Norpregnadienes; Pregnancy | 2017 |
Use of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients: a case series.
Topics: Adolescent; Contraceptive Agents, Female; Female; Heart Transplantation; Humans; Intestine, Small; Intrauterine Devices, Medicated; Kidney Transplantation; Levonorgestrel; Liver Transplantation; Practice Guidelines as Topic; Pregnancy; Transplant Recipients; Young Adult | 2017 |
Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
Topics: Abdominal Pain; Adolescent; Adult; Belgium; Contraception Behavior; Contraceptive Agents, Female; Device Removal; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Lost to Follow-Up; Middle Aged; Parity; Patient Acceptance of Health Care; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Uterine Hemorrhage; Young Adult | 2017 |
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Time Factors; United States; United States Food and Drug Administration; Young Adult | 2017 |
Emergency contraception: when and how to use it.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Female; Humans; Levonorgestrel; Menstrual Cycle; Pregnancy; Pregnancy in Adolescence; United States | 2008 |
Emergency contraception: when the pharmacist conscience clause restricts access.
Topics: Adolescent; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Nurse Practitioners; Patient Care Planning; Pharmacists; Pregnancy; Pregnancy, Unplanned; Refusal to Treat; Rural Population; United States | 2008 |
Cost effectiveness of contraceptives in the United States.
Topics: Contraceptive Agents; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Intrauterine Devices, Copper; Levonorgestrel; Markov Chains; Pregnancy; Pregnancy, Unplanned; United States; Vasectomy | 2009 |
Ectopic pregnancy following levonorgestrel emergency contraception: a case report.
Topics: Adult; Contraception, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Tubal | 2009 |
[Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Hormonal; Embolization, Therapeutic; Endometrial Hyperplasia; Estrogens; Female; Humans; Hysterectomy; Infertility, Female; Leiomyoma; Levonorgestrel; Metrorrhagia; Polyps; Pregnancy; Progestins; Tranexamic Acid; Uterine Neoplasms; Uterus | 2008 |
Term pregnancy with intraperitoneal levonorgestrel intrauterine system: a case report and review of the literature.
Topics: Adult; Cesarean Section; Female; Foreign-Body Migration; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Male; Pregnancy; Pregnancy Outcome | 2009 |
Trends in levonorgestrel emergency contraception use, births, and abortions: the Utah experience.
Topics: Abortion, Induced; Adolescent; Adult; Birth Rate; Contraception, Postcoital; Female; Humans; Levonorgestrel; Pregnancy; Unsafe Sex; Utah; Young Adult | 2009 |
Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study.
Topics: Abortion, Spontaneous; Adult; Cohort Studies; Congenital Abnormalities; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Male; Pregnancy; Pregnancy Outcome; Prospective Studies | 2009 |
The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraception; Contraceptive Agents, Female; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Parity; Pregnancy; Progesterone Congeners; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
The morning-after pill.
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Postcoital; Female; Health Services Accessibility; Humans; Insurance, Pharmaceutical Services; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Treatment Outcome; United States | 2009 |
Ectopic pregnancy following levonorgestrel emergency contraception.
Topics: Abortifacient Agents, Nonsteroidal; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Fallopian Tubes; Female; Humans; Levonorgestrel; Methotrexate; Pregnancy; Pregnancy, Ectopic; Treatment Failure | 2009 |
Intrauterine devices: an effective alternative to oral hormonal contraception.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Breast Neoplasms; Chlamydia Infections; Contraception; Contraceptives, Oral, Combined; Dysmenorrhea; Endocarditis; Epilepsy; Female; Heart Valve Diseases; Humans; Infections; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Pelvic Infection; Pregnancy; Pregnancy Complications; Pregnancy, Ectopic; Uterine Perforation | 2009 |
Fertility and endocrine effects of intra-abdominally misplaced intrauterine system for more than 2 years: a case report and review of the literature.
Topics: Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Young Adult | 2009 |
Induction of a local pseudo-pregnancy via levonorgestrel-loaded microspheres for the treatment of endometriosis in a rabbit model.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Endometriosis; Female; Levonorgestrel; Microspheres; Pregnancy; Pseudopregnancy; Rabbits | 2010 |
Patient characteristics and provider practice patterns for emergency contraception in a pediatric emergency department.
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Emergency Service, Hospital; Female; Follow-Up Studies; Hospitals, Pediatric; Hospitals, Teaching; Humans; Levonorgestrel; Male; Patient Compliance; Patient Education as Topic; Pregnancy; Retrospective Studies; Urban Population | 2010 |
Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.
Topics: Adult; Endometrial Hyperplasia; Female; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Polycystic Ovary Syndrome; Pregnancy; Pregnancy, Multiple; Reproductive Techniques, Assisted | 2010 |
Progestogen treatment options for early endometrial cancer.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Curettage; Endometrial Neoplasms; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Neoplasm, Residual; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.
Topics: Adolescent; Contraceptive Agents, Female; Female; Humans; Infertility, Female; Intrauterine Devices, Copper; Levonorgestrel; Parity; Pelvic Inflammatory Disease; Pregnancy; Uterine Perforation | 2010 |
LNG may still be the best oral EC option.
Topics: Contraception, Postcoital; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unplanned; Receptors, Progesterone | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
[Extrauterine pregnancy with gestagen-releasing intrauterine device in situ].
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Tubal; Risk Factors; Ultrasonography | 2010 |
Levonorgestrel, not etonogestrel, provides contraception in free-ranging koalas.
Topics: Analysis of Variance; Animals; Animals, Wild; Contraception; Contraceptive Agents, Female; Desogestrel; Estrous Cycle; Female; Levonorgestrel; Phascolarctidae; Population Control; Pregnancy; Progesterone; Radioimmunoassay | 2010 |
Uptake and adherence to long-acting reversible contraception post-abortion.
Topics: Abortion, Induced; Adolescent; Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; New Zealand; Pregnancy; Prospective Studies; Sex Education; Socioeconomic Factors; Young Adult | 2010 |
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Pregnancy; Prospective Studies; Recurrence; Treatment Outcome; Young Adult | 2011 |
Is it worth paying more for emergency hormonal contraception? The cost-effectiveness of ulipristal acetate versus levonorgestrel 1.5 mg.
Topics: Contraceptive Agents, Female; Contraceptives, Postcoital; Cost-Benefit Analysis; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unplanned; United Kingdom | 2010 |
Inadvertent use of a levonorgestrel-releasing intrauterine device as postcoital contraception.
Topics: Adult; Chorionic Gonadotropin, beta Subunit, Human; Contraception, Postcoital; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2010 |
Ulipristal acetate: a new emergency contraceptive that is safe and more effective than levonorgestrel.
Topics: Clinical Trials as Topic; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Norpregnadienes; Ovulation Inhibition; Pregnancy; Time Factors; Treatment Outcome | 2011 |
Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2011 |
Long-acting reversible contraception (LARC) use among adolescent females in secondary institutions in Nnewi, Nigeria.
Topics: Adolescent; Child; Contraception; Culture; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices; Levonorgestrel; Nigeria; Pregnancy; Pregnancy in Adolescence; Religion | 2011 |
Ectopic pregnancy after levonorgestrel emergency contraception.
Topics: Contraception, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Tubal | 2011 |
Time to trim the loose ends of the tailstring debate.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Parity; Pregnancy | 2011 |
Heterotopic cesarean scar pregnancy associated with a levonorgestrel-releasing intrauterine device.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Leucovorin; Levonorgestrel; Methotrexate; Pregnancy; Pregnancy, Ectopic | 2011 |
ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices.
Topics: Abortion, Induced; Abortion, Spontaneous; Actinomyces; Antibiotic Prophylaxis; Bone Density; Breast Feeding; Cervix Uteri; Contraceptive Agents, Female; Copper; Desogestrel; Device Removal; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstrual Cycle; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Sexually Transmitted Diseases | 2011 |
Ectopic pregnancy that occurred after failure of levonorgestrel emergency contraception. Letter to the editor.
Topics: Contraception, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Tubal | 2011 |
Viable intrauterine pregnancy with levonorgestrel intrauterine system in situ--a case report.
Topics: Adult; Cesarean Section; Contraceptive Agents, Female; Female; Foreign-Body Migration; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Pregnancy; Pregnancy Outcome; Ultrasonography | 2011 |
Hormonal contraception--what kind, when, and for whom?
Topics: Cardiovascular Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Implants; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Papillomavirus Infections; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners; Risk Factors; Thromboembolism; Uterine Cervical Neoplasms | 2011 |
Term pregnancy with LNG-IUS embedded in the rectal mucosa.
Topics: Douglas' Pouch; Female; Foreign-Body Migration; Humans; Infant, Newborn; Intestinal Mucosa; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Live Birth; Male; Pregnancy; Pregnancy Outcome; Rectum; Ultrasonography; Young Adult | 2011 |
Unintended pregnancy in Australia: what more can we do?
Topics: Abortion, Induced; Adolescent; Adult; Australia; Contraception Behavior; Contraceptives, Postcoital; Female; Forecasting; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Norpregnadienes; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unwanted; Public Opinion; Young Adult | 2011 |
Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel.
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Female; Humans; Ireland; Levonorgestrel; Meta-Analysis as Topic; Norpregnadienes; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Risk Assessment; United States; Women's Health Services | 2011 |
Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Emergency Treatment; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovulation; Pregnancy; Pregnancy Outcome; Young Adult | 2011 |
Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas.
Topics: Adult; Brazil; Clinical Competence; Cohort Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Pregnancy; Retrospective Studies | 2011 |
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
Topics: Adolescent; Adult; Androstenes; Anticoagulants; Cohort Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pregnancy; Time Factors; Venous Thromboembolism; Young Adult | 2011 |
Update on and correction to the cost effectiveness of contraceptives in the United States.
Topics: Contraceptive Agents; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Vasectomy | 2012 |
Science, politics, and over-the-counter emergency contraception.
Topics: Adolescent; Age Factors; Child; Contraception, Postcoital; Contraceptive Agents, Female; Drug Approval; Female; Humans; Levonorgestrel; Nonprescription Drugs; Policy Making; Politics; Pregnancy; Public Policy; Science; United States; United States Dept. of Health and Human Services; United States Food and Drug Administration; Unsafe Sex | 2012 |
Fighting science with politics.
Topics: Adolescent; Contraceptives, Postcoital, Hormonal; Drug Approval; Female; Humans; Levonorgestrel; Nonprescription Drugs; Politics; Pregnancy; Science; United States; United States Dept. of Health and Human Services; United States Food and Drug Administration | 2012 |
HHS ruling on Plan B introduces new risk for drugmakers.
Topics: Adolescent; Contraceptive Agents, Female; Drug Approval; Drug Design; Drug Industry; Female; Humans; Levonorgestrel; Pregnancy; Public Policy; Science; United States; United States Dept. of Health and Human Services; United States Food and Drug Administration | 2012 |
Effects of quinestrol and levonorgestrel on populations of plateau pikas, Ochotona curzoniae, in the Qinghai-Tibetan Plateau.
Topics: Animals; Contraceptive Agents; Ecosystem; Female; Fertility; Levonorgestrel; Male; Pregnancy; Quinestrol; Rabbits; Seasons; Tibet | 2012 |
Ovarian pregnancy in a patient with a levonorgestrel intrauterine system in situ.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovary; Pregnancy; Pregnancy, Ectopic | 2012 |
[Clinic observation of a levonorgestrel-releasing intrauterine system inserted immediately after artificial abortion].
Topics: Abortion, Induced; Adult; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2011 |
Guidelines for the use of long-acting reversible contraceptives.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Practice Guidelines as Topic; Pregnancy | 2012 |
Update on and correction to the cost-effectiveness of contraceptives in the United States.
Topics: Contraceptive Agents; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Vasectomy | 2012 |
Post-ovulatory administration of levonorgestrel: interference with implantation is not excluded.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovulation; Pregnancy | 2012 |
[The use of levonorgestrel for emergency contraception--recommendations of the Polish Gynecological Society].
Topics: Congresses as Topic; Contraception Behavior; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Female; Gynecology; Humans; Inservice Training; Levonorgestrel; National Health Programs; Obstetrics; Poland; Pregnancy; Quality Assurance, Health Care; Reproductive Health Services; Societies, Medical; Women's Health | 2012 |
Retrospective review of intrauterine device in adolescent and young women.
Topics: Adolescent; Age Factors; Child; Contraceptive Agents, Female; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Kaplan-Meier Estimate; Levonorgestrel; Multivariate Analysis; Parity; Patient Acceptance of Health Care; Poisson Distribution; Pregnancy; Proportional Hazards Models; Retrospective Studies; Sexually Transmitted Diseases; Young Adult | 2012 |
Preventing unintended pregnancy among young women in Kenya: prospective cohort study to offer contraceptive implants.
Topics: Adolescent; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Injections; Kenya; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Young Adult | 2012 |
Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countries.
Topics: Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Family; Female; General Practitioners; Global Health; Gynecology; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Middle Aged; Midwifery; Obstetrics; Patient Education as Topic; Practice Patterns, Physicians'; Pregnancy; Professional Practice; Workforce | 2012 |
Emergency contraception.
Topics: Contraception, Postcoital; Contraindications; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Time Factors | 2012 |
Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
Topics: Adolescent; Adolescent Behavior; Adolescent Health Services; Confidentiality; Contraceptive Agents, Female; Desogestrel; Directive Counseling; Female; Humans; Informed Consent By Minors; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; United States | 2012 |
The price of emergency contraception in the United States: what is the cost-effectiveness of ulipristal acetate versus single-dose levonorgestrel?
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Cost-Benefit Analysis; Decision Support Techniques; Female; Humans; Levonorgestrel; Monte Carlo Method; Norpregnadienes; Pregnancy; Pregnancy, Unplanned; United States | 2013 |
Demand for long acting and permanent methods of contraceptives and factors for non-use among married women of Goba Town, Bale Zone, South East Ethiopia.
Topics: Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Ethiopia; Female; Humans; Intrauterine Devices; Levonorgestrel; Marital Status; Needs Assessment; Pregnancy; Socioeconomic Factors; Sterilization, Tubal | 2012 |
[Intrauterine system (Mirena) and ectopic pregnancy--case report].
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2012 |
Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Neoplasm Staging; Pregnancy; Remission Induction; Term Birth | 2013 |
Effects of quinestrol and levonorgestrel on prolactin serum concentration in lactating Mongolian gerbils (Meriones unguiculatus) and reproductive parameters of their offspring.
Topics: Animals; Contraceptive Agents, Female; Estrogens; Female; Fertility; Gerbillinae; Lactation; Levonorgestrel; Male; Ovary; Pregnancy; Prolactin; Quinestrol; Reproduction; Testis | 2012 |
Antenatal contraception - simple, feasible, but is it safe and ethical in resource-poor environments?
Topics: Administration, Cutaneous; Adolescent; Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Developing Countries; Female; Health Services Accessibility; Humans; Levonorgestrel; Middle Aged; Pregnancy; Prenatal Care; Young Adult | 2013 |
Response to letter to the editor.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unplanned | 2013 |
Cost-effectiveness of increased access to emergency contraceptive pills: probably not.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy, Unplanned | 2013 |
Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
Topics: Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Endothelium, Vascular; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Prospective Studies; Young Adult | 2013 |
Emergency contraception: no. 280 (replaces No. 131, August 2003).
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy, Unplanned | 2013 |
[The satisfaction, efficacy, and relative factors for Norplant in countryside of Sichuan].
Topics: Adult; China; Contraception; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Logistic Models; Multivariate Analysis; Pregnancy; Rural Health; Surveys and Questionnaires | 1999 |
Long-term fertility control in the kangaroo and the wallaby using levonorgestrel implants.
Topics: Animals; Australia; Contraception; Contraceptives, Oral, Hormonal; Drug Implants; Female; Levonorgestrel; Macropodidae; Population Control; Pregnancy; Time Factors | 2002 |
A clinico-pathological study of Neogynon as a new oral contraceptive steroid.
Topics: Africa; Africa, Northern; Biology; Birth Rate; Central Nervous System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developing Countries; Economics; Egypt; Endometrium; Ethinyl Estradiol; Family Planning Services; Fertility; Genitalia; Genitalia, Female; Histology; Lactation; Levonorgestrel; Middle East; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Dynamics; Pregnancy; Research; Social Class; Socioeconomic Factors; Urogenital System; Uterus | 1976 |
Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Injections; Intrauterine Devices; Lactation; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Norethindrone; Physiology; Pregnancy; Progesterone; Progestins; Reproduction; Signs and Symptoms | 1982 |
Post coital contraception.
Topics: Biology; Birth Rate; Breast; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Developed Countries; Digestive System; Disease; Embryo Implantation; Embryonic Development; Endocrine System; Ethics; Ethinyl Estradiol; Europe; Family Planning Services; Fertility; Hormones; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Nausea; Netherlands; Parity; Pelvic Inflammatory Disease; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy, Ectopic; Reproduction; Signs and Symptoms; Vomiting | 1986 |
[Norplant contraception at the Rabta Tunis maternity hospital].
Topics: Africa; Africa, Northern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Diabetes Mellitus; Disease; Family Planning Services; Heart Diseases; Hypertension; Lactation; Levonorgestrel; Menstruation Disturbances; Middle East; Physiology; Pregnancy; Prospective Studies; Research; Risk Factors; Tunisia; Vascular Diseases | 1994 |
IUDs, implants, Depo-Provera have "incredible return on investment".
Topics: Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Cost-Benefit Analysis; Demography; Developed Countries; Economics; Evaluation Studies as Topic; Family Planning Services; Fertility; Financial Management; Insurance, Health; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; North America; Population; Population Dynamics; Pregnancy; Research; Sexual Behavior; United States | 1995 |
[The morning-after pill: a second chance, for whom?].
Topics: Abortion, Induced; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Pregnancy | 2002 |
Nova T 380 and levonorgestrel IUS studies.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents, Female; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Pregnancy; Pregnancy Outcome | 2001 |
The levonorgestrel intra-uterine system: therapeutic application in family planning.
Topics: Adolescent; Adult; Contraception; Data Collection; Family Planning Services; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Satisfaction; Pregnancy; Pregnancy, Unwanted; Sampling Studies; Surveys and Questionnaires; Treatment Outcome; United Kingdom | 2001 |
Current perspectives on emergency contraception.
Topics: Contraception Behavior; Contraceptives, Postcoital; Drug Prescriptions; Emergencies; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hong Kong; Humans; Intrauterine Devices; Levonorgestrel; Mifepristone; Nonprescription Drugs; Patient Education as Topic; Pregnancy; Pregnancy, Unwanted; Self Administration | 2002 |
Lesson of the week--Norplant failure.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2001 |
Levonorgestrel--implant. Jadelle, Norplant-2.
Topics: Contraceptives, Oral, Synthetic; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Time Factors | 2002 |
Ectopic pregnancy in the levonorgestrel releasing intrauterinesystem (LNG-IUS) user: atypical presentation.
Topics: Adult; Contraceptive Agents, Female; Female; Gynecologic Surgical Procedures; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Ultrasonography | 2002 |
Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study.
Topics: Adult; Amenorrhea; Attitude; Coitus; Contraceptive Agents, Female; Dysmenorrhea; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstruation; Middle Aged; Patient Satisfaction; Pregnancy | 2003 |
Progestogen-only emergency contraception and ectopic pregnancy.
Topics: Contraceptives, Postcoital, Synthetic; Emergency Treatment; Female; Humans; Levonorgestrel; New Zealand; Pregnancy; Pregnancy, Ectopic; Progesterone Congeners; Risk Assessment; United Kingdom | 2003 |
Two cases of abortion and premature birth after removal of a levonorgestrel-releasing intrauterine system.
Topics: Abortion, Spontaneous; Adult; Device Removal; Female; Follow-Up Studies; Humans; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Risk Assessment; Time Factors | 2002 |
FFPRHC Guidance: emergency contraception (April 2003).
Topics: Aftercare; Contraceptives, Postcoital; Contraindications; Counseling; Drug Interactions; Emergency Treatment; Evidence-Based Medicine; Family Planning Services; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pharmacies; Pregnancy; Reproductive Health Services; United Kingdom | 2003 |
The role of the pharmacist in emergency contraception.
Topics: Contraceptives, Postcoital, Hormonal; Emergency Treatment; Female; Health Services Accessibility; Humans; Levonorgestrel; Nonprescription Drugs; Pharmacies; Pharmacists; Pregnancy; Professional Role; State Medicine; United Kingdom | 2003 |
Ectopic pregnancies following emergency levonorgestrel contraception.
Topics: Adult; Contraceptives, Postcoital, Hormonal; Emergencies; Female; Humans; Laparoscopy; Levonorgestrel; Ovulation; Pregnancy; Pregnancy, Tubal; Time Factors | 2003 |
The levonorgestrel two-rod implant for long-acting contraception: 10 years of clinical experience.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Patient Compliance; Patient Satisfaction; Pregnancy; Pregnancy, Unwanted; Retrospective Studies; Treatment Outcome | 2003 |
Emergency contraception and risk of ectopic pregnancy: is there need for extra vigilance?
Topics: Contraceptives, Postcoital; Drug Monitoring; Europe; Female; Humans; Incidence; Levonorgestrel; New Zealand; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Risk Factors; United Kingdom; United States | 2003 |
Emergency contraception.
Topics: Canada; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pharmaceutical Services; Pregnancy | 2003 |
Access to emergency contraception.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Postcoital; Emergencies; Female; Health Services Accessibility; Humans; Levonorgestrel; Pregnancy | 2003 |
Ectopic pregnancy following use of progestin-only ECPs.
Topics: Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Patient Education as Topic; Pregnancy; Pregnancy, Ectopic; Progestins; Risk Factors | 2003 |
Emergency contraception: the journey so far.
Topics: Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Pregnancy; United Kingdom | 2004 |
Minimum effectiveness of the levonorgestrel regimen of emergency contraception.
Topics: Adult; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Female; Humans; Levonorgestrel; Pregnancy; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Ectopic pregnancies following emergency levonorgestrel contraception.
Topics: Contraception, Postcoital; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2004 |
Ectopic pregnancies following emergency levonorgestrel contraception.
Topics: Contraception, Postcoital; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2004 |
Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity?
Topics: Condoms; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Humans; Injections; Intrauterine Devices; Levonorgestrel; Life Style; Logistic Models; Pregnancy; Progesterone; Surveys and Questionnaires; Time Factors | 2004 |
Pregnancy during the use of levonorgestrel intrauterine system.
Topics: Contraceptive Agents, Female; Female; Finland; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Medical Records; Pregnancy; Pregnancy Rate; Pregnancy, Ectopic; Surveys and Questionnaires | 2004 |
Ectopic gestation following emergency contraception with levonorgestrel.
Topics: Abortion, Induced; Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Follow-Up Studies; Humans; Levonorgestrel; Pregnancy; Pregnancy, Tubal; Risk Assessment | 2003 |
The abortifacient effect of the birth control pill and the principle of 'double effect'.
Topics: Abortifacient Agents; Beginning of Human Life; Christianity; Contraceptive Agents, Female; Double Effect Principle; Embryo Implantation; Endometrium; Female; Humans; Informed Consent; Intention; Levonorgestrel; Natural Family Planning Methods; Pregnancy; Pregnancy, Ectopic; Value of Life | 2000 |
Norplant insertions at the Zeynep Kamil Gynecologic and Pediatric Training Research Hospital in Istanbul.
Topics: Adult; Contraceptive Agents, Female; Family Planning Services; Female; Health Care Surveys; Humans; Levonorgestrel; Parity; Patient Acceptance of Health Care; Pregnancy; Pregnancy Rate; Socioeconomic Factors; Time Factors; Turkey | 2004 |
Post-coital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey Cebus apella.
Topics: Animals; Cebus; Contraceptives, Postcoital, Synthetic; Female; Fertility; Follicular Phase; Levonorgestrel; Male; Ovarian Follicle; Ovary; Ovulation; Pregnancy; Pregnancy Rate; Time Factors; Ultrasonography | 2004 |
Emergency contraception kept as prescription only in USA.
Topics: Contraceptives, Postcoital; Drug Prescriptions; Female; Humans; Levonorgestrel; Politics; Pregnancy; United States; United States Food and Drug Administration | 2004 |
Chile agrees to emergency contraception for rape victims.
Topics: Catholicism; Chile; Contraceptives, Postcoital; Female; Health Policy; Humans; Levonorgestrel; Pregnancy; Rape | 2004 |
[Emergency contraception with levonorgestrel for teenagers--efficacy, tolerability, and level of information awareness].
Topics: Adolescent; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Menstrual Cycle; Patient Education as Topic; Pregnancy; Pregnancy in Adolescence; Prospective Studies; Time Factors | 2004 |
Conceivable sterilization: a constitutional analysis of a Norplant/Depo-Provera welfare condition.
Topics: Abortion, Induced; Aid to Families with Dependent Children; Civil Rights; Contraceptive Agents, Female; Female; Financial Support; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Pregnancy; Privacy; Reproduction; State Government; Sterilization, Reproductive; Supreme Court Decisions; United States | 2002 |
The FDA, politics, and plan B.
Topics: Adolescent; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Drug Approval; Drug Labeling; Female; Humans; Informed Consent; Levonorgestrel; Nonprescription Drugs; Pregnancy; United States; United States Food and Drug Administration | 2004 |
I want my Mirena out!
Topics: Device Removal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Audit; Menorrhagia; Pregnancy; Risk Assessment; South Africa; Uterine Hemorrhage | 2004 |
Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling.
Topics: Cell Movement; Chemokine CX3CL1; Chemokines, CX3C; Contraceptive Agents, Female; CX3C Chemokine Receptor 1; Endometrium; Female; Humans; Immunohistochemistry; Immunologic Techniques; Intrauterine Devices; Leukocytes; Levonorgestrel; Medroxyprogesterone Acetate; Membrane Proteins; Pregnancy; Progestins; Receptors, Cytokine; Receptors, HIV; Reference Values; Staining and Labeling; Tissue Distribution | 2004 |
[Emergency contraception with levonorgestrel in adolescents].
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Patient Education as Topic; Pregnancy; Pregnancy in Adolescence | 2004 |
Emergency contraception moves behind the counter.
Topics: Canada; Contraceptives, Postcoital, Hormonal; Female; Humans; Legislation, Pharmacy; Levonorgestrel; Nonprescription Drugs; Pregnancy; Pregnancy, Unwanted | 2005 |
Post-coital administration of levonorgestrel and post-fertilization events in the new-world monkey Cebus apella.
Topics: Abortion, Spontaneous; Animals; Cebus; Contraceptives, Postcoital, Synthetic; Embryo Implantation; Embryo, Mammalian; Female; Fertility; Gestational Age; Heart Rate, Fetal; Humans; Levonorgestrel; Pregnancy; Research Design; Ultrasonography | 2005 |
Regarding Plan B: science and politics cannot be separated.
Topics: Contraceptives, Postcoital; Female; Humans; Interinstitutional Relations; Levonorgestrel; Politics; Pregnancy; Pregnancy, Unwanted; Risk Assessment; Science; United States; United States Food and Drug Administration; Women's Health | 2005 |
Viable cervical pregnancy with levonorgestrel containing intrauterine device, treated successfully with methotrexate and mifepristone.
Topics: Abortifacient Agents; Cervix Uteri; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Methotrexate; Mifepristone; Pregnancy; Pregnancy, Ectopic | 2005 |
[Emergency contraception, Levonorgestrel and ectopic pregnancy].
Topics: Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Risk | 2005 |
Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.
Topics: Adult; Contraceptive Agents, Female; Embryo Transfer; Female; Fertilization in Vitro; Humans; Levonorgestrel; Oocyte Donation; Ovarian Follicle; Pregnancy; Pregnancy Outcome | 2005 |
Ectopic pregnancy with postcoital contraception--a case report.
Topics: Adult; Contraception, Postcoital; Female; Follow-Up Studies; Humans; Laparoscopy; Levonorgestrel; Ovary; Parity; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Risk Assessment; Sterilization, Tubal; Treatment Outcome; Ultrasonography, Prenatal | 2005 |
Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study.
Topics: Adult; Cohort Studies; Contraceptives, Oral, Synthetic; Female; Fetal Development; Humans; Infant, Newborn; Levonorgestrel; Male; Pregnancy; Pregnancy Outcome; Retrospective Studies; Risk Factors; Treatment Failure | 2005 |
Emergency contraception.
Topics: Canada; Contraceptives, Postcoital, Hormonal; Counseling; Female; Health Services Accessibility; Humans; Legislation, Pharmacy; Levonorgestrel; Nonprescription Drugs; Pharmacists; Pregnancy; Pregnancy, Unwanted | 2005 |
Emergency contraception.
Topics: Canada; Contraceptives, Postcoital, Hormonal; Counseling; Female; Humans; Legislation, Pharmacy; Levonorgestrel; Nonprescription Drugs; Pharmacists; Pregnancy; Pregnancy, Unwanted | 2005 |
Emergency contraception.
Topics: Canada; Contraceptives, Postcoital, Hormonal; Female; Health Services Accessibility; Humans; Legislation, Pharmacy; Levonorgestrel; Nonprescription Drugs; Pharmacists; Pregnancy; Pregnancy, Unwanted | 2005 |
Women's health advocates dismayed at FDA's Plan B decision.
Topics: Contraceptives, Oral; Drug Approval; Female; Humans; Levonorgestrel; Patient Advocacy; Pregnancy; United States; United States Food and Drug Administration; Women's Health | 2005 |
Provision of emergency hormonal contraception through community pharmacies in a rural area.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Synthetic; Counseling; Delivery of Health Care; Female; Health Services Accessibility; Humans; Levonorgestrel; Pharmacies; Pregnancy; Pregnancy in Adolescence; Rural Health Services; Rural Population; United Kingdom | 2005 |
FDA's decision on Plan B: a surrogate for lack of commitment to women's health.
Topics: Contraceptives, Oral; Drug Approval; Female; Humans; Levonorgestrel; Patient Advocacy; Pregnancy; United States; United States Food and Drug Administration; Women's Health | 2005 |
Mirena at caesarean section.
Topics: Adult; Cesarean Section; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction; Pregnancy | 2005 |
Privacy issues raised over Plan B: women asked for names, addresses, sexual history.
Topics: Canada; Confidentiality; Contraceptives, Postcoital, Hormonal; Counseling; Female; Humans; Levonorgestrel; Pharmaceutical Services; Pharmacists; Pregnancy; Pregnancy, Unwanted; Societies, Medical | 2005 |
Emergency contraception and ectopic pregnancy: report of 2 cases.
Topics: Adult; Chorionic Gonadotropin, beta Subunit, Human; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Tubal | 2005 |
Now available: middle ground.
Topics: Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Religion and Medicine | 2005 |
Emergency contraception - a human rights issue.
Topics: Contraception, Postcoital; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Female; Freedom; Health Knowledge, Attitudes, Practice; Human Rights; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Women's Health | 2006 |
Ten years of experience with Norplant implantation in southern Thailand.
Topics: Blood Pressure; Body Mass Index; Contraceptive Agents, Female; Drug Implants; Female; Humans; Inflammation; Levonorgestrel; Pregnancy; Thailand | 2006 |
Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Treatment Outcome | 2006 |
Mirena and ectopic pregnancy -- a diagnostic challenge.
Topics: Abdominal Pain; Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Uterine Hemorrhage | 2006 |
The constitutionality of court imposed contraception as a condition of probation.
Topics: California; Child; Child Abuse; Coercion; Contraception; Criminal Law; Female; Humans; Informed Consent; Levonorgestrel; Pregnancy; Prisoners; Privacy; Punishment; Reproductive Rights; Treatment Refusal; United States; Women's Rights | 1992 |
Contra-contraception: a growing number of conservatives see birth control as part of an ailing culture that overemphasizes sex and devalues human life. Is this the beginning of the next culture war?
Topics: Abortion, Induced; Christianity; Condoms; Contraception; Contraceptives, Postcoital; Cultural Diversity; Europe; Female; Government Regulation; Humans; Internationality; Legislation as Topic; Levonorgestrel; Mifepristone; Morals; Nonprescription Drugs; Politics; Pregnancy; Public Policy; Reproductive Rights; Sex Education; Sexual Abstinence; Sexual Behavior; Sexually Transmitted Diseases; United States; United States Food and Drug Administration; Value of Life | 2006 |
What is the seminal exposition among women requiring emergency contraception? A prospective, observational comparative study.
Topics: Adolescent; Adult; Case-Control Studies; Contraception, Postcoital; Contraceptive Agents, Female; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Prospective Studies; Semen; Sperm Count; Unsafe Sex; Vagina | 2007 |
Mechanism of action of emergency contraceptive pills.
Topics: Animals; Contraceptives, Postcoital; Embryo Implantation; Ethinyl Estradiol; Female; Fertilization; Levonorgestrel; Ovulation; Pregnancy | 2006 |
[Morning after contraception].
Topics: Adolescent; Adult; Age Factors; Contraception; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Finland; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Pregnancy Tests; Pregnancy, Unplanned; Risk Factors; Sensitivity and Specificity | 2006 |
Plan B OTC.
Topics: Adolescent; Adult; Age Factors; Clinical Trials as Topic; Contraceptives, Postcoital, Hormonal; Drug Administration Schedule; Drug Approval; Drug Prescriptions; Female; Humans; Legislation, Drug; Levonorgestrel; Nausea; Nonprescription Drugs; Pregnancy; Tablets; United States; Vomiting | 2006 |
Minor error in our paper which was recently published in Contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Medical Records; Menstrual Cycle; Menstruation Disturbances; Pregnancy; Uterine Hemorrhage | 2006 |
Primary ovarian pregnancy with a levonorgestrel intrauterine system.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Obstetric Surgical Procedures; Pregnancy; Pregnancy, Ectopic; Ultrasonography | 2006 |
Emergency contraception: politics and science move forward.
Topics: Contraceptives, Postcoital; Drug Approval; Female; Humans; Levonorgestrel; Nonprescription Drugs; Norpregnadienes; Pregnancy; Sexual Behavior; United States; United States Food and Drug Administration | 2006 |
Effects of levonorgestrel on ovulation and oestrous behaviour in the female tammar wallaby.
Topics: Animals; Contraceptive Agents, Female; Drug Implants; Estrus; Female; Levonorgestrel; Luteinizing Hormone; Macropodidae; Male; Ovary; Ovulation; Ovulation Inhibition; Pregnancy; Sexual Behavior, Animal | 2007 |
The safety and complications of Norplant use in Calabar.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Nigeria; Patient Compliance; Pregnancy; Pregnancy Rate | 2007 |
Pregnancy in a patient with a displaced levonorgestrel-releasing intrauterine system: a case report.
Topics: Adult; Cesarean Section; Contraceptive Agents, Female; Female; Foreign-Body Migration; Humans; Incidental Findings; Infant, Newborn; Intrauterine Devices, Medicated; Levonorgestrel; Omentum; Pregnancy; Pregnancy Outcome; Pregnancy, Unplanned | 2007 |
Contraceptive implants in Kenya: current status and future prospects.
Topics: Contraception; Contraceptive Agents, Female; Cost-Benefit Analysis; Delayed-Action Preparations; Female; Health Services Needs and Demand; Humans; Kenya; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Women's Health Services | 2007 |
Ectopic pregnancy following emergency contraception with ethinyloestradiol-levonorgestrel: a case report.
Topics: Adult; Condoms; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2007 |
Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Fertility; Follow-Up Studies; Humans; Hypothalamo-Hypophyseal System; Levonorgestrel; Menstruation; Middle Aged; Ovary; Pregnancy; Regression Analysis; Time Factors | 2008 |
Fluctuations in brain concentrations of neurosteroids are not associated to changes in gephyrin levels.
Topics: Administration, Oral; Animals; Brain; Carrier Proteins; Cerebral Cortex; Estradiol; Estrogens; Estrus; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hippocampus; Levonorgestrel; Male; Membrane Proteins; Neural Inhibition; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; RNA, Messenger; Synapses; Synaptic Membranes; Synaptic Transmission | 2007 |
When 'emergency contraception' is neither.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Embryonic Development; Emergencies; Female; Fertilization; Humans; Levonorgestrel; Pharmacists; Pregnancy; Pregnancy, Unwanted; Terminology as Topic; Uncertainty; United States | 2007 |
Intrauterine pregnancy after salpingectomy for tubal pregnancy due to emergency contraception: a case report.
Topics: Adult; Contraceptives, Postcoital, Synthetic; Fallopian Tubes; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Tubal | 2007 |
Emergency contraception: overestimated effectiveness and questionable expectations.
Topics: Abortion, Induced; Choice Behavior; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Prescriptions; Female; Health Knowledge, Attitudes, Practice; Humans; Legislation, Drug; Levonorgestrel; Morals; Nonprescription Drugs; Ovulation; Personal Autonomy; Pregnancy; Sexual Behavior; Treatment Outcome; United States; United States Food and Drug Administration; Women's Health | 2008 |
Emergency contraception update: a Canadian perspective.
Topics: Canada; Choice Behavior; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Prescriptions; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Legislation, Drug; Levonorgestrel; Nonprescription Drugs; Ovulation; Personal Autonomy; Pregnancy; Treatment Outcome; United States; United States Food and Drug Administration; Women's Health | 2008 |
Emergency contraception: a reasonable personal choice or a destructive societal influence?
Topics: Abortion, Induced; Choice Behavior; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Prescriptions; Female; Health Knowledge, Attitudes, Practice; Humans; Legislation, Drug; Levonorgestrel; Morals; Nonprescription Drugs; Ovulation; Personal Autonomy; Pregnancy; Sexual Behavior; Treatment Outcome; United States; United States Food and Drug Administration; Women's Health | 2008 |
Modelling costs and outcomes of expanded availability of emergency contraceptive use in British Columbia.
Topics: British Columbia; Contraceptives, Postcoital; Cost Savings; Decision Support Techniques; Decision Trees; Drug Utilization; Ethinyl Estradiol; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Levonorgestrel; Norgestrel; Outcome Assessment, Health Care; Pharmaceutical Services; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unwanted | 2007 |
Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia.
Topics: Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrium; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome | 2008 |
Successful pregnancy outcome with the levonorgestrel-releasing intrauterine system.
Topics: Adult; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome | 2008 |
Return to fertility after cessation of a continuous oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fertility; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Prospective Studies | 2009 |
Effectiveness of levonorgestrel given after or before ovulation.
Topics: Administration, Oral; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Drug Administration Schedule; Female; Humans; Levonorgestrel; Ovulation; Pilot Projects; Pregnancy; Pregnancy Rate; Treatment Outcome | 2008 |
Serum lipids and high-density-lipoprotein cholesterol in women on long-term sustained low-dose IUD treatment with levonorgestrel.
Topics: Adult; Cholesterol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Pregnancy; Stereoisomerism; Triglycerides | 1981 |
Endocrinological studies with desogestrel.
Topics: Administration, Oral; Animals; Castration; Contraceptives, Oral, Combined; Decidua; Desogestrel; Endometrium; Estrogen Antagonists; Female; Levonorgestrel; Mice; Norethindrone; Norgestrel; Norpregnenes; Ovulation; Pregnancy; Progesterone Congeners; Rabbits; Rats; Species Specificity | 1983 |
Milestones in intrauterine device development.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Equipment Design; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Progesterone | 1983 |
Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Contraception with levonorgestrel-releasing subdermal capsules, Norplant, after pregnancy termination.
Topics: Abortion, Induced; Adolescent; Adult; Blood Pressure; Capsules; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Pregnancy | 1983 |
Case of ectopic pregnancy after postcoital contraception with ethinyloestradiol-levonorgestrel.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy, Tubal | 1983 |
Long-acting contraceptive agents: structure activity relationships in a series of norethisterone and levonorgestrel esters.
Topics: Animals; Biological Assay; Contraceptive Agents; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Estrus; Female; Levonorgestrel; Norethindrone; Norgestrel; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1983 |
Levonorgestrel as a new radioligand for determination of sex hormone binding globulin in human plasma.
Topics: Contraceptives, Oral, Combined; Dihydrotestosterone; Female; Humans; Kinetics; Levonorgestrel; Ligands; Male; Norgestrel; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Sex Factors; Sex Hormone-Binding Globulin; Stereoisomerism; Tritium | 1983 |
A two-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Egypt; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Pregnancy, Unwanted; Silicone Elastomers | 1984 |
Plasma levels and progestational activity of levonorgestrel after repeated intravenous and subcutaneous administration in the beagle bitch.
Topics: Animals; Cell Division; Contraceptives, Oral, Combined; Dogs; Endometrium; Estrus; Female; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Norgestrel; Plasma; Pregnancy | 1984 |
[Postcoital contraception with steroid hormones].
Topics: Contraceptives, Oral, Combined; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Danazol; Embryo Implantation; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Norpregnadienes; Pregnancy; Risk | 1984 |
[Experiences with levonorgestrel in postcoital contraception].
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Administration Schedule; Embryo Implantation; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstruation; Norgestrel; Pregnancy; Risk | 1984 |
Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.
Topics: Abortion, Induced; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Fertility; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Pregnancy; Progesterone | 1984 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Statistics as Topic; Vagina | 1981 |
Effects of levonorgestrel and STS 557 on testis in rodents.
Topics: Animals; Castration; DNA; Female; Fertility; Levonorgestrel; Libido; Luteinizing Hormone; Male; Nandrolone; Norgestrel; Organ Size; Pregnancy; Rats; Sexual Maturation; Testis | 1980 |
Oral contraception and breast pathology.
Topics: Adenofibroma; Adenoma; Adult; Animals; Breast Feeding; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estradiol Congeners; Female; Fibrocystic Breast Disease; Humans; Levonorgestrel; Menarche; Middle Aged; Norgestrel; Parity; Pregnancy; Progesterone Congeners; Retrospective Studies; Stereoisomerism | 1981 |
[Chromosomal analysis of baboons and their mothers, following application to mothers of potentially post-ovulation fertility-inhibiting steroids (author's transl)].
Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Chromosome Mapping; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Levonorgestrel; Lymphocytes; Nandrolone; Norgestrel; Papio; Pregnancy | 1981 |
Fertility after discontinuation of levonorgestrel-releasing intrauterine devices.
Topics: Adult; Female; Fertility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism; Time Factors | 1982 |
Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device.
Topics: Adolescent; Adult; Amenorrhea; Apgar Score; Breast Feeding; Female; Humans; Infant, Newborn; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Male; Norgestrel; Otitis Media; Postpartum Period; Pregnancy; Respiratory Tract Infections; Sex Ratio | 1982 |
Low dosage oral contraception in women with previous gestational diabetes.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Prospective Studies | 1982 |
Further report on the interceptive STS 557 in baboons.
Topics: Administration, Oral; Animals; Contraceptives, Oral, Combined; Female; Levonorgestrel; Nandrolone; Norgestrel; Papio; Pregnancy; Progesterone | 1982 |
[Changes in vaginal cytograms of female beagle dogs during toxicologic long-term examinations of gestagens].
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dogs; Estrus; Female; Levonorgestrel; Long-Term Care; Menstruation; Nandrolone; Norgestrel; Pregnancy; Vaginal Smears | 1982 |
Immediate postabortal insertion of a levonorgestrel-releasing IUD.
Topics: Abortion, Legal; Adolescent; Adult; Chorionic Gonadotropin; Contraceptives, Oral, Combined; Estradiol; Evaluation Studies as Topic; Female; Follicle Stimulating Hormone; Humans; Intrauterine Device Expulsion; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Luteinizing Hormone; Menstruation; Norgestrel; Ovulation; Pregnancy; Progesterone | 1982 |
Body iron stores and patterns of bleeding after insertion of a levonorgestrel- or a copper-releasing intrauterine contraceptive device.
Topics: Amenorrhea; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Erythrocyte Count; Erythrocyte Indices; Female; Ferritins; Hematocrit; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Norgestrel; Postpartum Period; Pregnancy | 1982 |
A cohort study of Norplant implant: side-effects and acceptance.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Pregnancy Rate; Risk Factors; Surveys and Questionnaires; Uterine Hemorrhage | 1995 |
[Extrauterine pregnancy after hormonal postcoital contraception].
Topics: Adult; Contraceptives, Postcoital, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Laparoscopy; Levonorgestrel; Pregnancy; Pregnancy, Tubal; Rupture, Spontaneous | 1995 |
Outcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methods.
Topics: Adolescent; Adolescent Behavior; Condoms; Contraceptives, Oral; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Prognosis; Prospective Studies; Sexually Transmitted Diseases | 1995 |
Teen pregnancy in the state of New Mexico.
Topics: Adolescent; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; New Mexico; Pregnancy; Pregnancy in Adolescence | 1995 |
Which teen mothers choose Norplant?
Topics: Adolescent; Analysis of Variance; Chi-Square Distribution; Colorado; Family Planning Services; Female; Humans; Levonorgestrel; Mothers; Postpartum Period; Pregnancy; Pregnancy in Adolescence; Pregnancy Outcome; Prospective Studies; Risk Factors; Socioeconomic Factors | 1995 |
Progestin-releasing intrauterine devices.
Topics: Contraindications; Counseling; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Progestins; Uterine Perforation | 1994 |
Implantable contraception.
Topics: Adolescent; Adult; Contraindications; Drug Implants; Drug Interactions; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Ovarian Cysts; Pain; Pregnancy; Pregnancy, Ectopic | 1994 |
Implantable hormonal contraceptives: emerging controversy.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Child Welfare; Drug Implants; Female; Health Policy; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; Social Welfare; United States | 1994 |
Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor.
Topics: Animals; Drug Combinations; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone | 1995 |
After the morning after and the morning after that.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Time Factors | 1995 |
Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
Topics: Adult; Aging; Drug Implants; Female; Fertility; Humans; Levonorgestrel; Menstruation; Pregnancy; Pregnancy Outcome | 1995 |
Removal rates of subdermal levonorgestrel implants.
Topics: Adolescent; Adult; Alopecia; Drug Implants; Female; Follow-Up Studies; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy; Pregnancy, Unwanted; Sex Counseling | 1994 |
Contraceptive outcomes among post-partum and post-abortal adolescents.
Topics: Abortion, Induced; Adolescent; Black or African American; Contraception; Contraceptives, Oral; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Retrospective Studies; White People | 1994 |
Norplant.
Topics: Adolescent; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence | 1995 |
Politics and practice: introducing Norplant into a school-based health center in Baltimore.
Topics: Adolescent; Baltimore; Community Participation; Family Planning Services; Female; Health Policy; Humans; Levonorgestrel; Outcome Assessment, Health Care; Pilot Projects; Pregnancy; Pregnancy in Adolescence; School Health Services | 1995 |
The contraceptive effects of levonorgestrel in the domestic cat.
Topics: Animals; Blood Glucose; Cats; Contraceptive Agents, Female; Drug Implants; Estrus; Female; Levonorgestrel; Ovary; Pregnancy; Progesterone; Uterus | 1994 |
The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
Topics: Adolescent; Adolescent Behavior; Condoms; Contraception Behavior; Contraceptives, Oral; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Life Tables; Logistic Models; Male; Postpartum Period; Pregnancy; Prospective Studies | 1994 |
Levonorgestrel implants as a contraceptive in captive white-tailed deer.
Topics: Animals; Contraception; Deer; Drug Implants; Estrus; Female; Fertility; Levonorgestrel; Pregnancy; Time Factors | 1994 |
[Norplant contraception at the Rabta Tunis maternity hospital].
Topics: Adolescent; Adult; Diabetes Mellitus; Drug Implants; Female; Heart Diseases; Humans; Hypertension; Levonorgestrel; Menstruation Disturbances; Pregnancy; Pregnancy Complications; Prospective Studies; Risk Factors; Tunisia | 1994 |
Who uses Norplant. A study from Finland.
Topics: Abortion, Induced; Adult; Drug Implants; Female; Finland; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Pregnancy; Surveys and Questionnaires | 1994 |
Levonorgestrel inhibits luteinizing hormone-stimulated progesterone production in rat luteal cells.
Topics: Animals; Bucladesine; Corpus Luteum; Female; Levonorgestrel; Luteinizing Hormone; Ovary; Pregnancy; Pregnenolone; Progesterone; Rats | 1994 |
Teen sex, AIDS, and contraception.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adolescent Behavior; Female; Humans; Levonorgestrel; Pilot Projects; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; United States | 1993 |
Youssef's syndrome: an appraisal of hormonal treatment.
Topics: Adult; Cesarean Section; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fistula; Humans; Levonorgestrel; Pregnancy; Syndrome; Urinary Bladder Fistula; Uterine Diseases | 1994 |
Comparison of adolescent and adult experiences with Norplant levonorgestrel contraceptive implants.
Topics: Adolescent; Adult; Drug Implants; Female; Humans; Levonorgestrel; Life Tables; Patient Satisfaction; Pregnancy; Reproductive History | 1994 |
Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat.
Topics: Androgens; Animals; Female; Kinetics; Levonorgestrel; Male; Norgestrel; Orchiectomy; Organ Size; Pregnancy; Pregnancy Maintenance; Progesterone Congeners; Prostate; Rats; Seminal Vesicles | 1994 |
One-year experience with subdermal contraceptive implants in the United States.
Topics: Adolescent; Adult; Child; Consumer Behavior; Drug Implants; Female; Headache; Humans; Levonorgestrel; Middle Aged; Pregnancy; United States; Uterine Hemorrhage; Weight Gain | 1993 |
Intrauterine contraceptive devices.
Topics: Adolescent; Adult; Equipment Design; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 1993 |
[Risk of an unwanted pregnancy after a single unprotected coitus; observations on the current hormonal postcoital contraceptive methods].
Topics: Contraceptives, Postcoital, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Risk | 1993 |
Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Topics: Abortion, Spontaneous; Adult; Drug Implants; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovarian Follicle; Ovary; Ovulation; Pregnancy; Progesterone; Time Factors; Ultrasonography | 1993 |
Norplant: a welcome new contraceptive.
Topics: Cohort Studies; Drug Implants; Family Planning Services; Female; Humans; Levonorgestrel; Pregnancy | 1993 |
Hormonal intrauterine devices.
Topics: Adolescent; Adult; Amenorrhea; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pelvic Inflammatory Disease; Pregnancy; Sweden; Uterine Hemorrhage | 1993 |
A better way of approaching adolescent pregnancy.
Topics: Adolescent; Cross-Cultural Comparison; Family Planning Services; Female; Forecasting; Health Knowledge, Attitudes, Practice; Humans; Infant, Newborn; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Sex Education | 1995 |
Can chronic maternal drug therapy alter the nursing infant's hepatic drug metabolizing enzyme pattern?
Topics: Adult; Breast Feeding; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydrocortisone; Infant; Infant, Newborn; Levonorgestrel; Liver; Milk, Human; Pregnancy | 1995 |
Levonorgestrel as a postcoital contraceptive.
Topics: Animals; Blastocyst; Contraceptive Agents, Female; Contraceptives, Postcoital; Delayed-Action Preparations; Drug Implants; Embryo Implantation; Embryonic and Fetal Development; Female; Levonorgestrel; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Pregnancy; Time Factors | 1995 |
Experience with side effects and health risks associated with Norplant implant use in adolescents.
Topics: Adolescent; Condoms; Contraceptive Agents, Female; Drug Implants; Female; Humans; Incidence; Levonorgestrel; Menstruation; Pregnancy; Pregnancy in Adolescence; Sex Counseling; Sexually Transmitted Diseases; Weight Gain | 1995 |
Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience.
Topics: Adolescent; Adult; Africa; Asia; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Latin America; Levonorgestrel; Life Tables; Menstruation; Pregnancy; Pregnancy Rate | 1995 |
IUDs and ectopic pregnancy.
Topics: Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Randomized Controlled Trials as Topic; Risk Factors | 1995 |
Adolescents' use of levonorgestrel implants for contraception.
Topics: Adolescent; Adolescent Behavior; Black or African American; Child; Condoms; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Prospective Studies; Sexually Transmitted Diseases | 1996 |
A better way of approaching adolescent pregnancy.
Topics: Adolescent; Decision Making; Female; Health Knowledge, Attitudes, Practice; Humans; Infant, Newborn; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Risk Factors; Sex Education | 1996 |
Norplant subdermal contraceptive system: experience in Taiwan.
Topics: Abortion, Induced; Chromosome Aberrations; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Taiwan; Time Factors | 1996 |
Beliefs about Depo-Provera among three groups of contraceptors.
Topics: Adolescent; Adult; Community Health Services; Contraceptive Agents, Female; Contraceptives, Oral; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Risk Factors; Urban Population; Weight Gain | 1996 |
Introduction of Norplant implants in four counties of rural China: a two-year evaluation.
Topics: Adult; China; Contraceptive Agents, Female; Drug Implants; Family Planning Services; Female; Follow-Up Studies; Humans; Levonorgestrel; Pregnancy; Reproduction; Retrospective Studies; Rural Population | 1995 |
Norplant implants in the UK: first year continuation and removals.
Topics: Capsules; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Evaluation Studies as Topic; Female; Humans; Levonorgestrel; Menstruation; Patient Compliance; Patient Dropouts; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Time Factors; United Kingdom | 1996 |
Contraceptive development and better family planning.
Topics: Abortion, Induced; Adolescent; Adolescent Behavior; Adult; Cohort Studies; Contraception; Contraceptive Agents, Female; Contraceptive Devices; Contraceptives, Oral; Drug Implants; Family Planning Services; Female; Health Policy; Humans; Levonorgestrel; Male; Pregnancy; Pregnancy, Unwanted; Sexual Behavior; United States; Urban Health | 1996 |
Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
Topics: Adolescent; Body Mass Index; Chi-Square Distribution; Condoms; Drug Administration Schedule; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation; Patient Compliance; Patient Education as Topic; Patient Satisfaction; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; United States | 1996 |
The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
Topics: Antithrombin III; Blood Coagulation; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Female; Humans; Levonorgestrel; Postpartum Period; Pregnancy; Prospective Studies | 1996 |
Five-year evaluation of safety, efficacy and acceptability of Norplant implants in Nepal.
Topics: Adolescent; Adult; Consumer Behavior; Contraceptive Agents, Female; Drug Implants; Evaluation Studies as Topic; Female; Humans; Levonorgestrel; Menstruation Disturbances; Nepal; Pregnancy; Surveys and Questionnaires | 1996 |
Risk factors for discontinuation of Norplant implant use due to menstrual problems.
Topics: Adult; Body Weight; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Pregnancy; Risk Factors; Smoking | 1996 |
[Continuity of utilization of a levonorgestrel releasing contraceptive implant: prospective study in Belgium].
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Parity; Pregnancy; Progesterone Congeners; Prospective Studies; Time Factors | 1996 |
Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
Topics: Adolescent; Case-Control Studies; Child; Condoms; Contraceptives, Oral; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Weight Gain | 1997 |
Does licensing of drugs in industrialized countries guarantee drug quality and safety for Third World countries? The case of norplant licensing in Finland.
Topics: Contraceptive Agents, Female; Developed Countries; Developing Countries; Drug Approval; Female; Finland; Government Regulation; Humans; Information Dissemination; Internationality; Levonorgestrel; Pregnancy; Research Subjects; Risk Assessment; Sweden | 1997 |
Use of Norplant implants in asymptomatic HIV-1 infected women.
Topics: Adolescent; Adult; Drug Implants; Family Planning Services; Female; HIV Seropositivity; HIV-1; Humans; Levonorgestrel; Menstruation; Pregnancy; Thailand | 1997 |
Norplant in South Africa--the first 100 patients.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Progesterone Congeners; South Africa | 1997 |
[Vaginal bleeding patterns and the regularity in use of Norplant].
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Uterine Hemorrhage | 1996 |
Acceptance, efficacy, and side effects of Norplant implants in four counties in north China.
Topics: Adult; China; Family Planning Services; Female; Humans; Levonorgestrel; Logistic Models; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy; Program Evaluation; Prospective Studies; Rural Health Services; Sampling Studies; Treatment Outcome | 1997 |
Selection and performance of the levonorgestrel-releasing intrauterine system.
Topics: Adult; Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Retrospective Studies | 1997 |
[Tubal ligation using minilaparotomy under local anesthesia. Apropos of 800 cases at the University Hospital Center in Dakar].
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia, Local; Costs and Cost Analysis; Female; Heart Diseases; Humans; Laparotomy; Levonorgestrel; Minimally Invasive Surgical Procedures; Parity; Pregnancy; Pregnancy, High-Risk; Prospective Studies; Senegal; Sterilization, Tubal; Treatment Outcome | 1997 |
Social factors predicting postpartum choice of Norplant among African-American and non-Hispanic white adolescents.
Topics: Adolescent; Adult; Black or African American; Family; Female; Humans; Levonorgestrel; Logistic Models; Medicaid; Parity; Peer Group; Pregnancy; Pregnancy in Adolescence; United States; White People | 1997 |
mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system.
Topics: Adult; Blotting, Northern; Contraceptive Agents, Female; Decidua; Endometrium; Female; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; RNA, Messenger; Time Factors | 1997 |
Use of hormonal methods of birth control among sexually active adolescent girls.
Topics: Adolescent; Adult; Cannabis; Child; Contraceptives, Oral; Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Pregnancy; Pregnancy in Adolescence; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; Smoking; Surveys and Questionnaires | 1997 |
A comparison of the clinical performance, contraceptive efficacy, reversibility and acceptability of Norplant implants and Ortho Gynae T380 intrauterine copper contraceptive device.
Topics: Adult; Drug Implants; Female; Hemoglobins; Humans; Infertility, Female; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Pregnancy | 1997 |
Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant). A prospective study in Belgium.
Topics: Adolescent; Adult; Age Factors; Belgium; Cohort Studies; Consumer Behavior; Contraceptive Agents, Female; Culture; Drug Costs; Drug Implants; Female; Humans; Levonorgestrel; Middle Aged; Parity; Pregnancy; Prospective Studies; Time Factors | 1997 |
Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Retrospective Studies | 1998 |
Endothelin receptor expression in human decidua.
Topics: Abortion, Induced; Biopsy; Collagen; Decidua; Female; Humans; Laminin; Levonorgestrel; Ligands; Menorrhagia; Norethindrone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Progesterone Congeners; Receptors, Endothelin | 1998 |
Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
Topics: Adult; Choriocarcinoma; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Contraceptive Agents, Female; Drug Implants; Female; Fluorescent Antibody Technique; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Time Factors; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms | 1998 |
In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments.
Topics: Abnormalities, Drug-Induced; Animals; Cells, Cultured; Contraceptives, Oral, Synthetic; Drug Delivery Systems; Female; Levonorgestrel; Norethindrone; Nylons; Pregnancy; Rats; Rats, Wistar | 1998 |
Norplant selection and satisfaction among low-income women.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Family Planning Services; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Patient Acceptance of Health Care; Patient Satisfaction; Poverty; Pregnancy | 1998 |
Depot medroxyprogesterone acetate (Depo-Provera) and levonorgestrel (Norplant) use in adolescents among clinicians in Northern Europe and the United States.
Topics: Adolescent; Adolescent Health Services; Adult; Attitude of Health Personnel; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Prescriptions; Europe; Female; Health Care Surveys; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Patient Compliance; Practice Patterns, Physicians'; Pregnancy; Pregnancy in Adolescence; United States | 1998 |
Ectopic pregnancy with levonorgestrel releasing intrauterine system.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Tubal; Pregnancy, Unwanted | 1998 |
Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers.
Topics: Adolescent; Adolescent Behavior; Contraception Behavior; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unwanted; Risk Factors; Time Factors | 1998 |
[Newest contraceptive agents].
Topics: Contraceptives, Oral, Synthetic; Family Planning Services; Female; Humans; Levonorgestrel; Pregnancy | 1998 |
Pregnancy while using Norplant.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Progesterone Congeners | 1998 |
The introduction and use of Norplant implants in Indonesia.
Topics: Adolescent; Adult; Developing Countries; Family Planning Services; Female; Humans; Indonesia; Levonorgestrel; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Quality Assurance, Health Care; Rural Population | 1998 |
Norplant as a contraceptive device in Enugu, eastern Nigeria.
Topics: Age Distribution; Chi-Square Distribution; Choice Behavior; Contraceptive Agents, Female; Cross-Sectional Studies; Educational Status; Female; Humans; Intrauterine Devices; Levonorgestrel; Nigeria; Parity; Patient Acceptance of Health Care; Pregnancy; Retrospective Studies; Statistics, Nonparametric | 1998 |
Self-administering emergency hormonal contraception.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Emergency Medical Services; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Unwanted; Prospective Studies; Randomized Controlled Trials as Topic; Scotland; Self Administration | 1998 |
Combined oral contraceptives versus levonorgestrel for emergency contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Emergencies; Female; Humans; Levonorgestrel; Pregnancy; Research Design | 1998 |
Norplant utilization in a Latina inner-city population.
Topics: Caribbean Region; Contraceptive Agents, Female; Drug Implants; Drug Utilization; Emigration and Immigration; Female; Health Knowledge, Attitudes, Practice; Hispanic or Latino; Humans; Levonorgestrel; Life Tables; Massachusetts; Patient Acceptance of Health Care; Pregnancy; Survival Analysis; Urban Population | 1999 |
Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation.
Topics: Bias; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Pregnancy; Randomized Controlled Trials as Topic; Time Factors | 1999 |
Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel.
Topics: Adult; Biopsy; Collagenases; Decidua; Endometrium; Female; Homeostasis; Humans; Levonorgestrel; Matrix Metalloproteinase 9; Menstrual Cycle; Middle Aged; Placenta; Pregnancy; Progesterone Congeners; Uterus | 1999 |
Comparison of continuation rates for hormonal contraception among adolescents.
Topics: Adolescent; Adolescent Behavior; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mothers; Patient Compliance; Pregnancy; Pregnancy in Adolescence; Psychology, Adolescent; Retrospective Studies; Survival Analysis | 1999 |
Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany.
Topics: Adolescent; Adult; Aged; Child; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Patient Satisfaction; Pregnancy | 1999 |
Safety and effectiveness of hormonal postcoital contraception: a prospective study.
Topics: Adolescent; Adult; Child; Coitus; Contraception; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Emergency Service, Hospital; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Spain; Treatment Outcome | 1999 |
[Pregnancy and hormone replacement therapy in a patient with resistant ovary syndrome].
Topics: Adult; Amenorrhea; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Infertility, Female; Levonorgestrel; Pregnancy; Pregnancy Outcome; Primary Ovarian Insufficiency | 1999 |
[Norplant: a 3-year experience of the National Institute of Perinatology in Mexico].
Topics: Adolescent; Adult; Contraception; Contraceptive Agents; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Mexico; Pregnancy | 1999 |
Efficacy and continuation rates of Norplant in Pakistan.
Topics: Adult; Age Factors; Body Weight; Contraceptive Agents, Female; Educational Status; Employment; Female; Follow-Up Studies; Humans; Levonorgestrel; Middle Aged; Pakistan; Parity; Patient Satisfaction; Pregnancy; Pregnancy Rate | 1999 |
The role of matching menstrual data with hormonal measurements in evaluating effectiveness of postcoital contraception.
Topics: Contraceptives, Postcoital, Hormonal; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Pregnancy; Progesterone; Prospective Studies | 1999 |
Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users.
Topics: Adult; Aged; Analysis of Variance; Contraception Behavior; Female; Finland; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Unwanted; Proportional Hazards Models; Reproductive Medicine; Time Factors; Uterine Hemorrhage; Weight Gain | 2000 |
Modern approaches to management of menorrhagia.
Topics: Adult; Endometrium; Female; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Patient Education as Topic; Pregnancy; Randomized Controlled Trials as Topic | 2000 |
Synthesis and biological activity of a new progestogen, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3, 20-dione acetate.
Topics: Animals; Biological Assay; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Endometrium; Female; Levonorgestrel; Male; Norprogesterones; Pregnancy; Pregnancy Maintenance; Progesterone; Progesterone Congeners; Rabbits; Rats; Rats, Sprague-Dawley | 2000 |
Emergency contraception with levonorgestrel: one hormone better than two.
Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Drug Administration Schedule; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Pregnancy, Unwanted; Randomized Controlled Trials as Topic | 2000 |
The timing of norplant insertion and postpartum depression in teenagers.
Topics: Adolescent; Analysis of Variance; Contraceptive Agents, Female; Depression; Depression, Postpartum; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Prevalence; Psychiatric Status Rating Scales; Risk Factors; Social Support; Time Factors | 2000 |
[Pruritus during treatment with an estrogen-gestagen combination].
Topics: Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Middle Aged; Pregnancy; Progesterone Congeners; Pruritus; Time Factors | 2000 |
Emergency contraception in clinical practice: global perspectives.
Topics: Adolescent; Adult; Contraception; Contraceptives, Postcoital; Female; Gonadotropin-Releasing Hormone; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices; Levonorgestrel; Male; Mifepristone; Patient Compliance; Pregnancy; Pregnancy, Unwanted; Random Allocation; Sex Education | 2000 |
Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. United Nations Development Programme/ United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Re
Topics: Adult; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Menstruation Disturbances; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2000 |
Clinical performance of the levonorgestrel intra-uterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 12-month report.
Topics: Abortion, Spontaneous; Adolescent; Adult; Age Distribution; Family Planning Services; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy Outcome; Pregnancy Rate; United Kingdom | 2000 |
Informed consent for postfertilization effects of hormonal and surgical forms of birth control for women.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Embryo Implantation; Female; Fertilization; Humans; Informed Consent; Levonorgestrel; Ovulation; Pregnancy; Pregnancy, Ectopic | 2000 |
[Sonographic demonstration of a levonorgestrel-releasing IUD (Mirena)].
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pelvic Inflammatory Disease; Pregnancy; Ultrasonography | 1999 |
Birth control method choice and use of barrier methods for sexually transmitted disease prevention among low-income African-American women.
Topics: Adolescent; Adult; Alabama; Black or African American; Contraception; Contraceptive Devices, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Male; Medroxyprogesterone Acetate; Parity; Pregnancy; Sexual Behavior; Sexually Transmitted Diseases; Socioeconomic Factors; Sterilization, Tubal | 2000 |
Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception.
Topics: Activins; Blotting, Northern; Contraceptive Agents, Female; Endometrium; Female; Gene Expression Profiling; Humans; Immunoenzyme Techniques; In Situ Hybridization; Inhibins; Leukocytes; Levonorgestrel; Longitudinal Studies; Menstrual Cycle; Pregnancy; Progesterone Congeners; Prostatic Secretory Proteins | 2000 |
Contraceptive effects of levonorgestrel implants in a marsupial.
Topics: Animals; Contraception; Contraceptive Agents, Female; Drug Implants; Female; Lactation; Levonorgestrel; Macropodidae; Pregnancy; Reproduction; Seasons | 2000 |
Pregnancy in premature ovarian failure: a possible role of estrogen plus progesterone treatment.
Topics: Adult; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Primary Ovarian Insufficiency; Progesterone Congeners | 2000 |
Contraceptive implant matches effect of IUDs and sterilisation.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Sterilization, Tubal | 2001 |
Appeal court bans use of emergency contraceptive in Chile.
Topics: Abortion, Criminal; Abortion, Induced; Chile; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Pregnancy | 2001 |
Adverse reactions and emergency contraception.
Topics: Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Pregnancy | 2001 |
Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
Topics: Abdominal Pain; Adult; Breast Neoplasms; Contraceptive Agents, Female; Developing Countries; Drug Implants; Female; Fertility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Marital Status; Ovarian Cysts; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Prospective Studies; Sterilization, Tubal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vaginal Discharge; Vaginitis | 2001 |
Post-marketing surveillance of Norplant((R)) contraceptive implants: II. Non-reproductive health(1).
Topics: Accidents; Adult; Bone Diseases; Cardiovascular Diseases; Cohort Studies; Connective Tissue Diseases; Contraceptive Agents, Female; Developing Countries; Drug Implants; Endocrine System Diseases; Female; Gallbladder Diseases; Headache; Homicide; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mental Disorders; Muscular Diseases; Neoplasms; Nervous System Diseases; Pregnancy; Product Surveillance, Postmarketing; Respiratory Tract Diseases; Skin Diseases; Sterilization, Tubal; Suicide; Urologic Diseases | 2001 |
Postmarketing surveillance study of Norplant in developing countries.
Topics: Developing Countries; Female; Humans; Levonorgestrel; Population Control; Pregnancy; Product Surveillance, Postmarketing | 2001 |
A village would be nice but...it takes a long-acting contraceptive to prevent repeat adolescent pregnancies.
Topics: Adolescent; Adolescent Health Services; Colorado; Community Participation; Comprehensive Health Care; Family Planning Services; Female; Follow-Up Studies; Health Services Research; Humans; Levonorgestrel; Logistic Models; Maternal Health Services; Patient Care Team; Predictive Value of Tests; Pregnancy; Pregnancy in Adolescence; Program Evaluation; Recurrence | 2001 |
Faculty of Family Planning and Reproductive Health Care. Royal College of Obstetricians and Gynaecologists. Guidance April 2000. Emergency contraception: recommendations for clinical practice.
Topics: Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pregnancy | 2000 |
Levonorgestrel intrauterine device: new preparation. An alternative.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Copper; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Pregnancy; Pregnancy, Ectopic; Progesterone Congeners; Treatment Outcome | 1999 |
The need for more active promotion of emergency contraception.
Topics: Contraceptive Agents, Female; Contraceptives, Postcoital; Emergency Treatment; Female; Health Services Accessibility; Health Services Needs and Demand; Humans; Levonorgestrel; Pregnancy | 2001 |
Young women requesting emergency contraception are, despite contraceptive counseling, a high risk group for new unintended pregnancies.
Topics: Adolescent; Adult; Contraceptives, Postcoital, Synthetic; Counseling; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Risk Factors; Sweden; Time Factors; Treatment Outcome | 2001 |
Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Blood Specimen Collection; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Regression Analysis; Time Factors | 2001 |
The Norplant condition: protecting the unborn or violating fundamental rights?
Topics: California; Child Abuse; Civil Rights; Coercion; Contraception; Fathers; Hormones; Humans; Judicial Role; Jurisprudence; Levonorgestrel; Liability, Legal; Mothers; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Privacy; Punishment; Reproduction; Risk; Risk Assessment; State Government; Substance-Related Disorders; United States | 1992 |
Crime, race, and reproduction.
Topics: Black or African American; Civil Rights; Coercion; Contraception; Criminal Law; Eugenics; Federal Government; Female; Genetics, Behavioral; Government; History; Humans; Jurisprudence; Law Enforcement; Levonorgestrel; Liability, Legal; Pregnancy; Pregnant Women; Prejudice; Prenatal Exposure Delayed Effects; Punishment; Reproduction; Social Control, Formal; Social Problems; Socioeconomic Factors; State Government; Sterilization, Involuntary; Substance-Related Disorders; United States; Vulnerable Populations; Women | 1993 |
Norplant meets the new eugenicists: the impermissibility of coerced contraception.
Topics: California; Child Abuse; Civil Rights; Coercion; Contraception; Eugenics; Female; Freedom; Hormones; Humans; Informed Consent; Judicial Role; Jurisprudence; Legislation as Topic; Levonorgestrel; Mandatory Programs; Medicaid; Minority Groups; Mothers; Motivation; Personal Autonomy; Pharmaceutical Preparations; Poverty; Pregnancy; Pregnant Women; Prejudice; Prenatal Exposure Delayed Effects; Privacy; Punishment; Reproduction; Risk; Risk Assessment; Socioeconomic Factors; State Government; Sterilization, Involuntary; Substance-Related Disorders; United States; Vulnerable Populations; Women; Women's Rights | 1992 |
The Norplant condition: one step forward or two steps back?
Topics: Black or African American; California; Child Abuse; Civil Rights; Coercion; Contraception; Female; Fetus; Freedom; Hormones; Humans; Jurisprudence; Law Enforcement; Levonorgestrel; Minority Groups; Personal Autonomy; Pharmaceutical Preparations; Poverty; Pregnancy; Pregnant Women; Prejudice; Privacy; Punishment; Rehabilitation; Reproduction; Social Control, Formal; Treatment Refusal; United States; Women | 1993 |
Reproductive freedoms and African American women.
Topics: Abortion, Induced; Adolescent; Black or African American; Civil Rights; Coercion; Contraception; Counseling; Decision Making; Family Planning Services; Federal Government; Female; Financing, Government; Freedom; Government; Hazardous Substances; Human Experimentation; Humans; Infant; Informed Consent; Jurisprudence; Labor, Obstetric; Levonorgestrel; Medicaid; Minors; Mortality; Motivation; Occupational Exposure; Parent-Child Relations; Poverty; Pregnancy; Pregnant Women; Reproduction; Reproductive Techniques, Assisted; State Government; Sterilization, Reproductive; Supreme Court Decisions; Surrogate Mothers; United States; Women; Women's Health; Women's Health Services; Women's Rights | 1992 |
Class, race, and poverty: medical technologies and socio-political choices.
Topics: Abortion, Induced; Black or African American; Civil Rights; Coercion; Contraception; Deception; Education, Medical; Eugenics; Federal Government; Female; Financing, Government; General Surgery; Government; History; History, 18th Century; History, 19th Century; History, 20th Century; Hospitals, Public; Human Experimentation; Humans; Immunization; Informed Consent; Jurisprudence; Levonorgestrel; Men; Minority Groups; Paternalism; Patient Selection; Patients; Pharmaceutical Preparations; Physicians; Pregnancy; Pregnant Women; Prejudice; Professional Misconduct; Public Policy; Reproduction; Research Personnel; Research Subjects; Schools, Medical; Scientific Misconduct; Sex Offenses; Sexuality; Socioeconomic Factors; Southeastern United States; Sterilization, Involuntary; Substance-Related Disorders; Syphilis; United States; Vulnerable Populations; Withholding Treatment; Women; Women's Health Services | 1994 |
The creation and perpetuation of the mother/body myth: judicial and legislative enlistment of Norplant.
Topics: Black or African American; Child Abuse; Coercion; Contraception; Criminal Law; Equipment and Supplies; Female; History; Hormones; Humans; Informed Consent; Judicial Role; Jurisprudence; Legislation as Topic; Levonorgestrel; Mandatory Programs; Minority Groups; Mothers; Motivation; Persons with Mental Disabilities; Poverty; Pregnancy; Pregnant Women; Punishment; Reproduction; Risk; Risk Assessment; Single Person; Social Control, Formal; Socioeconomic Factors; State Government; Stereotyping; Sterilization, Involuntary; United States; Women | 1993 |
Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods.
Topics: Abortion, Induced; Adult; Aftercare; Cohort Studies; Coitus Interruptus; Contraception Behavior; Drug Implants; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction; Pregnancy; Sexual Abstinence; Time Factors; Turkey | 2001 |
Use of the equivalence approach in reproductive health clinical trials.
Topics: Confidence Intervals; Contraception; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Levonorgestrel; Misoprostol; Oxytocics; Pregnancy; Prenatal Care; Randomized Controlled Trials as Topic; Reproductive Medicine; Sample Size; Statistics as Topic; Therapeutic Equivalency; Uterine Hemorrhage | 2001 |
Failed cervical pregnancy with levonorgestrel containing intrauterine contraceptive device.
Topics: Adult; Cervix Uteri; Contraception; Dilatation and Curettage; Endosonography; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy, Ectopic; Risk Assessment; Treatment Outcome | 2002 |
Decisions for Norplant programs.
Topics: Contraceptive Agents, Female; Counseling; Developing Countries; Drug Implants; Family Planning Services; Female; Health Personnel; Humans; Levonorgestrel; Pregnancy | 1992 |
Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Topics: Adult; Age Factors; Capsules; Copper; Drug Delivery Systems; Drug Implants; Family Planning Services; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Parity; Pregnancy; Pregnancy Outcome | 1992 |
Acceptability of Norplant implants for fertility regulation in Singapore.
Topics: Adult; Drug Implants; Female; Fertility; Follow-Up Studies; Humans; Levonorgestrel; Patient Satisfaction; Pregnancy | 1992 |
Innovations in contraception: the Norplant system.
Topics: Adult; Counseling; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Patient Education as Topic; Pregnancy; Pregnancy, Ectopic | 1992 |
The problem of indigent children: shutting off the supply.
Topics: Adolescent; Child; Delayed-Action Preparations; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Poverty; Pregnancy | 1992 |
Emergency contraception.
Topics: Contraceptives, Postcoital; Emergencies; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Menstrual Cycle; Pregnancy; Referral and Consultation | 1991 |
The significance of bleeding patterns in Norplant implant users.
Topics: Contraceptive Agents, Female; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Pregnancy; Time Factors | 1991 |
A subdermal progestin implant for long-term contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1991 |
Obstetrics and gynecology.
Topics: Contraceptive Agents, Female; Female; Fertilization in Vitro; Gynecology; Humans; Infant, Newborn; Levonorgestrel; Norgestrel; Obstetrics; Pregnancy; Respiratory Distress Syndrome, Newborn | 1991 |
Contraceptive implants.
Topics: Adolescent; Adult; Capsules; Cervix Mucus; Contraceptive Agents, Female; Drug Implants; Equipment Design; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Progestins; Risk Factors | 1991 |
A subdermal progestin implant for long-term contraception. The Medical Letter.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1991 |
Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Hormonal; Cytoplasm; Desogestrel; Female; Humans; Kinetics; Levonorgestrel; Male; Norgestrel; Norpregnenes; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Transcortin; Uterus | 1990 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first two years of use.
Topics: Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Patient Compliance; Pelvic Inflammatory Disease; Pregnancy | 1989 |
Fertility control in female white-tailed deer.
Topics: Animals; Contraception; Contraceptive Agents, Female; Deer; Drug Implants; Female; Fertility; Labor, Obstetric; Levonorgestrel; Melengestrol Acetate; Norgestrel; Pregnadienes; Pregnancy | 1989 |
[Initial experiences with a levonorgestrel-ethinyl estradiol combination for interception].
Topics: Adolescent; Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Pregnancy; Progesterone; Prospective Studies | 1989 |
[Long-term follow-up of women treated with contraceptive implants of levonorgestrel Norplant].
Topics: Adult; Contraceptives, Oral, Combined; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1989 |
Contraceptives: a look at the future.
Topics: Abortifacient Agents; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Implants; Female; Forecasting; Humans; Injections; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel; Pregnancy | 1989 |
Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
Topics: Binding, Competitive; Desogestrel; Female; Humans; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnancy; Pregnancy Trimester, Third; Sex Hormone-Binding Globulin; Testosterone | 1989 |
Pulsatile ovarian fossa ectopic and the 'morning after' pill.
Topics: Adult; Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Ovary; Pregnancy; Pregnancy, Ectopic | 1989 |
[Impetigo herpetiformis].
Topics: Adult; Biopsy; Contraceptives, Oral, Combined; Cysts; Dermatitis Herpetiformis; Drug Eruptions; Ethinyl Estradiol; Etretinate; Female; HLA Antigens; HLA-C Antigens; Humans; Impetigo; Levonorgestrel; Norgestrel; Prednisolone; Pregnancy; Pregnancy Complications, Infectious; Skin; Splenic Rupture | 1988 |
Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
Topics: Abortion, Induced; Administration, Intravaginal; Adult; Age Factors; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norgestrel; Parity; Pregnancy; Time Factors | 1988 |
Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.
Topics: Animals; Contraceptive Agents, Female; Decidua; Drug Combinations; Drug Implants; Endometrium; Estradiol; Female; Hydatidiform Mole, Invasive; Levonorgestrel; Male; Mice; Mice, Nude; Microscopy, Electron; Norgestrel; Ovary; Polyps; Pregnancy; Rabbits; Silicone Elastomers; Spleen; Uterine Neoplasms; Uterus | 1987 |
Influence of pregnancy, oophorectomy and contraceptive steroids on gall bladder concentrating function and hepatic bile flow in the cat.
Topics: Absorption; Animals; Bile; Body Water; Cats; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Gallbladder; Levonorgestrel; Norethindrone; Norgestrel; Ovariectomy; Pregnancy; Pregnancy, Animal; Prolactin; Stereoisomerism | 1986 |
Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants.
Topics: Adult; Drug Interactions; Epilepsy; Female; Humans; Kinetics; Levonorgestrel; Menstruation; Norgestrel; Ovulation; Phenytoin; Pregnancy; Sex Hormone-Binding Globulin | 1986 |
Bleeding pattern, outcome of accidental pregnancies and levonorgestrel plasma levels associated with method failure in Norplant implants users.
Topics: Abortion, Spontaneous; Female; Humans; Infant, Newborn; Levonorgestrel; Male; Menstruation; Norgestrel; Pregnancy; Pregnancy, Ectopic | 1986 |
Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
Topics: Adult; Anticonvulsants; Drug Implants; Drug Interactions; Epilepsy; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy | 1986 |
Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their breast-fed
Topics: Administration, Oral; Adult; Breast Feeding; Female; Follicle Stimulating Hormone; Humans; Infant; Infant, Newborn; Injections, Intradermal; Kinetics; Lactation; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Pregnancy; Testosterone | 1986 |
Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |
Effect of Norplant on mothers and infants in the postpartum period.
Topics: Adult; Child Development; Contraceptive Agents, Female; Female; Humans; Infant; Intrauterine Devices, Copper; Lactation; Levonorgestrel; Norgestrel; Pregnancy | 1986 |
Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
Topics: Adult; Blood Glucose; Cholesterol; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |
Five-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Age Factors; Blood Pressure; Body Weight; Egypt; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Uterine Hemorrhage | 1987 |
Recovery of fertility and outcome of planned pregnancies after the removal of Norplant subdermal implants or Copper-T IUDs.
Topics: Age Factors; Female; Fertility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pregnancy; Probability; Time Factors | 1987 |
Postcoital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle. Task Force on Post-ovulatory Methods for Fertility Regulation.
Topics: Adult; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Evaluation; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Ovulation; Pregnancy | 1987 |
Pregnancy after removal of Norplant implants contraceptive.
Topics: Adult; Age Factors; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy | 1987 |
Five-year experience with Norplant.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Pregnancy | 1987 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
Topics: Adult; Carbamazepine; Cervix Uteri; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1987 |
Effective interception with the levonorgestrel-20-IUD contrarily to WHO advocated Lng-2-microdose IUD.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pregnancy; World Health Organization | 1988 |
[A comparative study on the antifertility action of levonorgestrel oxime and levonorgestrel].
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Combinations; Embryo Implantation; Endometrium; Female; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism | 1988 |
A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China.
Topics: Adolescent; Adult; Cardiovascular System; China; Contraceptive Agents, Female; Drug Evaluation, Preclinical; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Platelet Count; Pregnancy | 1988 |
Phase III-clinical trial with Norplant-2 (covered rods). Report of a 24-month study. National Programme of Research in Human Reproduction. Division of Human Resource Development Research Indian Council of Medical Research Ansari Nagar, New Delhi, India.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy | 1988 |
"Free levonorgestrel index" (FLI) is a better parameter than plasma level of levonorgestrel for predicting risk of pregnancy during use of subdermal contraceptive implants releasing levonorgestrel.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Norgestrel; Predictive Value of Tests; Pregnancy; Risk Factors | 1988 |
Effects of antifertility estrogens and progestins on the endometrial surface of early pregnant rats. A scanning electron microscopic study.
Topics: Animals; Contraceptives, Oral, Combined; Endometrium; Estriol; Estrogens; Female; Levonorgestrel; Mestranol; Microscopy, Electron, Scanning; Microvilli; Nandrolone; Norgestrel; Pregnancy; Pregnancy, Animal; Progestins; Rats; Rats, Inbred Strains | 1985 |
Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Levonorgestrel; Lipids; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1985 |
Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants.
Topics: Adult; Breast Feeding; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Infant; Infant, Newborn; Levonorgestrel; Norgestrel; Postpartum Period; Pregnancy | 1985 |
[Influence of Norplant contraceptive implants on lactation and infant growth].
Topics: Body Weight; Breast Feeding; Female; Growth; Humans; Infant; Infant, Newborn; Intrauterine Devices, Copper; Lactation; Levonorgestrel; Male; Milk, Human; Norgestrel; Pregnancy | 1985 |